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ABSTRACT 
 
Medical applications of technical textiles are an expanding field of research. One of the 
added values of these new materials would be that they were suitable to contain and 
release pharmaceutical and cosmetic active compounds in a controlled and sustained 
manner. 
 
Drug incorporation and release from synthetic fibers is related to the interaction of the 
drug with the polymer and greatly depends on the surface chemistry of the fiber. 
Plasma technology is a tool that enables to modify physical and chemical properties of 
the first nanometers of the surface of the fibres without affecting the bulk of the 
material. Applied to the medical textile field, plasma treatment of polymer fibres could 
lead to the design of new textile-based drug delivery systems.  
 
The novelty of this PhD. Thesis rests upon the modification of the drug/fiber 
interactions by plasma treatment to allow the modulation of the loading and the 
release of active principles (pharmaceutics and cosmetics) from the textile-based drug 
delivery systems, without requiring the use of any further chemicals.  
 
 
Figure 1: Proposed modulation of the drug release kinetics from synthetic fibers to an isotonic media 
using plasma treatment to modify chemical and topographical properties of the fibre surface previous 
to loading of active principles in the fibres. 
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This PhD. Thesis aims at the development of two families of textile-based drug delivery 
systems, based on a novel surface functionalization by plasma treatment, with suitable 
characteristics for topical use as medical devices, or for clinical application in soft 
tissue repair. It is therefore organized in two distinct parts.  
 
In both parts of this thesis a general scheme has been followed: we have investigated 
the surface modification of textile materials with different types of plasmas 
(atmospheric and low pressure plasma), characterizing the surface modifications 
achieved by different complementary techniques. The effects of the plasma treatment 
have been evaluated on the subsequent incorporation of active pharmaceuticals or 
cosmetics. In the last step, the drug release has been studied by “in-vitro” dissolution 
assays.  
 
The first part is focused on medical textiles for topical application. Therein, the surface 
modification of polyamide 66 elastic-compressive knitted fabrics has been studied by 
corona plasma and low pressure plasma. The experimental work has studied in parallel 
laboratory prepared fabrics and industrially finished fabrics, with views on the 
potential implementation of the proposed process in the textile industrial chain. 
Plasma treatment improved the release kinetics of anti-inflammatory pharmaceutic 
(ketoprofen) and of lipolitic cosmetic (caffeine) active principles, loaded in the plasma-
treated polyamide 66 fabrics. A fundamental study comparing three different 
molecules of the same chemical family (caffeine, theobromine and pentoxifylline) has 
been performed measuring their loading to the textile material and the subsequent 
release of the drugs.  
The second part focuses on textiles used as implants for soft tissue repair (e.g. hernia). 
The fiber surface of a polypropylene mesh, clinically approved for surgical use, has 
been modified by corona plasma and low-pressure plasma. The treatments evaluated 
had a major effect on the loading of antibiotic (ampicillin), presenting an important 
increase of the active principle loaded. Release kinetics of the ampicillin from the 
polypropylene meshes to an isotonic liquid media was very fast. The effect of coating 
the ampillicin-loaded polypropylene meshes by plasma polymerization with a 
biocompatible polymer was also investigated.   
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RESUMEN 
 
Las aplicaciones médicas de los textiles técnicos son un campo de investigación en 
expansión. Uno de los valores añadidos de estos nuevos materiales puede ser su 
capacidad para contener y liberar principios activos farmacéuticos y cosméticos de una 
forma controlada y sostenida. 
La incorporación de fármacos y su liberación a partir de fibras sintéticas está 
relacionada con la interacción del fármaco con el polímero y puede depender en gran 
medida de la química de superficie de la fibra. La tecnología de plasma es una 
herramienta que permite modificar las propiedades físicas y químicas de los primero 
nanómetros de la superficie de las fibras sin afectar el interior del material. Aplicado al 
campo de los textiles médicos, el tratamiento con plasma de fibras poliméricas podría 
conducir al diseño de nuevos sistemas de liberación de fármacos basados en soportes 
textiles. 
La novedad de esta Tesis Doctoral se basa en la modificación de las interacciones 
fármaco / fibra por tratamiento de plasma para permitir la modulación de la 
incorporación y la liberación de los principios activos (farmacéuticos y cosméticos) a 
partir de sistemas de administración de fármacos basados en material textil, sin 
requerir el uso de productos químicos adicionales. 
 
Figura 1: Propuesta de modulación de la cinética de liberación del fármaco a partir de fibras sintéticas 
a un medio isotónico usando tratamiento de plasma para modificar las propiedades químicas y 
topográficas de la superficie de la fibra antes de la incorporación del principio activo a la fibra. 
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Esta Tesis tiene como objetivo el desarrollo de dos familias de sistemas de liberación 
de fármacos basados en soportes textiles, por funcionalización de la superficie 
mediante tratamiento de plasma, con características adecuadas bien para uso tópico 
como dispositivos médicos, bien para aplicación clínica en la reparación de tejidos 
blandos. Por tanto, esta Tesis se organiza en dos partes bien diferenciadas. 
 
En ambas partes de esta Tesis se ha seguido el siguiente esquema general: en primer 
lugar se ha investigado primero la modificación superficial de los materiales textiles 
con diferentes tipos de plasmas (plasma corona y plasma de presión atmosférica), 
caracterizando las modificaciones de la superficie obtenidas mediante diferentes 
técnicas instrumentales. Los efectos del tratamiento con plasma se han evaluado 
entonces sobre la incorporación de principios activos farmacéuticos o cosméticos. En 
el último paso, se ha estudiado la liberación del fármaco mediante ensayos de 
disolución "in vitro". 
 
La primera parte de la Tesis Doctoral se centra en los textiles médicos para aplicación 
tópica. Para ello, se ha estudiado la modificación de la superficie de tejidos de punto 
elástico-compresivos de poliamida 66 con plasma corona y plasma de baja presión. En 
este trabajo experimental se han estudiado en paralelo tejidos preparados en 
laboratorio y tejidos industrialmente acabados, con vistas a la posible implementación 
del proceso propuesto en la cadena de producción industrial textil. Se ha observado 
que el tratamiento con plasma mejora la cinética de liberación de un fármaco anti-
inflamatorio (ketoprofeno) y de un principio activo cosmético lipolítico (cafeína), 
incorporados en los tejidos de poliamida 66 tratados con plasma. Se ha desarrollado 
un estudio fundamental comparando tres moléculas diferentes de la misma familia 
química (cafeína, teobromina y pentoxifilina) con respecto a la incorporación al 
material textil y a la liberación del principio activo. 
 
La segunda parte se centra en los textiles utilizados como implantes para la reparación 
de tejidos blandos (por ejemplo, hernias abdominales). La superficie de la fibra de una 
malla de polipropileno approvada para su uso clínico ha sido modificada por el plasma 
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corona y plasma de baja presión. Los tratamientos estudiados tuvieron un efecto 
importante sobre la carga de un antibiótico (ampicilina) mostrando un importante 
incremento del porcentaje de impregnación. La cinética de liberación in vitro del 
antibiótico de la malla de polipropileno a un medio líquido isotonico fue rápida. 
También se investigó la posibilidad de realizar un recubrimiento de la malla de 
polipropileno cargada con ampicilina mediante polimerización por plasma con un 
polímero biocompatible. 
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1. INTRODUCTION 
 
1.1. Technical textiles 
 
Technical textiles include all those textile-based products which are mainly used for 
their performance or functional characteristics rather than for their aesthetics, and 
that can be used for non-consumer (i.e. industrial) applications. The definition includes 
from finished products to textile components of other products. Thus, the definition 
does not depend on the textile material used (yarn or fibre), but on the end-use of the 
product itself. 
 
An outstanding feature of the technical textiles industry is the range and diversity of 
raw materials, processes, products and applications. Indeed, the growth of the sector 
is closely linked to the development of science and research, which has allowed finding 
numerous new applications for textiles. 
 
Technical textiles have been developed thanks to key innovations in new textile fibres, 
textile material processing, production processes and final products. Therefore, their 
diversity renders difficult to identify them as they are very often mixed with other 
materials, are part of a product or used as a semi-product, all of these in different 
economic sectors or activities. Technical textiles are today being used in a wide range 
of industries such as aeronautics, construction, automotive, agriculture, cosmetics, 
pharmaceutics and even the sport industry. 
 
According to the TECHTEXTIL classification, technical textiles are classified into 12 
categories: 
- AGROTECH (Textile products for agriculture, horticulture, aquaculture, forestry, 
gardening, landscaping, and forestry applications.)      
- BUILDTECH (Textile products for architectural structures, and construction. 
Membrane construction, lightweight construction, solid and hydraulic 
earthworks, road construction.)      
Introduction 
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- CLOTHTECH (Textile products with technical components for footwear and 
clothing.) 
- GEOTECH (Geotextiles and civil engineering textile materials. Used for Public 
Construction, construction of dikes or landfill construction.)                         
- HOMETECH   (Technical components of tapestry, carpets, and home textiles.) 
- INDUTECH (Textiles for industrial applications: filtration, conveyor belts, 
cleaning, etc.) 
- MEDTECH (Textile products for medical applications and hygiene.) 
- MOBILTECH (Textile products for automotive, boats, trains, planes and 
satellites.)     
- OEKOTECH (Textiles for environmental protection applications, recycling and 
waste disposal.)   
- PACKTECH (Textile Materials for packaging and transportation.) 
- PROTECH (Textile products for personal and property protection.) 
- SPORTTECH (Textile products for sports, leisure and entertainment industry.) 
 
 
1.1.1. Medical textiles  
 
Medical textiles are used in different areas of medicine and pharmaceutical technology 
as sanitary materials (bandages, dressings, surgical clothing, patches, etc.) or as 
implants. Materials used include monofilament and multifilament yarns, woven, 
knitted, and nonwoven fabrics, and composite structures. The number of applications 
is huge and diverse, ranging from a bio-absorbable single thread suture to the complex 
composite structures for bone replacement, and from a simple cleaning wipe for 
wound hygiene to advanced barrier fabrics used in operating rooms. These materials 
can be categorized into four separate and specialized areas of application as follows 
(Figure 2): 
 
 Non-implantable materials: wound dressings, bandages, plasters, etc. 
 Extracorporeal devices: artificial kidney, liver, and lung 
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 Implantable materials: sutures, vascular grafts, artificial ligaments, artificial 
joints, etc. 
 Healthcare/hygiene products:  bedding, clothing, surgical gowns, cloths, wipes, 
etc. 
 
In this PhD. Thesis the study has been focused on two kinds of medical textile: non-
implantable textile materials for topical application and implantable textile materials 
for hernia repair respectively.  
 
Figure 2: Textile materials and products include non-implantable materials (a), implantable materials 
(b) and healthcare and hygiene products (c). 
 
The MEDTECH market is forecasted to grow at 4.5 percent per year between 2011 and 
2018, to reach $455 billion, according to the EvaluateMedTech™ World Preview 2018, 
reported at the AdvaMed 2012 conference taking place in Boston, October 1-3 (Figure 
3). This growth will outpace the global prescription drug market, which is expected to 
grow 2.5 percent per year between 2011 and 2018. Global worldwide MEDTECH R&D 
spends set also to grow by 3.9% to $ 26.7 billion by 2018. In-vitro diagnostics is 
expected to be the largest MEDTECH segment in 2018, with sales of $58.8 billion. 
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Figure 3: Medical textiles industry trends from the EvaluateMedTech™ World Preview 2018 report. 
 
Therefore, this PhD. Thesis is focused on an area of interest not only from the scientific 
point of view but also from the applied market perspective. 
 
1.1.2.  Cosmetotextiles 
 
Cosmetotextiles are a branch of the medical textiles (MEDTECH) and are also a growing 
trend in the world, with promising developments. A cosmetotextile, consequence of 
the fusion of cosmetics and the textile industry through various techniques, is a textile 
consumer article containing a durable cosmetic substrate which is released over a 
certain time. A cosmetotextile is a textile containing a cosmetic preparation mainly for 
dermatology applications such as moisturizing, anti-aging, anti-cellulite, or slimming, 
designed for aesthetic skin conditions. Cosmetotextiles can be considered as cosmetic 
textiles when the cosmetic ingredients linked onto the textiles have to be transferred 
to the wearer’s skin, and the amounts transferred have to be enough to ensure that 
cosmetic benefits are possible (Singh, 2011). 
 
Until today, commercialized cosmetotextiles are usually based on finished fabrics with 
microcapsules containing the cosmetic active principle. The preparation of such active 
nano- or micro-capsules is generally based on the encapsulation of active molecules by 
a polymer matrix (particles or capsules) and deposited or fixed on the fiber. The textile 
functionalization described in literature mainly rests upon the immobilization or 
impregnation of textile fibers by microcapsules containing drugs, or upon hollow fibres 
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containing microcapsules in the nano- or micro-channels, methods in which the 
release of the drug is then due to the physical degradation of the polymer matrix or via 
molecular diffusion processes (Singh, 2011). In this PhD. Thesis, the loading of the 
active ingredients in the fiber does not involve any encapsulation technique and the 
active molecules have been directly loaded to the textile fiber after previous 
modification of surface fibre by plasma treatment, being this process the novelty of 
the work. 
 
Impregnated textiles and/or chemically grafted textiles allowing the release of active 
molecules have been developed since the 1990s’. The first cosmetotextiles include 
hygiene and/or maintenance wipes, bactericide and insecticide drapery and bedding 
containing essential oils, perfumes, etc. (Nelson, 2002; Kukovic, 1996). Applications 
combining clothes and cosmetics have been added to this list over the years to finally 
be used in a wide range of applications, for all functional dressings (belts, socks, pants, 
underwear) and for all purposes (slimming, anti-bacterial, anti-cellulite, anti-odor, 
moisture, ect.) (Nelson, 2002). 
 
In 2002, FIRTEX L.L.C. (Firstex L.L.C., 2002) patented a technique for application of 
nanoparticles to textiles that can be occluded in the natural fibers. Nanoparticles were 
starch-based and had a helicoidal configuration with a nano- hydrophilic cavity and 
hydrophobic inner wall. It was claimed that such cavities can contain several types of 
active molecules. The nanoparticles were immobilized by covalent grafting on natural 
fibers by the use of epichlorohydrin, polycarboxylic acid, dimetilol dihydroxy etilenurea 
or other formaldehyde-free substances. In some cases, the immobilization was 
performed by adsorption or special binders.  
 
In 2002, Combe filed a patent for textiles for clothing related to the loading of cosmetic, 
sanitary, a medical substances in textile fabrics for human or veterinary use. The impregnation 
process according to the invention consists in spraying on one or both sides of the fabric one 
or more substances in solution or dispersion in a liquid medium, so as to produce one 
continuous sprayed film which is accommodated in the meshes of the textile structure and 
thus fill the holes (Combe, 2002). The described solution or dispersion for the 
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impregnation of the textile fabric is compound by a drug, a binder and a gelling agent 
in liquid phase. According to Combe, the binder may be defined as a substance which 
facilitates immobilization of an active ingredient to the fiber to ensure that it remains 
fixed during at least 3 washing processes of the textile fabric. As binder it has been 
mentioned more particularly cellulose derivatives, soluble or dispersible in water, such 
as methylcellulose, ethylcellulose, β-hydroxyethyl cellulose, hydrxypropylcellulose, 
hydroxypropylmethylcellulose and similar products, as well as polymers of ethylene 
glycol or propylene glycol with an average molecular weight between 1,000 and 
30,000. As gelling or thickening agent, it has been mentioned, in particular, polymers 
of acrylic acid or methacrylic acid, polymers of esters of methacrylic acid, 
polyacrylamides, or others cationic, anionic or amphoteric thickeners depending on 
the chemical nature of the fabric. Reloading of the textile article is possible and done 
by heating and moistening the fabric article before exposing the desired locations or 
the entire dressing under the same spraying conditions, with the same solution or 
suspension of active ingredient. 
 
In 2008, Skin’up patented a process for textile fabric treatment with encapsulated 
nanoparticles. The synthetic fibers described are polyamides, polyesters, acrylics, and 
polyolefins, such as polypropylene or polyethylene, or polytetrafluoroethylene. The 
textile for which the monitoring and/or the following of the release of the active 
principle is intended can be an item of clothing, gloves, slippers, underwear, stockings 
or pantyhose, but also curtains, cushion or sofa covers, or else medical articles, such as 
bandages, splints or dressings but also compresses, head bandages or masks (Patent 
WO 08/068418 2008). 
 
According to the patent, the incorporated molecules may be a colorant or an active 
principle in the form of nanoparticles, with a size of less than 300 nm, fullerenes, 
nanocrystals and nanoemulsions, nanocapsules, nanospheres, nanovesicles or 
spherulites.  The active principle applied can be pharmaceutical or cosmetic active 
principles, deodorizing agents, insecticides, acaricides, slimming, refreshing or 
moisturizing active principles. Fat-soluble pharmaceutical active principles have been 
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described such as fluvastatin, ketoprofen, verapamil, atenolol, griseofulvin or 
ranitidine as well as hydrophilic active principles from aminoglucosides (gentamicin), 
antibiotics ([β-lactam, sulbenicillin, cefotiam, cefmenoxime), peptide hormones (TRH, 
leuprolide, insulin), antiallergic, to antimycotic or cytostatic agents, anxiolytics, 
contraceptives, sedatives, mineral salts (calcium, chlorine, magnesium, phosphorus, 
potassium, sodium, sulfur), amino acids, peptides, proteins, etc. Textile fabrics were 
impregnated in an exhaustion bath or by spray. In addition to the compound of interest 
and/or active principle, the aqueous solution in which the dipping of the textile is carried out 
can comprise other additives, such as those chosen from preservatives and/or antibacterials, 
fillers, antifoaming agents, antistatic agents, stabilizers, antioxidants and/or UV screening 
agents. The aqueous solution can also comprise flame retardants, plasticizers, pigments and 
agents which make possible the formation of a protective sheath around the fibers of which 
the textile is composed, which protective sheath slowly disintegrates on contact with the 
subject wearing the textile. In parallel, the authors developed a monitoring technique to 
follow the drug release as a function of the number of washes, by using a labeled 
sample treated with a dye. (Patent WO 08/068418 2008). The concentration of the 
colour solution is adjusted depending on the drug release kinetics. 
 
Numerous studies describe microparticles immobilized on textile or included in the 
textile fiber (Ying, 2004; Da Rocha Gomes, 2006; De Lucas Martinez, 2007; Da Silva 
Ribeiro, 2008; Mondal, 2008; Ripoll, 2010). A general problem of the cosmetotextiles is 
their low resistance to repeated washing. Currently, this resistance is improved with 
the development of new particles and new methods of fixation. The textile industry 
has also developed charging systems that increase the life of the product. These 
systems allow the recharging of the fibers with drugs, when these are used up. 
Recharging usually consists in the addition of a single dose in the final domestic wash 
stage. 
 
As studied in this PhD. Thesis, an alternative to the use of chemical binders or fibres 
containing microcapsules to achieve the release of cosmetic compounds from textile 
fabrics could be based on the modification of the interactions between the fiber and 
the active molecule by plasma treatment, as a way to attach the drug directly to the 
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textile fibre surface and achieve an adequate release profile as a function of the 
application.  
 
1.1.3. Textile materials for drug delivery systems 
 
Drug delivery is a term that refers to the delivery of a pharmaceutical compound to 
humans or animals. Most common methods of delivery include the preferred non-
invasive oral (through the mouth), nasal (inhalation), rectal, topical dermal and 
transdermal routes.  
 
Current investigations in the area of drug delivery systems include the development of 
targeted delivery in which the drug is only active in the target area of the body and 
drug formulations which are released over a predetermined period of time in a 
sustained and controlled manner from a formulation. When these concepts are 
applied to textiles, innovative medical textiles can be designed.  
 
Thus, textiles can be used as an interesting support for drug delivery systems, 
conferring an important added value to the primary function of such material. A wide 
number of wound dressings constitute good drug delivery systems and can own the 
ability to release active principles loaded into the fiber from different formulations 
(gels, foams, hydrogels…). Besides their added value, the main highlights for wound 
dressing-based drug delivery systems are the non-invasive administration way and the 
improved targeting of the disease or the dysfunction, due to the localized behavior of 
the application. Non-implantable textile materials eligible for topical and transdermal 
drug delivery and their requirements for this kind of application are reported in section 
1.1.3.1. 
  
This principle can be also transposed to some textile-based body implants. Antibiotic-
loaded implants can be a solution to the device-associated infections that is the result 
of bacterial adhesion and subsequent bio-film formation at the implantation site 
(Zilberman, 2008), of a surgical mesh, for example. Textile-based surgical meshes 
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commercially available or described in literature for potential application are 
presented in section 1.1.3.2. 
 
1.1.3.1. Non-implantable textile materials for topical and transdermal 
applications 
 
Topical drug delivery is the term used for local treatment of the dermatological 
condition where the medication is not targeted for systemic delivery (Osborne, 2008); 
examples include treatment of dermatological conditions like eczema or psoriasis by 
application on the skin from a pharmaceutical dosage form such as gel, cream, 
ointment, powder, spray, liquid lotion, etc. Examples of drugs delivered topically 
include antifungals, antivirals, antibiotics, antiseptics, local anesthetics, and 
antineoplasics.  
 
Transdermal drug delivery refers to the administration of active compounds in 
discrete dosage forms through the skin (at controlled rate and concentration) to the 
systemic circulation. The transdermal route has numerous advantages over the more 
traditional drug delivery routes. These include high bioavailability, absence of first pass 
hepatic metabolism, steady drug plasma concentrations, and the fact that therapy is 
non-invasive. The main obstacle to permeating drug molecules is the outermost layer 
of the skin, the stratum corneum. 
 
Drug delivery systems based on textile materials and structures can improve the 
efficiency and the therapeutic benefits of compressive elastic knitwear and provide 
them with an additional value. Therefore, in the first part of this PhD. Thesis we have 
used elastic-compressive fabrics where the incorporation of cosmetic or 
pharmaceutical compounds and their controlled release from such fabrics may be of 
interest. For example, adding the advantages of compressive stockings (improved 
venous return) with the presence of an active principle (caffeine) with action on body 
lipids (cellulite), and is one of the investigation lines studied in this PhD. Thesis to 
improve the efficiency of such materials and to provide a textile-based cosmetic 
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product for topical application. In the same way, the loading of compressive sockings 
with non steroidal anti-inflammatory drugs (NSAIDs), like ketoprofen in this work, can 
provide improved results for the treatment of rheumatoid arthritis via transdermal 
route, which has been also studied in this PhD. Thesis.  
 
However, in general if drugs are incorporated directly to the textiles without any 
additional agent or mechanism, the release is immediate. Therefore, in the way to 
uptake this major issue, different means have been studied to limit drug release with 
the elapse of time and achieve the release of an active ingredient to its topical 
therapeutic concentration for a predetermined time period, such as coating of the 
fibers with different biocompatible polymers, microcapsules, or even more complex 
approaches such as the use of: 
 Hollow fibers as drug reservoirs (Okuda, 2010) 
 Electrospun nanofibers with a high surface area to volume ratio (Yoo, 2009). A 
basic concept of electrospinning is to employ electrostatic repulsions of highly-
charged polymer jets to produce randomly oriented or aligned nanofibers 
deposited on the collector surface. Upon applying an electric field, the 
polymeric solution with a moderate viscosity value forms the Taylor cone at the 
tip of an injecting device (Doshi, 1995). In order to apply electrospun 
nanofibers in biomedical uses, their surfaces have been chemically and 
physically modified with bioactive molecules and cell recognizable ligands after 
the electrospinning method; this subsequently provides bio-modulating or 
biomimetic microenvironments to contacting cells and tissues and for that 
reason, they have received much attention because of their potential 
applications for biomedical devices, tissue engineering scaffolds, and drug 
delivery carriers (Pham, 2006; Yoo, 2009). 
 
Development of medical textiles for topical application needs to take into account 
different parameters such as the natural barrier of the skin, the diffusion mechanism 
of the active principle molecule from the fabrics through the skin, and the 
requirements of the fabric, as described in the following sections.  
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1.1.3.1.1. Textile materials for non-implantable medical textiles 
 
Traditional wound dressings include mainly natural (principally cotton) or synthetic 
bandages and gauzes. Unlike the topical pharmaceutical formulations, these dressings 
are dry and do not provide a moist wound environment. They may be used as primary 
or secondary dressings, or be part of a composite of several dressings, each performing 
a specific function. Bandages are made from natural (cotton and cellulose) and 
synthetic (e.g. polyamide, polypropylene, etc.) fibres which perform different functions 
(Boateng, 2008). Non-implantable medical textiles for wound care and bandages can 
be classified as described in Table 1. 
 
Table 1: Non-implantable medical textiles. Examples of non-implantable textiles, type of fiber and 
manufacture system (adapted from Bektaş, 2010). 
Product application Type of fibre Manufacture system 
Wound care 
 
Absorbent pad Cotton, viscose Nonwoven 
Wound contact layer 
Silk, polyamide, viscose, 
polyethylene 
Knitting, weaving, 
nonwoven 
Base material Viscose, plastic film Weaving, nonwoven 
Bandages and elastic-compressive textiles 
Simple inelastic/ elastic Cotton, viscose, polyamide, 
elastomeric yarns 
Knitting, weaving, 
nonwovens 
Light support Cotton, viscose, elastomeric 
yarns 
Knitting, weaving, 
nonwoven 
Compression Cotton, polyamide, elastomeric 
yarns 
Knitting, weaving, 
Orthopaedic Cotton, viscose, polyester, 
Polypropylene, polyurethane 
foam 
Weaving, nonwoven 
 Viscous, plastic film, cotton, 
polyester, glass, polypropylene 
Knitting, weaving, 
nonwoven 
Plasters Cotton, viscose Weaving, nonwoven 
Gauzes Cotton Weaving 
 
A number of wound dressings are available for a variety of medical and surgical 
applications. The functions of these materials are to provide protection against 
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infection, absorb blood and exudates, promote healing and, in some instances, apply 
medication to the wound. The wound contact layer should prevent adherence of the 
dressing to the wound and be easily removed without disturbing new tissue growth. 
The base materials are normally coated with an acrylic adhesive to provide the means 
by which the dressing is applied to the wound. Developments in coating technology 
have led to pressure sensitive adhesive coatings that contribute to wound dressing 
performance by becoming tacky at room temperature but remain dry and solvent free. 
The use of collagen, alginate and chitin fibers has proved successful in many medical 
and surgical applications because they contribute significantly to the healing process. 
For instance, when alginate fibers are used for wound contact layers, the interaction 
between the alginate and the exuding wound creates a sodium alginate gel. The gel is 
hydrophilic, permeable to oxygen, impermeable to bacteria and contributes to the 
formation of new tissue. 
 
Bandages and elastic-compressive textiles are designed to perform a whole variety of 
specific functions depending upon the final medical requirement. They can be woven, 
knitted, or nonwoven and possess either elastic or non elastic properties. The most 
common application for bandages is to hold dressing in place over wounds. Such 
bandages include lightweight knitted or simple open weave fabrics made from cotton 
or viscose that are cut into strips then scoured, bleached and sterilized. Elastic yarns 
are incorporated into the fabric structure to impart support and conforming 
characteristics. Knitted bandages can be produced in tubular form, as those employed 
in this work, in varying diameters on weft knitting machines. Woven light support 
bandages are used in the management of sprains or strains (ligaments) and the elastic 
properties are obtained for example by weaving cotton crepe yarns that have high 
twist content. Similar properties can also be achieved by weaving two warps together; 
one beam under a normal tension and the other under a high tension. When applied 
under sufficient tension, the stretch and recovery properties of the bandage provide 
support for the sprained limb. Compression bandages are also used for the treatment 
and prevention of deep vein thrombosis, leg ulceration, and varicose veins and are 
designed to exert a required compression to different areas of the leg. Compression 
bandages are classified by the degree of compression and can be either woven and 
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contain cotton and elastomeric yarns or wrap and weft knitted in both tubular and 
fully fashioned forms. Orthopedic cushion bandages are used under plaster casts and 
compression bandages to provide padding and comfort. 
New MEDTECH products incorporate new reactive agents which have therapeutic 
value, and overcome some of the disadvantages associated with the use of topical 
pharmaceutical agents. The modern dressings used to deliver active agents to wounds 
include hydrocolloids, hydrogels, alginates, polyurethane foam/films, and silicone gels 
(Heenan, 1998). So, they often do not rely on the textile structure or the fibres 
themselves, but those are rather used as a support layer for other substances.  The 
incorporated drugs play an active role in the wound healing process either directly or 
indirectly as cleansing or debriding agents for removing necrotic tissue, antimicrobials 
which prevent or treat infection or growth agents (factors) to aid tissue regeneration. 
 
 
1.1.3.1.2.  The skin: natural barrier for drug delivery 
 
Numerous drugs have undesirable side effects for oral administration due to their low 
solubility and susceptibility to first pass metabolism in the liver. Drugs, such as non-
steroidal anti-inflammatory drugs (NSAIDs), have patient related drawbacks, such as 
undesirable gastrointestinal side effects. For such drugs, alternative routes of 
administration are of interest, and practically every available body surface and 
entrance has been considered. Since the skin is readily accessible and has a large 
surface area, dermal and transdermal drug delivery has been the subject of a great 
interest in research and product development. In humans, skin is the largest organ of 
our body, which guards the underlying muscles, bones, ligaments and internal organs, 
and acts as a protective barrier against the entry of foreign material and possible 
invasion of pathogens.  Its other functions are insulation, temperature regulation, 
sensation, and it also prevents the loss of excessive endogenous material such as 
water (Brown, 2006; Proksch, 2008). 
 
Introduction 
 
 
37 
 
The primary barrier layer of skin is the stratum corneum (Figure 4). The stratum 
corneum is the outermost layer of skin that forms the main barrier for diffusion of the 
permeants through the skin (Wertz, 1989). The stratum corneum consists of 18–21 
layers of flat, roughly hexagonal cells called corneocytes that are constantly shed and 
renewed (Menon, 2002). These keratin-rich dead cells, measuring 20–40 μm in 
diameter, are interspersed within a crystalline lamellar lipid matrix to assume a ‘‘bricks 
and mortar’’ arrangement (Elias, 1983). The extracellular lipid contributes 10% of the 
dry weight of this layer, while 90% is the intracellular keratin. The barrier function of 
the skin can be attributed to the lamellar lipids that are synthesized in the granular 
layer and subsequently organized into the extracellular lipid bilayer domains of the 
stratum corneum (Landmann, 1986; Proksch, 2008).  
 
 
Figure 4: Cross-section representation of skin layers. 
 
Lipophilic drugs can readily diffuse through the first skin layer at a rate that depends 
primarily on their molecular size and lipophilic properties. Low molecular-weight 
drugs enter also into the dead cells, and the lipid pathways for diffusion are marked by 
numerous detours.  
After passing through the stratum corneum, drug encounters more hydrophilic layers: 
the epidermis and the dermis, which constitute the two main layers of the skin (Figure 
4), before being absorbed in capillaries perfusing the dermis. The epidermis is 
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avascular in nature, consisting of several types of cells (corneocytes, melanocytes, 
Langerhans cells, and Merkel cells) and a variety of catabolic enzymes (esterases, 
phosphatases, proteases, nucleotidases, and lipases) (Jansen, 1969; Mier, 1975). The 
stratified epidermis is about 100–150 μm thick and comprises four distinct layers, 
namely the stratum basale, stratum spinosum, stratum granulosum, and stratum 
corneum. The dermis that forms the bulk of the skin (1–2 mm thick) is made up of 
connective tissue elements. Dermis is highly vascular and filled with pilosebaceous 
units, sweat glands, adipose cells, mast cells, and infiltrating leukocytes (Menon, 2002). 
Drug that is absorbed through the skin is not susceptible to first pass metabolism by 
intestine and liver, although some metabolism may occur in the skin itself.  
 
While ointments, gels and creams are usually used for topical delivery to the skin, 
patches have been developed for controlled systemic delivery. Thus, patches are 
transdermal drug delivery systems consisting in self-contained discrete dosage forms 
designed to deliver a therapeutically effective amount of drug through intact skin 
(Wokovich, 2006). Most commercially available transdermal drug delivery systems are 
of three different types:  
 Reservoir systems 
 Matrix systems with drug-release rate-controlling membrane 
 Matrix systems without drug-release rate-controlling membrane.  
 
The reservoir system is made up of three major components, namely the drug 
reservoir, the rate-controlling membrane, and the adhesive. The active principle 
present in the reservoir, along with the other excipients, has to permeate through the 
rate-controlling membrane before reaching the skin. The adhesive that holds the 
system in place on the skin can completely cover the drug release area or only the 
perimeter around the non-adhering drug release surface.  
 
In the matrix type, the drug may be embedded in the adhesive matrix. A rate 
controlling membrane may be present between the drug-loaded matrix and the 
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adhesive or sometimes the matrix itself can control the rate of release of the actives 
from the system (Murthy, 2010). 
 
The simplest patch consists of an adhesive layer containing drug in a dissolved or in a 
finely divided solid form, and an impermeable backing layer. For such patches, delivery 
rate is controlled primarily by the permeability of the stratum corneum, which 
depends on the drug’s partition coefficient between the patch material and the 
stratum corneum, the drug’s diffusivity in the stratum corneum, and the thickness of 
the stratum corneum. Provided these parameters remain constant during application 
of the patch, and if drug activity in the patch remains constant by dissolution of solid 
drug into the adhesive, then zero order, constant rate delivery can be achieved (Siegel, 
2012).  
 
The simple adhesive patch design is best for drugs with a large therapeutic range, since 
skin permeability may vary across patients and between sites of application in an 
individual patient. When more precise control of drug concentration in blood is 
desired, it is useful to insert a rate controlling membrane between the drug reservoir 
and the adhesive layer. The membrane’s permeability must be less than that of the 
skin in order to achieve a controlled release rate. 
 
Figure 5: Conceptual design of transdermal commercial delivery patches based on (a) Skin 
permeability control and (b) membrane control adapted from Siegel, 2012. 
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There is a wide variety of research on the topical and transdermal delivery of active 
molecules based on dissolution assays, defined by Pharmacopeias, such as the 
Farmacopea Española employed as standard for the experiments designed in this PhD. 
Thesis. This variety is due to the numerous possibilities offered by the existing number 
of active molecules, combined with the use of different physical carriers and supports, 
and the different formulations that can be found (Ueda, 2009; Paudel, 2010; Siegel, 
2012). However, every investigation has the skin properties as the common limitation 
to take into account in the selection of the drug, the formulation and the viability of 
the administration way for the specific application. 
 
1.1.3.1.3. Considerations to take into account in the selection of 
drugs for topical applications  
 
Passive methods of drug application for topical applications include carriers as 
ointments, creams, gels and patches. However, the amount of drug that can be 
delivered using these methods is still limited because the barrier properties of the skin 
essentially do not change. 
Since the skin naturally acts as a natural barrier, only a limited number of drugs can 
penetrate and diffuse through it at an adequate rate. Generally, a drug molecule 
should be sufficiently lipophilic to overpass the stratum corneum, but sufficiently 
hydrophilic to also cross the viable layers. Its molecular weight should be low to 
ensure adequate mobility in the stratum corneum, so the maximum molecular 
weight for a compound involved in this route of administration cannot exceed 500 
g.mol-1 (Bos, 2000; Brown, 2006). Finally, the concentration of the drug and its 
pharmacokinetic properties should be such that the delivery of the drug to the site of 
action places the drug concentration within the therapeutic range. While the rate of 
delivery can be increased by using larger patches, there are practical size limitations 
(Siegler, 2012) which could be overcome using textiles as vehicle for drug delivery, as 
the contact area with the skin would be much larger. The drugs presented in the 
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market for transdermal application by means of patches include scopolamine, 
nitroglycerine, nicotine, clonidine, fantanyl, estradiol, testosterone, lidocaine, and 
oxybutinin (Langer, 2004). 
Because the skin is so accessible, much effort has been devoted to expanding the 
spectrum of transdermally deliverable drugs by using more complex delivery systems. 
Drug delivery systems based on textile supports can be one way to improve the 
delivery of the drug, to maintain the continuous release along day and night for 
chronic disease or dysfunction or to treat diseases affecting directly the skin. 
 
The following table (Table 2) presents a selection of benefits and limitations related to 
the dermal and transdermal release of active principles.  
 
Table 2: Benefits and limitations associated with cutaneous release. 
Benefits Limitations 
 Avoid the first pass metabolism and 
other variables associated with the 
gastrointestinal tract. 
 Allow a controlled sustained release 
over a prolonged period 
 Reduction of the side effects 
associated with systemic toxicity. 
 Improve the acceptance and patient 
compliance. 
 Direct access to the target (e.g. 
treatment of skin disorders such as 
psoriasis, eczema, fungal infections). 
 Easy to suspend the dosage in case of 
adverse systemic and local reaction. 
 Easy and painless administration. 
 The facility of use can reduce the 
overall costs of healthcare 
treatments. 
 Provide an alternative when it is not 
possible oral administration. 
 
 
 A molecular weight less than 500 
g.mol-1 is essential to ensure ease of 
diffusion through the stratum 
corneum, since the diffusivity of 
solute is inversely related to their 
size. 
 Sufficient solubility in water and oil. It 
is recommended (octanol / water) a 
partition coefficient value (Log P) 
between 1 and 3 for the permeant to 
cross the stratum corneum and to 
access the lower layers for systemic 
release. 
 Intra-and inter-variability related to 
the permeability of intact and 
diseased skin. This implies different 
absorption profiles, with different 
biological responses. 
 Pre-systemic metabolism: the 
presence of enzymes in the skin can 
metabolize the drug to an inactive 
form, reducing its effectiveness. 
 Irritation and skin sensitization. 
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Nowadays, patch-type products currently on the market are used to release a limited 
number of drugs, and although they do not overcome all the physicochemical 
restrictions mentioned above, which offer an improvement in controlling the dose, in 
the patient acceptance and the compliance, compared to formulations such as creams 
or gels. Similarly, the incorporation of drugs to textile fabrics directly in contact with 
the skin can be an advantage from the viewpoint of improving the dose compliance 
and acceptance by the patient. 
 
1.1.3.2. Implantable medical textiles  
 
Medical textiles can also be aimed for implantation in the body. Implantable textiles 
are used in effecting repair to the body whether it is wound closure (sutures) or 
replacement surgery. Table 3 illustrates the range of specific products employed within 
this category with the type of associated materials and their manufacture. 
Biocompatibility is of prime importance if the textile material has to be accepted by 
the body. Biocompatibility is defined as the ability of a biomaterial to perform its 
designed function with respect to a medical therapy, without eliciting any undesirable 
local or systemic effects in the host body and generating the most appropriate 
beneficial cellular or tissue response and optimizing the clinical performance of the 
therapy (Williams, 2008).  
 
Polyamide has been used mainly for artificial ligaments, tendons and artificial joints, 
and recently for artificial hip prostheses and inguinal meshes (Wisniewski, 2002; 
Singhal, 2002; Shmack, 2006). Polypropylene (PP) is the least reactive polymer 
together with polytetrafluoroethylene (PTFE) and polyester (PES) and one of the most 
employed in abdominal repair surgery.  
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Table 3: Implantable medical textiles. Examples of implantable textiles, type of fiber and manufacture 
system. 
Product application Type of fibre Manufacture system 
Sutures 
 
Biodegradable 
 
Collagen, polylactide, 
polyglycolyde 
Monofilament, strip, yarn 
 
Non-Biodegradable 
 
Polyamide, polyester, 
Teflon, polypropylene, 
polyethylene 
Monofilament, strip, yarn 
Soft tissue implants 
Artificial tendon 
Teflon ®, polyester, 
polyamide,  
polyethylene, silk 
Braided, woven 
Artificial ligaments Polyester, carbon Braided 
Artificial cartilage 
Low-density 
polyethylene 
Nonwoven 
Artificial skin 
 
Chitin Nonwoven 
Eye contact lenses, artificial 
cornea 
Polymethyl 
methacrylate, silicone, 
collagen 
 
Hernia repair mesh Polypropylene, Teflon ® 
Nonwoven, knitting, polymer 
film 
Orthopedic implants 
Artificial joints / bones Silicon, polyacetal, 
polyethylene 
 
Cardiovascular implants 
Artificial blood vessels 
 
Polyester, Teflon Knitting, weaving 
Heart valves Polyester Knitting, weaving 
 
 
1.1.3.2.1. Hernia repair 
 
A hernia is an abnormal protrusion of an organ or a part of it outside the body cavity 
which normally contains it. The opening through which organs bulge outside the body 
cavity is called the hernia gate or the hernia port. Most frequently, hernias occur in the 
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groin or the abdomen, and statistically in four cases of inguinal hernia there is one case 
of abdominal hernia (Ciechańska, 2012).  
 
An abdominal wall defect or abdominal hernia is defined as a protrusion through the 
abdominal wall of intra-abdominal content with an intact lining of the sac. The only 
effective treatment for abdominal wall defects is surgery to restore integrity and 
maintain function of the abdominal wall and prevent incarceration and strangulation 
of intra-abdominal content (Engelsman, 2007). In the past, hernia surgery and 
abdominal wall reconstructions frequently have used tense sutures to approximate 
and close a hernial port or defect. This has led to wound dehiscence, recurrent hernias 
and non-healing of the wound due to tissue ischaemia, with the sutures cutting 
through the soft tissue (George, 1986). 
 
 
Figure 6: A schematic presentation of the normal anatomy of the abdominal wall (a), the mechanism 
of an abdominal wall defect (b) and the possibility of open (c) and laparoscopic (d) implantation of a 
surgical mesh. (Adapted from Engelsman, 2007) 
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Nowadays, the methods by which hernia repairs are performed can be divided into 
two general categories: 
 Tension methods, which involve an approximation of tissue edges and stitching 
them together to close the hernia gate. In this type of repair, stitches or sutures 
exert tension on the body tissues on each side of the hernia gate in order to 
keep it closed. 
 Tension-free methods, which involve an implantation of prosthesis, which is to 
complement the defect in the fascia and close the hernia gate without exercing 
a tension in the surrounding tissue. 
 
Figure 6a  illustrates the normal anatomical situation with the peritoneum covering the 
entire abdominal cavity. Also, the relation between the main anatomical structures 
such as the abdominal cavity, abdominal muscles and fasciae, aorta and spine is 
shown. Figure 6b demonstrates a midline abdominal wall defect due to detachment of 
the bilateral rectus abdominal muscles. A hernia sac lined with peritoneum protrudes 
(arrow) through the hernial port of the abdominal fascia and muscles and is bilaterally 
enclosed by the rectus abdominal muscle. A protrusion can occur when the abdominal 
wall is exposed to chronically elevate intra-abdominal pressure (Figure 7). 
 
Figure 7: Protrusion formation to an elevate intra-abdominal pressure in case of a midline abdominal 
wall defect. 
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A tension-free closure may be accomplished by the placement of a surgical mesh to 
relieve tension from tissue surrounding the hernial port (Amid, 1992). To allow the 
placement of the mesh between the external facial layer and the rectus abdominal 
muscles, the abdominal wall has to be opened. Two surgical methods for hernia repair 
are commonly used and differ by the placement of the surgical mesh (Lichtenstein, 
1989; Awad, 2004; Gray, 2008): 
  
 Open hernia repair surgery consists in a single long incision which is made in 
the groin. If the hernia is bulging out of the abdominal wall (a direct hernia), 
the bulge is pushed back into place. If the hernia is going down the inguinal 
canal (indirect), the hernia sac is either pushed back or tied off and removed. 
After reducing the hernial sac into the abdominal cavity, the defect is covered 
with a surgical mesh (Figure 6c).  
 Laparoscopic hernia repair consists in a small incision made in or just below 
the navel. The abdomen is inflated with air so that the surgeon can see the 
abdominal organs. A thin, lighted scope called a laparoscope is inserted 
through the incision. The instruments to repair the hernia are inserted through 
other small incisions in the lower abdomen. The mesh is then placed over the 
defect to reinforce the abdominal wall. Figure 6d illustrates the placement of 
an intra-abdominally placed mesh by means of laparoscopic surgery covering 
the internal hernial port (Engelsman, 2007). 
 
1.1.3.2.2. Abdominal meshes and prosthetic devices 
 
Polypropylene (PP), polyester and expanded polytetrafluoroethylene are nowadays the 
most common polymers used for medical meshes (Orenstein, 2012), with PP meshes 
being one of the most frequent materials used in hernia repair. PP meshes are 
produced with mono or multifilaments and are currently preferred over biological and 
synthetic absorbable meshes (Figure 8).  
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Figure 8: Multifilament PP meshes currently used in hernia repair. 
 
The use of prosthetic material for abdominal wall surgery dates back more than one 
century. Around 1900, the ﬁrst prosthesis used for the treatment of inguinal hernia 
was an inoxidable steel metallic mesh, later abandoned because of its rigidity, 
responsible for sequellar pain. The modern era started in 1958 with the introduction 
by Usher et al. of polypropylene mesh implants (Usher, 1958; Usher, 1962), and 
popularized later by Lichtenstein (Lichtenstein, 1986). The positive effects of the use of 
a mesh on recurrence of the hernia stimulated the search for an optimal mesh with 
high biocompatibility, low adhesion formation and low infection rates. The aim of the 
first studies was focused on the PP mesh closure of the complicated abdominal wound 
(Fansler, 1995), on the integration, adhesion formation and resistance to traction of PP 
prostheses used in the partial or total repair of abdominal wall defects (Bellón, 1998), 
the functional and morphological evaluation of different PP mesh modifications for 
abdominal wall repair (Klosterhalfen, 1998) and/or the influence of polyglactin-coating 
on functional and morphological parameters of polypropylene-mesh modifications for 
abdominal wall repair (Klinge, 1999). Engelsman et al., in 2007, reviewed the clinical 
background for abdominal wall reconstruction, the different types of surgical meshes 
employed and known mechanisms of infection. It has been shown that there are major 
physico-chemical differences between available meshes, which, in combination with 
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the location of the mesh, the surgical technique applied and hernia type involved 
influence the infection potential (Engelsman, 2007).  
A large number of clinical trials have been published to compare the different types of 
polymeric meshes, emphasizing on tissue adhesion (Van’t Riet, 2003), recurrence 
(Luijendijk, 2000) and infection (Leber, 1998). Studies on heavy weight, mid-weight, 
and light weight PP mesh in a porcine ventral hernia model have been described 
(Cobb, 2006) as well as comparative analysis of histopathologic effects in mice of 
synthetic meshes as a function of the material used (PP, PE, PTFE), the weight, and the 
pore size of the mesh (Orenstein, 2012), which bring out the importance of the 
biocompatibility on the mesh performances. Advanced polymeric meshes have also 
been studied in vivo as drug delivery systems. An antibiotic-releasing polyester mesh 
to reduce prosthetic sepsis has been designed by Harth et al., loading the antibiotic 
(vancomycin) into the coated polymer mesh placed in aqueous solution of vancomycin 
(VM) (5 mL of 25 wt%) for 4 days at room temperature (Harth, 2010). Using an in vivo 
wound infection model, the drug delivery polymer mesh was able to effectively 
prevent a Staphylococcus aureus mesh infection with efficacy demonstrated at 2 and 4 
weeks. 
 
In the past decade, PP mesh has been used as prosthetic biomaterial not only to 
buttress the defect of incisional hernias, abdominal or inguinal, creating a tension-free 
repair (Matthews, 2003; Engelsman, 2007; Wong, 2011; Deeken, 2011) but also for the 
treatment of stress urinary incontinence (Hung, 2004), for vaginal prolapse (Siniscalchi, 
2011) or to prevent prosthetic device infection (Harth, 2010).  
 
Surgical operations for soft tissue reinforcement are common procedures in medical 
field and every year require at least one million prostheses (Rutkow, 2009) and surgery 
for inguinal hernia is one of the most common techniques performed in a general 
surgical service. Even if this type of surgery is considered clean and the meshes used 
on prolapsed pelvic organs or on abdominal wall hernia decrease postoperative 
complications, reoperation rates are still significant (Bako, 2009; Diwadkar, 2009). 
Mesh-related infection is one of the limitations on the use of synthetic prostheses, and 
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generally occurs in 1–2% of cases for laparoscopic ventral and incisional hernia repair 
(Condon, 1991; Page, 1993; Dellinger, 1994; Woods, 1998; Heniford, 2000; Kirshtein, 
2002; Heniford, 2003; Engelsman, 2007) and up to 8% for open incisional hernia repair 
(Petersen, 2001; Cobb, 2003; Falagas, 2004).  
 
Infection complications can appear after the mesh implantation and may generate 
patient’s health risks in the post-operatory period (Baessler, 2005; Saïhi, 2005). 
Sources for infectious bacteria include the ambient atmosphere of the operating room, 
surgical equipment, clothing worn by medical professionals, resident bacteria on the 
patient's skin and bacteria already in the body (An, 1996; Zilberman, 2008). Prosthetic 
device infection is a broad problem that can occur at varied stages of the materials 
lifespan and can be acute or delayed in their presentation.  The nature of device 
infections requires both preventive and therapeutical strategies. 
 
 
Figure 9: Cross-section of abdominal wall with classification of surgical site of infection (Adapted from 
Horan, 1992) with positioning of the surgerical mesh in case of and of open implantation (*) and 
laparoscopic abdominal repair (**). 
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Incisional surgical site infections (SSIs) resulting from abdominal wall implant are 
divided into superficial incisional (only involves skin and subcutaneous tissue) and 
deep incisional (involves deeper soft tissue, including fascia and muscle layers), as 
shown in Figure 9. Despite improvements in operating room practices, instrument 
sterilization methods, better surgical technique and the best efforts of infection 
prevention practitioners, surgical site infections remain a major cause of nosocomial 
infections—and rates are increasing globally (Alvarado 2000). 
One of the current approaches to prevention of infection includes the administration 
of prophylactic antibiotics systemically. This approach should achieve adequate local 
tissue antimicrobial levels to fight the infection but comes at the risk of systemic 
secondary effects to the antibiotic exposure (Harth, 2010). A common solution to 
avoid bacterial contamination of a wound is the systemic treatment of the patient with 
antibiotics (ABs), but it requires large doses of administered drugs are necessary 
because only a small part of it reaches the target zone (Avtan, 1997).  
As alternative to avoid systemic treatment of the patient with antibiotics, some 
investigations were performed to obtain an antimicrobial implant by using a silver 
coating (Kumar, 2002; Kumar, 2005; Monteiro, 2009). This metal is well-known for its 
broad-spectrum antimicrobial activity against gram-positive and gram-negative 
bacteria, fungi, protozoa and certain viruses (Balazs, 2004), including antibiotic-
resistant strains (Melaiye, 2005; Stobie, 2008), and used to reduce infections, to 
prevent bacterial colonisation on medical devices as well as in textile fabrics (Taylor, 
2005; Panácek, 2006; Ip, 2006).  
 
Another alternative consists of local antibiotic delivery by the immersion of the 
implant in an antibiotic solution prior to its use. Antibiotic-loaded implants present a 
straightforward approach for the prevention of implant-associated infections. They can 
provide an immediate response to the threat of implant contamination and do not 
necessitate the use of an additional carrier for the antibacterial agent other than the 
implant itself (Zilberman, 2008). 
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Most biomaterials present only a low affinity towards drugs, which are subsequently 
adsorbed onto the medical device in only small amounts, and are then released with a 
too short delay to produce the expected benefits to the patient. In 2008, El Ghoul et al. 
proposed an improvement in the sorption and release rates of the antibiotic after 
chemical modifications of the biomaterial surface by means of functionalization with 
cyclodextrins (CDs). Recently, improved surgical meshes have been developed with 
some finishing agents such as cyclodextrin and maltodextrin for the prolonged release 
of ciprofloxacin form a PP artificial abdominal wall implant (Laurent, 2011), and 
improved surgical mesh with a degradable polymer coating as a carrier for the 
sustained release of the antibiotic, ofloxatin, with an in-vitro evaluation of the mesh 
preparation and antimicrobial efficacy to minimize the risk of post-implantation 
infection (Guillaume, 2012a; Guillaume, 2012b). In this work, Guillaume et al. designed 
a new antibiotic-eluting mesh from pre-existing polypropylene prostheses using an 
airbrush spraying technology. An anti-infective drug (e.g. ofloxacin) is incorporated 
into a poly(lactic acid) (PLA) or a poly(e-caprolactone) (PCL) coating, presenting a 
homogeneous, regular and smooth shell around the polypropylene filaments of the 
mesh. The in vitro release kinetics of the antibiotic from the modified meshes to a 
phosphate buffer saline (PBS) present a limited burst effect followed by sustained drug 
diffusion for several days as a function of the thickness of the coated polymer, with a 
longer sustain release for PLA coating. 
 
A recent study about plasma pre-treated PP meshes deals with the physico-chemical 
characterization of polypropylene fibers for prosthetic applications, pre-treated by 
atmospheric pressure plasma in a dielectric barrier discharge apparatus (APP-DBD) and 
later functionalized with chitosan, known for its antibacterial properties (Nisticò, 
2012). Unlike this work, the purpose of the PhD. Thesis is to design an antibiotic 
delivery system in which the modification of fibre surface for the attachment of the 
active principle and the modulation of the release is the result of dry processes, 
using plasma treatments.  
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 In this PhD. Thesis, the study on implantable medical textile and its modification by 
plasma treatment has been focused on the polypropylene, currently used as implant 
mesh for abdominal hernia repair due to its long-lived nature and its biocompatibility, 
as described before. The aim of the present work is to investigate the effects of plasma 
treatment on the PP meshes with regard to antibiotic incorporation and release. 
 
1.2. Chemical fibers of synthetic polymer 
 
In this PhD. Thesis two types of chemical fibers have been used: polyamide 6.6 (PA66) 
and polypropylene (PP). First, an elastic-compressive knitted polyamide 6.6 fabric 
designed as compressive sockings has been selected as textile-based drug release 
system for topical applications, in views of studying how the modification of fibre 
surface properties achieved by plasma treatment influences the loading and the 
release of selected drugs from the fibres.  Then, a polypropylene surgical mesh, made 
from a homopolymer polypropylene monofilament has been chosen as implantable 
medical textile to study how the fibre surface properties modification achieved by 
plasma treatment influences the loading and the release of an antibiotic from the 
fibres.   
 
1.2.1. Polyamide 
 
1.2.1.1. Structure and classification  
Polyamide fibres (or nylon fibres) are defined by the ISO standards as chemical fibres 
formed from a polymer of synthetic linear macromolecules in which the chain is a 
sucession of amide groups, with a minimum of 85% of them linked to alifatic or 
cycloalifatic groups (Gacén, 1991). Polyamides are semi crystalline polymers typically 
produced by the condensation of a diacid and a diamine. Depending on the number of 
carbon atoms in the monomers or intermediate products used in the synthesis, a 
specific polyamide is obtained. There are several types of polyamides and each type is 
often described by a number, such as polyamide 6, 11, 12, 4.6, 6.10, 6.12… or 
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polyamide 6.6 (PA66) used in this investigation. The numeric suffixes refer to the 
number of carbon atoms present in the molecular structures of the amine and acid, 
respectively (or a single suffix if the amine and acid groups are part of the same 
molecule). The most common fibres are polyamide 6 and 6.6 and are very similar in 
properties. The general synthesis reaction for polyamides is shown in Figure 10. 
 
 
 
Figure 10: General polyamide polycondensation reaction. 
 
The -COOH acid group reacts with the -NH2 amine group to form an amide. A molecule 
of water is given off as the nylon polymer is formed. The properties of the polymer are 
determined by the R and R' groups in the monomers and the average degree of 
polymerization. Following Figure 10, in polyamide 6.6, R' =6C and R =4C alkanes, but 
one has to also include the two carboxyl carbons in the diacid.  
 
 
Figure 11: Chemical structure of polyamide 6.6. 
 
Polyamide 6.6 (Figure 11) is prepared by step growth polymerization of hexamethylene 
diamine and adipic acid. After drying, polyamide 6.6 is melt spun into fibres at 280 °C – 
290 °C and drawn to mechanically orient the filaments followed by processes such as 
thermal stabilization, cutting, spinning, etc.  
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1.2.1.2. Physical and chemical properties 
 
Polyamide 6.6 presents a specific weight of 1.14 g/cm3, a glass point transition of 245 
°C and a melting point of 255 °C. PA66 is known and usually used for its outstanding 
balance of mechanical properties, toughness in equilibrium moisture content, chemical 
resistance and oil resistance, wear and abrasion resistance, long-term heat resistance 
(at a long-term, continuous, maximum temperature ranging between 80 °C and 150 
°C). PA66 also offers high water absorption and outstanding gas barrier properties 
(Rouette, 2002) 
 
1.2.1.3. Applications 
 
Conventional polyamide fibres are usually rodlike with a smooth surface. Polyamides 
are extensively used in hosiery, lingerie, underwear, sweaters, and other knitted goods 
such as carpets, tie cord, parachutes, sails, ropes, thread, and outdoor wear. 
 In this work, a polyamide 6.6 knitted fabric designed as finished elastic-compressive 
socking was used. 
 
1.2.2. Polypropylene 
 
1.2.2.1. Structure and classification 
 
Polypropylene (PP) is the generic name of fibres constituted by linear macromolecules 
of saturated alifatic hydrocarbons, in which one of every two atoms has a methyl 
ramification, usually in isotactic configuration (-CH2-CH(CH3)-)n (Figure 12) (Gacén, 
1991). It is a thermoplastic polymer synthesized by polymerization of propylene 
monomers [(CH2=CH-CH3)]. The relative orientation of each methyl group relative to 
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the methyl groups on neighboring monomers has a strong effect on the finished 
polymer's properties.  
 
 
Figure 12: Chemical structure of polypropylene in isotactic configuration. 
 
The polymer is melt, spun into filaments and drawn to orient them. PP enters in a wide 
range of applications such as packaging, technical textiles, automotive components or 
in plastic parts of various types. 
 
1.2.2.2. Physical and chemical properties 
 
Polypropylene, manufactured according to the melt-spin process and drawn began in 
1959. They are important as monofilaments and multifilaments. Polypropylene 
filaments are strong fibers with good elongation and recovery properties. They present 
a breaking strength between 2.5–6 cN/dtex with an elongation to break between 15 % 
and 30% and the fibers recover well from stress, with 95% recovery at 10% elongation. 
Moisture does not affect these properties, since polypropylene is hydrophobic and has 
a moisture regain of 0%. They present a softening range of 149–160 °C and a melting 
point range of 163 –170 °C (Rouette, 2000). The polypropylene is extremely inert and 
resistant to chemical attack. It is unaffected by chemical and biological agents under 
normal conditions. Polypropylene fiber only slowly undergoes oxidative decomposition 
at its melting point (Needles, 1986). 
 
 
1.2.2.3. Applications 
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Polypropylene is becoming increasingly employed in the textile industry in the form of 
filaments and fibres. PP is known as a versatile and valuable fibre-forming polymer 
material. Due to the improvement of their water absorbency and dyeability, the 
original fields of application (technical textiles, geotextiles, carpet primary backing 
fabrics, nonwovens) has been expanded, and now, for example, furnishing and 
decorative materials or swimming costumes and knitgoods are manufactured from 
texturized polypropylene. (Rouette, 2000). PP is widely used for the production of 
medical and hygienic products, carpets and floor coverings, apparel and household 
textiles, filtering media, agro-textiles, automotive interior and many other technical 
textiles. The wide range of goods comprises a variety of products including mono- and 
multifilaments, staple fibres, tapes and fibrillated fibres as well as spun-bonded and 
melt-blown nonwovens. As described in section 1.1.3.2.2, polypropylene has also been 
implanted in the medical textile field for its biocompatibility and low-degradability and 
is well established as implantable mesh for abdominal wall and hernia repair or as 
prosthetic device.   
 
 
1.3. Cosmetic and pharmaceutical active principles  
 
In this PhD. Thesis different active principles are applied to textiles: 
 In the first part, where PA66 elastic-compressive fabrics are concerned, two 
families of drugs have been selected: Non-Steroidal Anti-Inflammatory Drugs 
(NSAIDs) for rheumatoid arthritis, where ketoprofen has been chosen, and 
different methylxantines, in particular caffeine as cosmetic active principle for 
the treatment of a dermal disorder such as cellulite.  
 In the second part, with views on the prevention of surgery-derived infections, 
an antibiotic, ampicillin, was selected for application in PP meshes. 
 
1.3.1. Anti-inflammatory active principles for topical applications 
 
Drug products topically administered via the skin fall into two general categories, those 
applied for local action and those for systemic effects. Local actions include those at or 
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on the surface of the skin, those that exert their actions on the stratum corneum, and 
those that modulate the function of the epidermis and/or the dermis. Common 
products in the former category include creams, gels, ointments, pastes, suspensions, 
lotions, foams, sprays, aerosols, and solutions. Creams, ointments, and gels generally 
are referred to as semisolid dosage forms (Ueda, 2009). Topical dosage forms include 
solutions (for which release testing is not indicated), collodion, suspensions, emulsions 
(e.g., lotions), semisolids (e.g., foams, ointments, pastes, creams, and gels), solids (e.g., 
powders and aerosols), and sprays. The physical characteristics of these dosage forms 
vary widely. 
 
The most common drug products applied to the skin for systemic effects are referred 
to as self-adhering transdermal drug delivery systems (TDS) or transdermal patches. 
TDS or transdermal patches are physical devices applied to the skin and vary in their 
composition and method of fabrication. Therefore, they release their active 
ingredients by different mechanisms. In the local use, most commercial NSAID 
patches are frequently applied to the elbows and knees for the remedy of 
inflammation and joint pains; therefore, flexibility becomes the most important 
condition for the backing materials of these dosage forms to enable the skin to move 
in a natural way (Ueda, 2009; Vanniasinghe, 2008). To avoid these constraints, 
woven and non-woven fabrics, that are the materials on which is focused this PhD. 
Thesis, could be one way for the use of drug delivery system for local topical 
applications on the skin.   
 
Many of the current drugs used for the management of rheumatic disorders and other 
inflammatory arthritis are nonsteroidal anti-inflammatory drugs (NSAIDs) and 
corticosteroids (Vanniasinghe, 2008). Recent studies highlight glucocorticoids’ (GC) 
effectiveness in reducing inflammation and slowing joint damage, especially when 
patients are treated at an early stage of disease propagation (Goekoop-Ruiterman, 
2007). However, the toxicity associated with these drugs is also well documented 
particularly with long-term use and administration (Boers, 2004). For this reason 
NSAIDs are the most commonly used drugs to reduce pain and inflammation in topical 
application (Escribano, 2003; Baboota, 2007; Vanniasinghe, 2008). 
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Oral therapy of NSAIDs is very effective, but its clinical use is often limited because of 
adverse side effects, such as irritation and ulceration of the gastro-intestinal mucosa. 
Topical administration of these agents can prevent these side effects associated with 
oral use and may help to maintain consistent blood plasma levels for long-term 
therapy from a single dose (Beetge, 2000; Jantharaprapap, 2007; Okur, 2011). 
Common tradicional NSAIDs are: aspirin and ibuprofen which are the most used 
NSAIDs molecules in oral administration for general anti-inflammatory application 
(Swarbrick, 2007). Ketoprofen, naproxen (Okur, 2011), diclofenac, etc. are currently 
used for the treatment of rheumatoid arthritis, osteoarthritis and traumatic contusions 
in gel dosage form. Two commercial examples include Voltaren® diclofenac 1% and 
ketoprofen Powergel® 2.5% w/w topical gels. 
 
1.3.2. Anti-lipidic active principles for topical cosmetic applications 
 
Cellulite is the unsightly skin dimpling that is frequently found on the thighs and 
buttocks of women, and its appearance is often described as resembling the surface of 
an orange peel. Approximately 85% of post-adolescent women have some degree of 
cellulite (Draelos, 1997; Sainio, 2000). Many successful cosmetic and medical 
treatments show little effect in improving cellulite, and none of them has been shown 
to cause its complete disappearance. The anatomy and pathophysiology of cellulite are 
poorly understood. A review of the literature demonstrates a lack of studies to validate 
currently popular theories and treatments. The condition is best described by Goldman 
as a normal physiologic state in post-adolescent women, which maximizes adipose 
retention to ensure adequate caloric availability for pregnancy and lactation (Goldman, 
2002). Adipose tissue is also essential for nutrition, energy, support, protection, and 
thermal insulation (Querleux, 2002). 
 
When using topical treatments to reduce the appearance of cellulite, the 
concentration and pharmacokinetics of the active drugs as well as the nature of the 
vehicle must be considered. Vehicles can be in the form of gels, ointments, foams, 
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creams, and lotions, all of which aim to efficiently deliver active product to the skin. 
Factors that affect the clinical response to treatment are: (i) the interaction of the drug 
with the vehicle and the skin, (ii) the method by which the drug is applied, and (iii) 
other biological and environmental factors (Addicks, 1989; Hadgraft, 1993; Riviere, 
1993). The main barrier to drug penetration is the stratum corneum, the cornified 
outermost layer of the epidermis. Formulations for topical use may include ‘‘skin 
enhancers,’’ which significantly increase cutaneous penetration when included in the 
formulation. Skin enhancers can be common solvents (water, alcohol, and methyl alkyl 
sulphoxide) or surfactants. They may also be phospholipid molecules called 
phytosomes, which, when attached to the active drug, increase their lipid solubility. 
Also percutaneous delivery systems utilize liposomes, which are specially designed 
lipid vesicles that are filled with active medication (Zatz, 1993; Seiller, 1994). Topical 
anticellulite preparations can be divided into four major groups according to their 
proposed mechanism of action (Hexler, 2006): 
 
1. Agents that increase microvascular flow. 
This includes most of the active ingredients in cellulite treatments. They are included 
to increase microvascular flow and lymphatic drainage, which is thought to play a role 
in cellulite pathogenesis. 
 
2. Agents that reduce lipogenesis and promote lipolysis. 
With the goal of reducing the size and volume of adipocytes, decreased tension on 
surrounding connective tissue is thought to decrease the clinical appearance of 
puckering. 
 
3. Agents that restore the normal structure of the dermal and subcutaneous tissue.  
By thickening the dermis or preventing fat herniation into superficial tissue, the 
appearance of cellulite may be reduced. 
 
4. Agents that prevent or destroy free-radical formation. 
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It is believed that free radicals modify free fatty acids by peroxidation, contributing to 
the availability of lipids for cellulite formation. Free radicals may also damage elements 
of the microcirculation, further assisting cellulite development. 
 
Table 4: Topical therapies for cellulite based on the proposed mechanism of action, from Hexsler, 
2006. 
Topical Therapies for Cellulite 
 
Agents that increase microvascular flow 
Ivy 
Indian or horse chestnut (Aesculus hippocastanum) 
Ginkgo biloba 
Rutin 
Pentoxyfylline 
Butcher’s broom (Ruscus aculeatus) 
Asiatic centella 
Silicium 
Chofitol or artichoke (Cynara scolymus) 
Common ivy (Hedera helix) 
Ground ivy (Glechoma hederaceae) 
Sweet clover (Melilotus officinalis) 
Red grapes (Vitis vinifera) 
Papaya (Carica papaya) 
Pineapple (Ananas sativus, Ananas comosus) 
 
 
Agents that reduce lipogenesis and promote lipolysis 
Methylxanthines (theobromine, caffeine, aminophylline, theophylline) 
Beta-adrenergic agonists (isoproterenol, adrenaline) 
Alpha-adrenergic antagonists (yohimbine, piperoxan, phentolamine, 
dihydroergotamine) 
 
Agents that restore the normal structure of the dermal and subcutaneous tissue 
Retinol (vitamin A) 
Ascorbic acid (vitamin C) 
Bladderwrack (Fucus vesiculosus) 
 
Agents that prevent or destroy free-radical formation 
Alpha-tocopherol (vitamin E) 
Ascorbic acid (vitamin C) 
Gingko biloba 
Red grapes (Vitis vinifera) 
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In this PhD. Thesis, the research will be focused on caffeine and other compounds of 
the methylxantine family (caffeine, theobromine and theophylline) that act on the 
reduction of lipogenesis and promote lipolysis. These act through phosphodiesterase 
inhibition and are the most common active ingredients in commercial anticellulite 
formulations (Collis, 1999). The most useful and safest methylxanthine is caffeine, 
normally used at a concentration of 1% to 2% in topical gel forms. Whereas the 
solubility of caffeine in water is 2.2%, commercially available topical creams prepared 
with co-solvent systems can reach 3% caffeine content (Dias, 1999; Amnuaikit, 2008; 
Amnuaikit, 2011).  
 
Beside its widely known pharmacological effects on the central system and others 
(Ritchie, 1975), caffeine has been correlated with reduced adiposity through 
stimulation of lipolysis by increased expression of adiponectin and lipid oxidizing 
enzymes (Yun, 2008). This methylxantine has an important first-step metabolism 
(Liguori, 1997), which has justified investigation on topical treatment (Batchelder, 
2004). The combination of both parameters is related to its use as active principle in 
cosmetic formulations with views on treating cellulite (Bolzinger, 2008). Caffeine 
offers good skin penetration and is therefore rapidly absorbed, leading to rapid 
action. It acts directly on adipocytes, promoting lipolysis through the inhibition of 
phosphodiesterase (Portad, 1999). All methylxanthines activate the enzyme 
triglyceride lipase and transform triglycerides into free acids and glycerol. Caffeine 
also has a stimulating effect on the cutaneous microcirculation (Hexsler, 2006). 
Therefore, caffeine is found in a number of commercial preparations, mostly as a 
hydrophilic gel, for the treatment of skin disorder (e.g. Somatoline Cosmetic® gel), or 
for the reduction of puffy-eyes, applying around the eyes since it can provide clear 
appearance, cooling effect and non-greasy feeling (Dias, 1999; Dreher, 2002; Boonme, 
2007; Amnuaikit, 2008; Amnuaikit, 2011). 
 
In literature, different products can also be found products which are based on the 
combination of different active agents to reduce cellulite. Bertin et al. described a 
product combining retinol with a microencapsulated time-release mechanism to treat 
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cellulite. The compound contains caffeine to stimulate the lipolysis and prevent fat 
accumulation, esculoside to improve local microcirculation, asiatic centella as an anti-
inflammatory agent, and l-carnitine to stimulate free fatty acid transport and 
breakdown (Bertin, 2001). Efficacy parameters included cellulite appearance before 
and after treatment, histology, cutaneous flowmetry, and skin mechanical 
characteristics. The product also contains ruscogenine, which inhibits elastase activity, 
allowing recovery of extracellular matrix integrity that contributes to the thickening of 
the dermis and the masking of cellulite. 
 
In this PhD. Thesis, caffeine and other methylxantines molecules (theorbromine and 
pentoxifylline) are directly loaded into the polyamide 6.6 fibres from an aqueous 
solution, and low temperature plasma is used to modulate the interaction between 
the drug and the textile support. 
 
1.3.3. Antibiotic-loaded fibres for implantable textiles 
 
The use of antibiotics for textile-based drug delivery systems is oriented for 
implantable meshes. Postoperative antibiotic-based infection prophylaxis is usually 
administered following mesh implantation. But, even after decades of routine use, its 
capacity to minimize mesh-related infection is still a matter of debate (Aufenacker, 
2004; Hedrick, 2007; Taylor, 1997). Because management of infections associated with 
surgical implants can be both difficult and costly, prevention of such infections remains 
a priority. Preventive strategies comprise systemic perioperative administration of 
antibiotics and local application of antimicrobial agents (antibiotics or antiseptics). 
Local antimicrobial prophylaxis can be provided in various forms and aims to prevent 
implant-associated infections by impeding bacterial adherence to the implant surface 
and/or reducing the concentration of bacteria in the immediate vicinity of the implant 
(Darouiche, 2003).  
 
One of the new trends in biomedical research is to deliver active compounds directly 
into the surgical site from the medical device (Shukla, 2010; Wu, 2006). The main 
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objective of these new active prostheses is not only to restore a damaged function, but 
to also prompt tissue integration (Chen, 2005; Maciver, 2011; Steigerwald, 2009), 
avoid periprosthetic inflammation (Chen, 2003; Junge, 2005a) and prevent surface 
contamination (Blanchemain, 2008; Gomez-Alonsa, 2007; Junge, 2005b) (Guillaume, 
2012). 
There is a need for a system including antibiotics directly to the mesh, or via some 
antibiotic encapsulated-based nano-carrier (Fu-Giles, 2013), to treat and alleviate 
post surgical and post-transplantation infections, particularly in reaction to body 
implants. This approach provides a novel therapeutic approach, more efficient, with 
effective doses for the prevention and treatment of bacterial, fungal and viral 
infections that are often associated with implants. This design of such specific targeting 
drug delivery system also aims to reduce undesired side effects. It also eliminates the 
time that otherwise is needed for the drugs to be processed by the liver. Therefore, a 
reduced amount of the drug will produce comparable beneficiary effects compared to 
the amount of drug usually required for intravenous or oral administration. 
Furthermore, such kinds of delivery systems can be customized based on the needs of 
the patient by varying the entrapped antibiotics/drugs. 
 
Depending on the body implant, suitable antibiotics reported in literature include 
rifampicin, chloramphenicol, novobiocin, spectinomycin, trimethoprim, erythromycin, 
doxycycline, minocycline, vancomycin, acyclovir, amphotericin B, gentamicin, 
gentamicin sulfate, tobramycin, ampicillin, penicillin, ethambutol, clindamycin, and 
cephalosporins including pharmacologically acceptable salts and acids thereof (Fu-
Giles, 2013). 
 
In this PhD. Thesis, ampicillin, a β-lactam antibiotic that is active against both gram-
positive and gram-negative bacteria widely used clinically for the for the treatment of 
a broad range of bacterial infections (Mandell, 1990; Queiroz, 2001; Carafa, 2004) has 
been used as antibiotic for its application in implantable PP meshes. 
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1.4. Modification of textile materials by plasma treatment  
 
Synthetic polymer textile fibers have a lot of advantages such as high chemical 
stability, good mechanical properties, etc. However, despite these advantages, 
polymers have limitations. In general, special surface properties with regard to 
chemical composition, adhesion, hydrophilicity, roughness or conductivity are required 
for successful application of polymers in such wide fields as adhesion, coatings, thin-
film technology, biomaterials, and so on. Unfortunately, polymers very often do not 
possess the surface properties needed for these applications. In fact, polymer fibers 
that are mechanically strong, chemically stable, and easy to process usually will have 
inert surfaces both chemically and biologically. Due to this dilemma, surface 
modification of the polymer fibers with low-temperature plasma without altering the 
bulk properties has been a classical research topic during the last years, and is still 
extensively studied as new applications of polymeric materials emerge, especially in 
the fields of biotechnology, bioengineering, and in nanotechnology.  
 
The main hypothesis of this PhD. Thesis regards the drug incorporation and release 
from the surface of the polymer fibers, which is related to the interaction of the drug 
with the polymer and probably greatly depends on the surface chemistry of the fiber. 
Plasma technology is a tool that allows modifying physical and chemical properties of a 
material’s surface such as the textile fibers. The novelty of this investigation rests upon 
the implementation of plasma technology to medical and sanitary textiles aimed at 
constituting new drug delivery systems. The treatment of the textile material by 
plasma technology fits the aim of modifying the interactions drug/fiber and 
modulating its incorporation to the fibre and the release of the antibiotic from the 
fiber of the textile-based drug delivery systems. In the following sections, low-
temperature plasma is described, and the state of the art regarding the modification of 
textiles is reviewed. 
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1.4.1. Plasma definition 
 
The physical definition of a “plasma” is a state of mixed ions, free radicals, electrons, 
excited molecules, UV and visible radiation that preserves electrical neutrality. Plasmas 
can exist over an extremely wide range of temperature and pressure. Atmospheric 
pressure plasmas (APP) or low-temperature plasmas (LTP), used in this research work, 
are generated by gaseous electric discharges, they provide a source of high-energy 
electrons without excessive heating and are highly reactive chemically (Ward, 1982; 
Inagaki, 1996). The interactions of the electrically charged particles with each other, 
with the neutral gas and with contact surfaces produce the unique physical and 
chemical properties of the plasma environment. This environment is distinct from that 
found in solids, liquids or gases; hence plasmas are usually called the 4th state of the 
matter. 
 
1.4.2.  Plasma in nature and laboratory devices 
 
Although some phenomena related with plasma had already been described before, 
plasma was first defined by W. Cookes in 1879 as electrically charged gas molecules or 
ions. However, it was Langmuir in 1923 who gave the name plasma to the 4th state that 
occurred when a gas at low pressure was submitted to an electric field. Since then, 
many efforts have been done in order to understand better the plasma state but also 
in order to use plasma as a tool for processing technology. 
 
Much of the visible matter in the universe is in the plasma state. This is true because 
stars, as well as all visible interstellar matter, are in the plasma state. As described in 
Figure 13, plasmas are classified as a function of their electron number density and 
their generation temperature.  
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Figure 13: Classification of plasmas in nature as a function of generation temperature and electron 
number density. 
 
Besides the astro-plasmas, which are omnipresent in the universe, two main groups of 
plasmas can also be distinguished, i.e. the high-temperature or fusion plasmas, and the 
so-called low-temperature plasmas or cold plasmas (Bogaerts, 2002). Cold plasmas are 
divided in thermal plasmas, which regroup arc plasmas or plasma torches, and non-
thermal plasmas, which include laboratory plasmas such as corona plasma, glow 
discharge, dielectric barrier discharge, low-pressure plasmas, etc. (Figure 14).  The 
latter group of plasmas is the one that includes the plasmas used for this investigation.  
 
Cold plasmas can be obtained at an experimental level, from a gaseous media 
combined with an adequate power source. A gas is normally an electric insulator. 
However, when a sufficiently large voltage is applied across a gap containing a gas or 
gas mixture, it will break down and conduct electricity. The reason is that the 
electrically neutral atoms or molecules of the gas have been ionized, i.e. split into 
negatively charged electrons and positively charged ions. 
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Figure 14: General classification of plasmas. 
 
The nature of the breakdown and the voltage at which this occurs varies with the gas 
species, gas pressure (from low pressure to atmospheric pressure), gas flow rate, the 
materials and the geometry, nature and separation of the electrodes across which the 
voltage is sustained, the separation distance of the electrodes, the nature of the high 
voltage supply and the actual electrical circuitry. The resulting ionized gas is often 
called a discharge, low-temperature or cold plasma. The main effects of cold plasmas 
on a material’s surface in the first nanometers on the material surface (described in 
details in section 1.4.4) are: 
- Functionalization (covalent bonding of new chemical moieties) 
- Etching (elimination of material from the surface) 
- Thin film deposition (deposition of thin layers) 
 
1.4.3. Plasma reactors in research and at industrial level: Cold plasmas 
 
Cold plasmas can be used for various surface treatments such as: cleaning, surface 
activation, functionalization, plasma polymerization (gaseous monomers); grafting; 
deposition of polymers, chemicals and metal particles by suitable selection of gas and 
process parameters. They are commonly used for their low temperature ensuring the 
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preservation of the treated material and for being a dry process without the use of any 
chemical, avoiding the generation of wastewaters, to achieve the desired physical and 
chemical modification of a surface. 
 
Plasma reactors can be classified as a function of their power supply and applied 
frequency in:  
 Low-frequency reactors between 50 and 450 kHz,  
 Radio-frequency reactors at 13.56 MHz or 27.12 MHz, 
 Microwave reactors when the frequency achieves 915 MHz or 2.45 GHz.  
The power required may range from 10 to 5000 watts, depending on the size of the 
reactor and the desired treatment (Shishoo, 2007). In these types of generators, 
plasmas are produced when energy is transferred by an electric field to free electrons 
within a low-pressure environment (Lichtenberg, 1994). 
 
Plasmas can also be classified as a function of the working pressure into low-pressure 
plasma or atmospheric pressure plasma.  
 
1.4.3.1. Low-pressure plasmas 
 
On the one hand, in low pressure plasmas, a vacuum chamber (or vessel) is pumped 
down to a pressure in the range of 10-2 to 10-3 mbar (or below) with the use of high 
vacuum pumps. The gas which is then introduced in the chamber is ionized with the 
help of a high frequency generator or an AC power supply. The advantage of the low-
pressure plasma method is that it is a well-controlled and reproducible technique 
(Shishoo, 2007). This kind of plasma has been used in this PhD. Thesis. Cold plasmas 
are a mature technology originally developed for the microelectronics industry but 
now applied to a wide variety of fields. However, low-pressure plasma systems require 
an expensive and complicated vacuum environment (Liston, 1993).  
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Figure 15: Scheme of a low-pressure plasma reactor. 
 
 
1.4.3.2. Atmospheric pressure plasmas 
 
On the other hand, atmospheric pressure plasmas regroup corona plasmas and 
dielectric barrier plasmas. Atmospheric pressure plasma devices have been developed 
to overcome the drawbacks of low pressure plasma treatment in which a vacuum 
system is required. Typical atmospheric pressure plasma systems are corona 
discharges, dielectric barrier discharges (DBD) and plasma torches (Jeong, 1998; Jeong, 
1999; Shishoo, 2007).  
 
 
Corona treatment 
 
Corona discharge is characterized by sharp bright filaments extending towards the 
substrate, due to the high-voltage between two electrodes. Corona treatment is the 
longest established and most widely used plasma process; it has the advantage of 
operating at atmospheric pressure, the reagent gas usually being the ambient air 
(Shishoo, 2007). Corona systems have the manufacturing requirements for the textile 
industry (width, speed, etc.), even if in this type of plasma the spectrum of surface 
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functionalization of materials is not as broad as the low-pressure plasmas. Corona 
systems also rely upon very small inter-electrode spacing (millimeter scale) and 
accurate web positioning, which are incompatible with ‘thick’ materials (Figure 16). 
This type of plasma has been used in this PhD. Thesis for the treatment of polyamide 
and polypropylene fibres.  
 
 
Figure 16: Scheme of an atmospheric plasma reactor: corona system of potencial use in the textile 
industry. 
 
Dielectric barrier discharge (DBD) 
 
Dielectric barrier discharge is a broad class of plasma source that has an insulating 
(dielectric) cover over one or both of the electrodes and operates with high voltage 
power ranging from low frequency to 100 kHz. This results in a non-thermal plasma 
and a multitude of random, numerous arcs form between the electrodes. However, 
these micro-discharges are non-uniform and have potential to cause uneven 
treatment. 
 
 
1.4.4.  Plasma applied to polymeric surfaces and fibers 
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The surface modification of polymers using plasma technology has increasingly 
attracted attention in the recent years. Plasma treatments are an effective way to 
modify the wettability (or hydrophilicity) and the topography of the first nanometers 
of a polymer surface without affecting the bulk properties (Qui, 1993; Qiu, 2002a; Qiu, 
2002b; Okuno, 1992, Wakida, 1993; Wakida, 1998; Holländer, 1999; Liu, 2006; Ren, 
2007). The goal of surface treatment is to modify the interactions between the 
material and the environment. Surface properties of polymers and textiles can be 
modified by atmospheric or low-pressure plasma. Physical and chemical properties of 
a solid surface significantly affect adhesion, wetting, friction, anticorrosion and light 
reflection. Low-pressure and atmospheric plasma treatments are attractive for several 
reasons: they allow modification of the surface layers up to a depth of several 
nanometers of the substrate while maintaining its bulk properties, they can achieve 
the desired surface polarities, their low temperature avoids sample damage, they are 
of a dry, environmentally friendly nature (Shishoo, 1996) and they offer new research 
areas, in particular in material sciences.  
 
Atmospheric plasma technology is well established in different industrial applications. 
In the last decades, the plasma technology has been studied in the textile industry as 
well. Fields of application are desizing, functionalizing, and modification of fabric 
surface properties for different applications, among others, such as textile digital 
printing, functional finishes, etc. Applied to the textile field, plasma technology is 
suitable to modify the surface chemistry as well as the topography of the surface of 
the fibres. Therefore, plasma treatment on textiles can be used to give hydrophilic 
properties to a hydrophobic surface. This increased wettability can enable a better 
incorporation of chemical components into the fabrics. Modified wettability is one of 
the most apparent results of plasma treatment. Plasma-produced polar groups 
increase the surface free energy (γ) of the fibre and decrease the contact angle (θ), 
usually correlating with better bonding of adhesives; θ has often been used as an 
approximation to evaluate adhesion and wetting behavior (Shishoo, 2007). 
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Literature reports different treatment times used for surface modification of polymers 
ranging from milliseconds (Borcia, 2003; Borcia, 2004) to several minutes. A 
millisecond treatment often causes oxidation and removal of surface contaminants 
which is often sufficient to improve surface wettability. A further treatment usually 
causes chemical bonding of oxygen atoms at active sites on the polymer surface, 
leading to formation of various functional groups that modify the surface wettability. 
With prolonged treatment time excessive chain scission may appear leading to a layer 
of low-molecular-weight fragments on the surface (Strobel, 1994). Also, prolonged 
treatment often causes chemical etching of polymer materials, increased sample 
temperature and eventual irreversible damage of the bulk properties. In many cases, 
the longer exposure of the surface, not only of polymers, leads to creation of various 
nanostructures (Cvelbar, 2003; Chen, 2008; Mozetič, 2005; Ostrikov, 2007; Tam, 2006; 
Xu, 2005, Vessel, 2009). 
 
The type of gas and working parameters of the plasma treatment (time, power, 
pressure, etc.), as well as the fabric pre-treatment and its initial state, condition the 
effects obtained on the sample. This enables a variety of generic surface processes and 
effects such as surface activation by bond breaking to create reactive sites, grafting of 
chemical moieties and functional groups, material volatilization and removal (etching), 
dissociation of surface contaminants/layers (cleaning) and deposition of thin layers.   
 
Gases usually used for plasma treatments can be: 
 Chemically inert (e.g. helium and argon) 
 Reactive and non-polymerisable (e.g. ammonia, air, nitrogen, oxygen) 
 Reactive and polymerisable (e.g. tetrafluoroethylene, hexamethyldisiloxane). 
 
In the course of this PhD. Thesis, the three different kinds of gases are employed.   
 
The interaction of cold plasmas with polymer surfaces involves both gas and surface 
reaction mechanisms. The gas-phase reactions in the discharge volume leads to the 
production of species including atoms, molecules, free radicals, ions of both polarities, 
electrons, photons and excited species in different electronic, vibrational and 
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rotational states. Depending on the energy and the reactivity of the plasma-created 
species with respect to each other and with respect to the polymer surface, 
recombination on the surface, deposition process or etching of the polymer take place 
(D’Agostino, 2008). 
 
Polymer materials subject to plasma treatments undergo major chemical and physical 
(China, 2012) and both surface chemistry and surface topography may be affected, and 
the specific surface area of fibres can be significantly increased. The main effects that 
can be produced by plasmas are described in the following sections. 
 
1.4.4.1. Etching and surface cleaning 
 
Plasmas create a high density of free radicals by dissociating molecules through 
electron collisions and photochemical processes. This causes the disruption of the 
chemical bonds in the fibre polymer surface which results in the cleaning of the 
material surface and in the formation of new chemical species. 
 
Plasma etching or ablation is essentially used to remove material from a surface. It can 
be conducted with a variety of discharge sources, such as direct current glow 
discharges or RF discharge. The three important parameters for etching are: etched 
rate uniformity, anisotropy and selectivity. Usually, surface etching reactions are 
carried out to improve wettability of material surface and favor the formation of weak 
boundary layers. 
 
One can take advantage of this ablation effect of plasmas to eliminate deposited 
materials or contaminant layers often existing on the surface of polymers (Figure 17). 
This layer could be due to polymer processing products and finishing additives such as 
antistatic agents, lubricants (mineral oil, polyolefin waxes, fatty acid esters, etc.), 
antioxidants (phenols, amines, mercaptans, etc.), and light-protecting agents. 
Furthermore, the large molecular weight polydispersity of the polymer chains is also a 
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problem, and the presence of remnants of the initial monomers, oligomers, and 
solvents can never be excluded. Such compounds can be present over a thickness of 1 
to 10 nm and can constitute a weak boundary layer responsible for a great number of 
adhesion failures in different polymer assemblies with other materials (Bikerman, 
1961; Bikerman, 1968). 
 
 
Figure 17: Scheme of plasma etching of materials from the polymer surface. 
 
Plasma cleaning is an economical process if the build up of the contamination layer is 
not too massive, i.e. well below 1 mm. Depending on the type of contamination 
(oxidized surface, deposited material, etc.), different plasmas have been proposed: 
inert gases such as Ar to remove different contamination layers by sputtering, oxygen 
plasmas to oxidize organic contaminants, and hydrogen plasmas to reduce inorganic 
contaminants such as oxides or sulfides (Krüger, 1999). 
 
1.4.4.2. Surface activation  
 
The reaction of the polymer with the plasma-created species leads to bond cleavages 
of the polymer backbone, i.e. C–C and/or C–H bonds which results in the formation of 
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radicals in a process known as surface activation. Since all surfaces exposed to a 
plasma establish a negative potential (Grill, 1993; Lichtenberg, 1994), the positive ions 
in the plasma play a significant role in such processes. The ultraviolet radiations also 
contribute to the production of free radicals (Holländer, 1999). The activation step is 
shown below in the case of the simplest polyolefins, i.e. polyethylene giving rise to 
alkyl radicals: 
 
Figure 18: Activation step in the case of the polyethylene giving rise to alkyl radicals. 
 
These free radicals which are characterized by short lifetimes (Kuzuya, 1998) can then 
go through various chemical reactions involving plasma species (grafting or 
functionalization) in situ, result in cross-linking of the polymer layer (D’Agostino, 2008), 
or react with air in the gas extraction from the plasma reactor.  
The activation stands for the formation of polar functional groups on the polymer 
surface. Standard polar functional groups formed on a polymer surface after surface 
activation are C–O, C=O, O–C O, i.e. oxygen is bonded to carbon atoms, (partially) 
substituting hydrogen originally bonded to carbon atoms (Occhiello, 1991; Hody, 
2006). Oxygen may also break double bonds C=C to form the functional groups. In any 
case, the appearance of functional groups and resulting modification of surface 
properties of polymer materials are usually due to interaction of oxygen with surface 
carbon radicals (Cvelbar, 2007). 
 
1.4.4.3. Functionalization reactions 
 
Surface functionalization by plasma processes can be defined as the grafting of new 
chemical moieties to the surface substrate by covalent bonding. The selection of the 
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type of gas for plasma generation depends on the subsequent application of the 
treated material and the type of bond desired.  
 
Functionalization of polymer surfaces by plasma treatment can be of two types (Figure 
19): 
- A specific functionalization, being a process leading to the formation of 
functional groups, by bromination, fluorination, etc.  
- An unspecific functionalization, as the formation of different oxygen-containing 
groups by exposure to air or oxygen plasma, like the plasma treatments using 
air as gas for plasma generation performed in this PhD. Thesis. 
 
 
Figure 19: Concept of specific functionalization and unspecific functionalization of a polymeric surface 
by plasma treatment. 
 
Even for specific functionalization, that can show a selectivity >85%, it should be noted 
that plasma treatment usually does not produce only one type of a functional group on 
a polymer surface. Typically, several different functional groups appear on the surface 
of polymer during plasma treatment. It is therefore necessary to apply such plasma 
that facilitates formation of the functional groups that are most important for a given 
application and to attempt to shift the distribution in favor of a specific functionality by 
changing plasma parameters (Gerenser, 1996).  
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The surface tension (also called surface energy) of many polymers is rather low due to 
the lack of polar functional groups in the material. A broad range of surface energy can 
be achieved by using appropriate plasma for polymer treatment, from extreme 
hydrophilicity to significant hydrophobicity. The type of gas used for plasma 
generation and plasma working conditions influence the type of functionalization, 
enabling a variety of generic surface wettability for a same polymer. Increased 
hydrophobicity is usually achieved by application of plasma rich with fluorine (Yasuda, 
1984), while hydrophilicity is often achieved using oxygen plasma. In some 
applications, especially to increase the biological compatibility of organic materials, 
nitrogen or ammonia plasma gives better results (Meyer-Plath, 2003). 
 
 
Figure 20: Scheme of polymer surface functionalization by plasma processes using air as gas for 
plasma generation. 
 
Oxygen and air plasma treatments usually lead to the formation of different functional 
groups such as C-O, C=O, O=C-O. Sometimes, other groups can be produced on the 
surface of some polymers, like imides, amines, amides, etc. (Gerenser, 1996; Strobel, 
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1994) (Figure 20) due to the presence of N2 in the air. Reactive particles created in 
oxygen or air plasma react with organic materials at certain rates. The rates depend on 
the type of polymer and particle as well as the sample temperature and particles 
kinetic temperature. High oxidation selectivity for different types of organic materials 
can only be obtained with cold plasmas (Vessel, 2009).  
 
1.4.4.4. Plasma polymerization 
 
Besides the surface activation, the introduction of functional groups or the etching of 
the polymer fibers surface, plasma can be used for the deposition of thin polymer films 
by the so-called plasma polymerization. Coating by plasma polymerization is defined as 
the formation of polymer materials, on a surface, under the influence of plasma 
conditions. It refers to the deposition of polymer films due to the excitation of an 
organic monomer in gas state and subsequent deposition and polymerization of the 
excited species on the surface of a substrate. Polymers formed by plasma 
polymerization are, in most cases, highly branched and highly cross-linked. The 
deposition of solid polymer coatings under plasma conditions has been well studied 
since the 1960s, with a very wide range of materials now accessible (Yasuda, 1985).   
 
Before plasma polymerization, a previous surface activation step by plasma reaction is 
generally carried out to remove contaminants or finishing agents from the surface and 
to generate surface radicals which may then react with the precursor monomers and 
generate a stronger bond on the surface. In the plasma polymerization process, a 
monomer gas is pumped into a vaccum chamber where it is polymerized by a plasma 
to form a thin film on the surface. The monomer, which starts out from a liquid fed 
into an external recipient, is converted to a gas in an evaporator or dragged by 
bubbling with an inert gas, and is pumped into the vaccum chamber. A glow discharge 
initiates the polymerization. The excited electrons created in the glow discharge ionize 
the monomer molecules. The monomer molecules break apart creating free electrons, 
ions, excited molecules and radicals. The radicals absorb or react with the previously 
activated surface, condense, and polymerize on the substrate. The electrons and ions 
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crosslink, or create a chemical bond, with the already deposited molecules to form a 
polymer (Figure 21).  
 
 
Figure 21: Scheme of plasma polymerization process. 
 
The selection of monomers for plasma polymerization will determine the polymers 
produced on the surface. For biomedical applications, the monomer selected should 
yield biocompatible plasma polymers. In the present work, we have investigated the 
possibility of applying a biocompatible polymer to the surface of polypropylene 
meshes. 
 
1.4.4.5. Thin film deposition 
 
Plasma technology can also be used for thin film deposition. Using Physical Vapor 
Deposition (PVD), a film can be formed by atoms directly transported from a source to 
the substrate through gas phase by evaporation (thermal evaporation or e-beam 
evaporation), sputtering or reactive PVD. Another way to obtain plasma-assisted thin 
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film deposition is by Chemical Vapor Deposition (CVD), in particular Plasma-Enhanced 
CVD (PECVD), in which the film is formed by chemical reaction on the surface 
substrate.  
Both types of techniques are widely used to performed metallization of surfaces and 
are broadly develop in microelectronic industry. The last years, plasma assisted-PVD 
and CVD have also found attraction in textile investigation (Gulrajani, 2011). Ultra thin 
layers on textile can be developed by using plasma either in PVD or PECVD. For 
example, PVD has been used for Indium-Tin-Oxide coating of nonwoven fabrics (Wei, 
2010) or for the coating with copper to produce an antimicrobial finish on cotton 
textiles of a 60-70 nm thickness (Vihodceva, 2011) while PECVD has been used to 
obtain thin uniform coating of poly(allyl alcohol) on silk, wool and cotton fibres 
(Malkov, 2010), or PECVD of TiO2 films on cotton knits has been reported for 
photocatalytic applications (Szymanowski, 2005).  
 
1.4.5. Plasma treatments in the textile field  
 
As shown in the previous section, the main effects of plasma treatment using gas for 
plasma generation as unique reactive on polymer surfaces usually results in the 
formation of new functional groups (such as —OH,—C=O, —COOH in the case of 
oxygen-containing plasma gas) combined with the elimination of surface 
contaminants, which affect fabric wettability as well as facilitate graft polymerization. 
All these effects, combined with the advantages of being a dry technology which 
avoids the use of chemicals and does not produce any wastewaters, have lead plasma 
technology to be incrementally implemented in the recent years in the textile 
industrial field to create new technical textiles, to modulate the wettability of natural 
and synthetic fibres, to improve the adhesion or shrink resistance of fabrics or to 
improve textile manufacture processes. 
 
Until today, plasma technology has been studied in the textile field for specific 
applications. The first studies to modify textile fibres were carried out in the 1960’s by 
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Anderson et al. who used ionic bombardment ablation to prepare synthetic fibres for 
electron microscopy studies (Anderson, 1960). The first experiment in which low-
pressure plasmas were applied to textiles was in the 1970’s. By using Ar and volatile 
monomers, thin films were deposited on polyester, polyamide 6.6 and wool fabrics 
(Byrne, 1972). 
Since these initial experiments, a wide range of plasma applications for modification of 
textile fibres properties have been investigated. It was applied in particular to increase 
color depth of dyestuffs on wool, silk (Ryu, 1991), poliamide (Ryu, 1992) and aramide 
(Kobayashi, 1995) fabrics, to increase the wettability of wool fabrics (Kan, 1998a; Kan, 
1998b; Rouette, 2001; Kim, 2002), or to improve their shrink resistance (Zuchairah, 
1997; Erra, 1999). It has also been studied to produce water repellent fabrics by means 
of CF4 plasma (Yasuda 1984) or to improve the adhesive properties of both natural and 
synthetic fabrics (Rakowski, 1982; Wakida, 1996a); in dyeing processes to increase the 
color intensity of the fibres (Hirano, 1984) or the dyeing kinetics (Wakida, 1996b; 
Wakida, 1998; Yip, 2002a; Yip, 2002b). However, until now, investigation on plasma 
technology has been mostly applied to textiles for conventional textile applications 
but, to our knowledge, never to incorporate active principles in textile materials. 
 
One of the first works on polypropyelene fibers describing low temperature plasma 
treatments, was a study of the modification of the topography and the roughness of RF 
plasma treated polypropylene with several gases and at different treatment times and 
RF-potentials (Collaud Coen, 1996). Plasma treatments with reactive gases (N2, O2) 
lead to the incorporation of new chemical species on the PP surface, whereas plasma 
treatments with noble gases (He, Ar, Xe) induced the desorption of hydrogen and a 
graphitization (Collaud Coen, 2003).  
 
The influence of cold plasma parameters on wettability and adhesion of polymeric 
surfaces has also been investigated, focusing on the nature of the relationship 
between wettability and adhesion (Carrino, 2002). Surface characterization of plasma-
treated PP fibers has also been studied with a low pressure plasma with O2 as plasma 
activation gas (Wei, 2004; Wei, 2006) or with a vertical cold gas plasma (Huang, 2006) 
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with special emphasis on the influence of the plasma treatment on the dynamic 
contact angles of the PP fibers. Induced super hydrophilicity due to surface 
modification of PP membrane treated by O2 radio frequency glow discharge plasma 
was also reported (Jaleh, 2010). 
Plasma treatment of PP fabrics by means of atmospheric dielectric barrier discharge 
(DBD), has also been studied for improved dyeability with a textile dyestuff (Yaman, 
2009). The impact of plasma treatment parameters on the surface morphology, 
physical-chemical, and dyeing properties of PP using anionic and cationic dyestuffs 
were investigated. Argon plasma treatment was used to activate PP fabric surfaces. 
Plasma activation of nonwoven PP using two different ambient air plasma sources: 
volume dielectric barrier discharge (DBD) and diffuse coplanar surface barrier 
discharge (DCSBD) has also been described for its subsequent functionalization by 
silver ion deposition (Radić, 2012). 
 
Medical textiles are a field of increasing interest and growing applications, which 
include implantable and non-implantable textiles. To confer them with added value, 
various approaches to use the medical textiles as drug delivery systems have been 
described in literature, usually based on encapsulation techniques, hollow fibres, 
biodegradable fibres or the use of chemical linkers. However, to our knowledge, 
there is not any technique or drug delivery system in which the attachment of the 
pharmaceutical and/or cosmetic active principle is directly achieved as a result of the 
modification of the interface drug/fibers by a physical dry process such as plasma, 
well known and set in surface science as an efficient tool for polymer surface 
modification.  
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2. MOTIVATION, OBJECTIVES AND STRUCTURE OF THE THESIS 
 
 
2.1. Motivation 
 
Medical textiles (MEDTECH) constitute an expanding field within the technical textiles. 
MEDTECHs include healing and suture materials, elastic-compressive products, 
materials of protection and hygiene, and body implants. One of the added values of 
these materials can be the capacity to contain and release an active principle. 
Currently, R&D in the development of drug delivery systems is oriented in achieving 
controlled release of active agents over a predetermined lapse of time, in order to 
avoid the administration of several doses of drugs or cosmetic products and improve 
the therapy compliance by the patient. Nowadays, there are drug delivery systems 
based on textile fibres, which are used as drug reservoirs, (e.g. hollow fibers), as 
resorbable fibers, or with hydrogels or other polymeric coatings. 
The main investigation line of this PhD. Thesis is focused on textile-based drug 
delivery systems where pharmaceutic and cosmetic active principles are loaded into 
synthetic textile fibres, whose surface has been suitably modified chemically and/or 
topographically, at the nanoscale, using plasma technology. Therefore, the influence 
of the surface modification of the polymer fibres by plasma treatment has to be 
evaluated on the drug loading and latter release from the fibres to a suitable receptor 
media, in views of their biomedical applications as delivery systems for active 
substances. The use of plasma technology to modulate the drug incorporation and 
release is an innovative and original contribution of this thesis. By modifying the 
chemical bonds on the surface of textile fibers through the use of plasma, we foresee 
to improve the release kinetics of the active principles from the synthetic fibres, and 
the improvement of the therapeutic efficiency. 
The subject investigated in this PhD. is Thesis framed in the field of Textile Engineering, 
Biomaterials, Nanotechnology and Health, and therefore has an undoubted 
interdisciplinary component. One of the milestones associated with this thesis is to 
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bring innovative applications and high added value for textile-based materials in the 
field of biomaterials and on drug delivery systems. 
 
The application of nanotechnology in the fields of biotechnology and human health 
presents promising expectations in the field of materials science for biomedical 
applications. In this context, an emerging technology such as low-temperature plasma, 
which can modify the first nanometers of the surface of the material and which has 
been studied extensively for the modification of textile materials, can open the doors 
to new applications. 
 
 
2.2. Purpose of the investigation 
 
 
The PhD. Thesis will investigate if the controlled modification of the surface of two 
chemical fibers of synthetic polymer by means of two kinds of plasma systems 
modifies the quantity of pharmaceutics and cosmetics active principles that can be 
incorporated into these fibres and the “in vitro” release kinetics of the drug from the 
fibres to an isotonic liquid receptor. In this way, the surface modification of textile 
materials will be performed by atmospheric and low pressure plasmas, and the 
changes of surface chemistry and topography will be evaluated to determine how the 
subsequent incorporation of active pharmaceuticals and cosmetics to the fabric and 
the early release to the standard medium are affected by these surface modifications. 
The aim of this investigation is to determine if the plasma treatments of the fabrics can 
modulate the loading to the textile fibre and the release of the drugs from them, and 
in which way they bring this modulation (modification of the drug loaded in the fibres, 
modification of the release amount of drug and/orthe release kinetics, etc.).  
 
In this thesis, two types of textile materials will be studied: 
 An elastic-compressive PA66 knitted fabric, loaded with pharmaceutical and 
cosmetic active principles and aimed for a release in topical applications. 
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 A polypropylene mesh, loaded with antibiotics, and aimed to prevent infection 
and noseucomial desease after hernia repair surgery by releasing the antibiotic 
directly in the surgical site. 
 
2.3. Main objectives 
 
The main objective consists in designing drug delivery systems based on a new-loading 
technology using textile materials (fibers, yarns, fabrics) as supports, in which 
modulation of the release of the active principles is guided by the surface modification 
achieved by plasma treatment. By monitoring the parameters of plasma treatments, 
the objective is to determine the mechanisms by which low-temperature plasmas 
influence the loading of drugs in the fibre and their release for two types of 
applications of the textile-based drug delivery system: 
 
Modification of textile materials by plasma treatment for topical applications 
 
A first investigation line is focused on the evaluation of corona plasma and low 
temperature plasma in the modification of the incorporation and release of an anti-
inflammatory drug (ketoprofen) and an anti-lipidic active principle (caffeine) from 
PA66 knitted elastic-compressive fabrics. Theobromine and pentoxifylline, belonging to 
the methylxantines’ family as well as caffeine, have also been studied for a 
fundamental study to support the results obtained with caffeine. In this way, the 
objectives of this first part of the PhD. Thesis are the following: 
 
 To determine the effects of atmospheric and low-pressure plasma treatments, 
using air as gas for plasma generation on the surface chemistry and the 
topography of the PA66 fibres. The most relevant parameters of the plasma 
treatment (pressure, power supply, gas flow, etc.) leading this surface 
modification have thus to be determined to select the optimal conditions of 
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plasma treatment of the PA66 fabrics for subsequent loading of active 
molecules to the fibres.  
 
 To evaluate if the plasma treatment leads to an improvement of the loading of 
the active principle, and its relqtionship with the surface modifications on the 
PA66 fibres achieved by plasma treatment. 
 
 With views on industrial applications, it is an aim of this work to evaluate 
potencial differences between industrially finished fabrics and laboratory 
washed PA66 fabrics. 
 
 To determine if air atmospheric and low-pressure plasma treatments on PA66 
fabrics are able of modifying the release kinetics of the active principles, and to 
which extend depending on the conditions employed during the plasma 
treatments. It should also be verified that the modified release of the active 
principle from the plasma-treated PA66 fabrics is comprised within the 
therapeutic range of the active principle. 
 
Modification of textile materials by plasma treatment for implants 
 
The second part of this PhD. Thesis is focused on the evaluation of the potential of 
plasmas (both non- and polymerizing) with regards to the incorporation and release of 
an antibiotic (ampicillin) from PP meshes aimed as body implant for hernia repair, in 
views to confer an added value to the surgical mesh in order to prevent and avoid 
post-surgical infections. Thus, the main aims of the second part of the work are: 
 
 To determine how both atmospheric and low-pressure plasma treatments 
modify the surface chemistry and the topography of the PP fibres and select 
the optimal conditions for treatment.  
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 To study if the surface modification produced reverts in a modification of the 
loading of an antibiotic (ampicillin) on the polymer fibres. 
 
 To determine the influence of plasma treatments of the PP meshes with non-
polymering gases on the release properties of ampicillin. 
 
 Given the relevance of surface adhesion in biological properties, its 
modification will be investigated through plasma polymerization treatments. 
 
 To verify the conservation of the antibacterial activity of the drug loaded in the 
plasma-treated PP surgical meshes. 
 
2.4. Stages to reach the objectives 
 
To achieve the main objective of designing new delivery systems for active principles 
using textile materials as supports in which the modulation of the release of the active 
principles is the consequence of the surface modification by plasma treatment, the 
following strategies and stages have been stated: 
 
 Characterize the textile materials  
 Study the modification of the surface properties (physical, chemical and 
topographical) of plasma treated textiles. 
 Study the impregnation and release of various active ingredients from the 
untreated fabrics. 
 Study the impact of plasma modification of textile products on the 
impregnation and the release kinetics of the active pharmaceutical and 
cosmetic molecules selected. 
 Study the influence of the initial state and preparation of the textile fibres. 
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 Determine the plasma working parameters directly influencing the modulation 
of the release of the active principles (gas flow rate, power, processing time, 
pressure, etc.).  
 Find pharmacokinetics models that can adjust the release profiles according to 
the treatment plasma applied. 
 
2.5. Structure of the thesis 
 
After the introduction dedicated to the state of the art in the fields of medical textiles, 
chemical fibres, cosmetic and pharmaceutical active principles and plasma treatment 
of polymers and textile materials, and the exposition of the objectives presented in 
this section, the textile materials, experimental protocols, strategies and techniques 
used for the development of this Thesis are presented in the following experimental 
part. 
Afterwards, the results and discussion have been organized in two differentiated parts. 
The first part aims at the study of the influence of plasma treatment on the physical, 
chemical and topographical properties of a polyamide 6.6 knitted fibres, and its 
consequences on the loading of ketoprofen and methylxantines compounds into the 
fabric and on the subsequent release of such active principles from the fibres to an 
isotonic liquid media, in view to an application of the polyamide fabric as drug delivery 
system for topical application.     
The second part aims at the influence of plasma treatment on physical, chemical and 
topographical properties of a polypropylene mesh and its consequences on the loading 
of the ampicillin into the mesh and on the subsequent release of such antibiotics from 
the fibres to an isotonic liquid media, in view to an application of the polypropylene 
fabric as drug delivery system as implantable textile. Antibacterial properties of 
plasma-treated PP mesh has also been studied, as well as a subsequent polyethylene 
glycol coating by plasma polymerization of the ampicillin-loaded PP mesh to support 
the modulation of the antibiotic release from the PP fibres. 
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Figure 22: Structure of the PhD. Thesis. 
 
This PhD. Thesis will conclude with a final chapter in which the most relevant results 
will be recapitulated, leading to an opening regarding the further investigation lines. 
Therefore, the structure of the Thesis can be schematized as described in Figure 22. 
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3. EXPERIMENTAL PART 
 
3.1. Material 
 
3.1.1. Textiles and polymer films 
 
For this research, two different fabrics have been employed: 
 A polyamide 6.6. (PA66) elastic-compressive knitted fabric, undyed, kindly 
provided by Tejidos Elásticos Lloveras S.A. (Spain) with a density of 132 g.m-2 
has been used as medical textile support for topical applications (Figure 23). It 
is made by textured multifilaments of PA66 and multifilament of elastane 
(Lycra) fully covered with circular-section PA66 multifilaments, being only the 
polyamide filaments directly exposed to the surface. 
 
 
Figure 23: PA66 elastic-compressive knitted fabric (a) macroscopic image and (b) SEM image used as 
textile supports in this PhD. Thesis. 
 
 A polypropylene surgical mesh, made from a 0.15 mm diameter monofilament, 
with 1.3 x 1.0 mm pore size and 97 ± 2.0 g/m2 weight, provided by 
SurgicalMeshTM (USA) has been selected for this research (Figure 24). This PP 
mesh presents a 0.53 ± 0.10 mm thickness and a MD/CMD (Machine 
Direction/Cross Machine Direction) grab strength of 313 and 419 N/2.5 cm 
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(ASTM D-5034 standard). The fabric has been manufactured from 
homopolymer polypropylene monofilament. According to the supplier, the PP 
mesh fabric has been found to meet ISO-10993 (specially parts 4, 5 and 10) for 
biocompatibility with respect to hemolysis, cytotoxicity and intercutaneous 
reactivity.  
 
  
Figure 24: (a) PP mesh macroscopic image and (b) Scanning Electron Micrograph of the structure of 
the PP mesh. 
  
A homopolymer PP film (Goodfellow, England) with a 79.2 g.m-2 and 0.27 mm thickness 
has been used as a model surface for contact angle measurements in the study of the 
modification of polypropylene surface  by plasma treatment. 
 
3.1.2. Active principles 
 
3.1.2.1.  Ketoprofen 
Ketoprofen (2-(3-benzoylphenyl propionic acid)) (KP), is a nonsteroidal anti-
inflammatory drug (NSAID) with analgesic and antipyretic properties. Ketoprofen is 
poorly soluble in water and its molecular weight is 254.3 g.mol-1. Like other NSAIDs, KP 
has undesirable gastrointestinal side effects after oral administration. Among the 
efforts that have been made, topical and transdermal administration is one of the 
ways to overcome these side effects (Cordero, 1997). NSAIDs are widely used in the 
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treatment of rheumatoid arthritis, osteoarthritis, as well as mild remedy to moderate 
pain (Garcia, 2001). 
 
Figure 25: Chemical structure of ketoprofen. 
 
Ketoprofen (C16H14O3) (Figure 25), (KP), used as a model drug, has been purchased 
from Roig Farma, S.A., Spain, with a 99.8% purity. 
 
3.1.2.2.  Metylxantines  
 
Three molecules from the same chemical family (methylxantines) have been employed 
in this work:  
 Caffeine  
 Pentoxifylline  
 Theobromine  
 
As explained in the following sections, caffeine has been used for its cosmetic 
properties while pentoxifylline and theobromine have been used in the fundamental 
study of the interactions between the plasma-modified surface and the active 
principles. 
 
3.1.2.2.1.  Caffeine 
 
Caffeine (1,3,7-trimethylxanthine), with molecular structure shown in Figure 26, is a 
natural white crystalline xanthine alkaloid, occurring in coffee, cocoa beans, cola nuts 
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and tea leaves. It is mildly stimulating and is also used as a therapeutic agent. Caffeine 
has pharmacological effects on the central nervous system, heart, peripheral and 
central vasculature, renal, gastrointestinal and respiratory system (Ritchie, 1975).  
 
  
Figure 26: Chemical structure of caffeine. 
 
However, in this work caffeine is employed as a cosmetic active principle for the 
treatment of cellulite. For cosmetic purposes, caffeine is reported to be used as an 
active compound in anti-cellulite products (Bertin, 2001), as described in section 1.3.2. 
Caffeine (Fagron Iberica S.A, 99.0%) was used in aqueous solution.  
 
3.1.2.2.2. Pentoxifylline 
 
Pentoxifylline (1-(5-oxohexyl)-3,7-dimethylxanthine), also known as Pentopak, 
Pentoxil, and Trental, is a xanthine derivative haemorrheological agent (Figure 27). 
Pentoxifylline reduces the viscosity of blood by increasing the flexibility of 
erythrocytes, encouraging migration of white cells, inhibition of aggregation of 
platelets, and lowering of the viscosity of plasma, actions that might correct 
microcirculatory disorders (Ward, 1987). 
 
Pentoxifylline has been purchased by Sigma Aldrich® with a purity grade ≥ 99.0 %. It 
presents a molecular weight of 278.31 g/mol and a limit of solubility in water at 20 °C 
of 517 mg/L. 
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Figure 27: Chemical structure of pentoxifylline. 
 
 
3.1.2.2.3.  Theobromine 
 
Theobromine (3,7-dimethylxanthine) is a crystalline powder with a colour listed as 
either white or colorless, such as caffeine and pentoxifylline (Figure 28). It has a 
similar, but lesser, effect than caffeine on the human nervous system as well as on 
vascular disease, making it a lesser homologue. The only molecular difference with 
caffeine is that the N-H group of theobromine is an N-CH3 group. Theobromine 
(C7H8N4O2) has been purchased by Sigma Aldrich® with a purity grade ≥99.0 %. It 
presents a molecular weight of 180.164 g/mol and a slightly water-solubility of 330 
mg/L at 20 °C. 
   
Figure 28: Chemical structure of theobromine. 
 
3.1.2.3. Ampicillin  
 
Ampicillin is a β-lactam antibiotic that is active against both gram-positive and gram-
negative bacteria and is widely used for the treatment of infections (Farag, 1998; 
Queiroz, 2001). Ampicillin (C16H18N3NaO4S) possesses an amino group side chain 
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attached to the penicillin structure (Figure 29). This penicillin derivative inhibits 
bacterial cell-wall synthesis by inactivating transpeptidases on the inner surface of the 
bacterial cell membrane. Ampicillin sodium salt (371.39 g/mol), provided by Sigma 
Aldrich® in white powder, presents a water solubility of 50 mg/mL . 
 
Figure 29: Chemical structure of ampicillin sodium salt. 
 
In this PhD. Thesis, ampicillin was the drug selected for incorporation in PP mesh for 
the treatment of surgical infections.  
 
3.1.3.  Chemicals 
 
o ECE standard detergent without brightening agent proveeded by SDC 
(Bradford, England) has been used for the laboratory washing of the PA66 and 
PP fabrics according to ISO 105:C06. 
 
o Phosphate buffer saline (PBS), pH 7.4, was prepared from KH2PO4 (Fagron 
Iberica S.A.V, Spain), Na2HPO4 (Probus S.A, Spain), NaCl (Acofarma®, Spain), and 
Milli-Q® deionized water. All these chemicals were of analytical grade. 
 
o Orthophosphoric acid (H3PO4), 85% purity, from Scharlab S.L. (Spain) was used 
to adjust the pH value of the phosphate buffer solution. 
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o Ethanol (Fagron Iberica S.A.V, Spain) with 99.8% purity was used to prepare the 
hydro-alcoholic solution of ketoprofen. 
 
o Ambient air was used as reactive gas for corona plasma generation and low 
pressure plasma generation 
 
o Argon (Ar) (Air Liquide S.A., France), was employed as initiator gas during the 
surface activation process by pulsed-plasma, previous to the plasma 
polymerization of poly(ethylene glycol) (PEG) on the polypropylene fibres. 
 
o Tetraethylene glycol dimethyl ether (CH3O(CH2CH2O)4CH3), also called 
tetraglyme with purity ≥ 99% (Sigma-Aldrich), was employed as precursor in 
liquid form for the plasma polymerization to obtain coatings of PEG in the 
surface of PP fibres. 
 
o Agar bacteriological (Scharlau S.A., 07-004, 500 g, lot 100921) and Brain Heart 
Infusion Broth (BHI Broth) (Scharlau S.A., 02-599, 500 g, lot 10227) have been 
used to prepare the bacteriological culture media of Staphilococcus aureus. 
 
o Milli-Q water (Millipore Corp.)  
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3.2. Experimental strategies 
The research performed has been conducted in three main parts, as shown in Figure 25:  
 
 
Figure 30: Experimental scheme followed for (a) ketoprofen loading of industrially-finished PA66 knitted fabrics for pharmaceutical topical applications, (b) for the study 
of the influence of plasma treatment and initial preparation of the PA66 fabrics on the loading and the release of methylxantines, and (c) for obtaining plasma-treated 
ampicillin-loaded PP meshes to study of the influence of the plasma on the PP meshes for the loading and the release of ampicillin from the PP fibers. 
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3.3. Methods and techniques 
 
3.3.1. Washing processes of the fabrics 
 
Given that the polyamide fibers (IF-PA66) contain additives coming from industrial 
processing such as mineral oils, antistatic products, paraffin oils and/or silicone, a 
laboratory washing was carried out to obtain washed PA66 (W-PA66) and to study the 
influence of the surface state (and of these additives) on the plasma treatments and 
also on the subsequent impregnation and release of active principle from the fibers. All 
the PP mesh sampleshave been used after washing.  
Washing of both PA66 and PP was carried out using an Ahiba Polymat equipment with 
bath ratio of 1/10 and 5% v/v ECE standard detergent (ISO105:C06). Working 
conditions were maintained constant (60 ºC, 40 r.p.m.) during the 30 minutes of the 
process. Samples were rinsed five times under the same working conditions in distilled 
water. Finally they were dried at 60 ºC during 12 h followed by over-drying at 105 ºC 
during 15 min before their storage, in a desiccator (Figure 31).  
 
Figure 31: Storage of PP fabrics in a desiccator to avoid humidity absorption. 
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Two types of nomenclatures for polyamide 6.6 fabrics appear, corresponding to the 
initial preparation of the fabric, as the influence of the initial state of the PA66 fabrics 
has also been evaluated and compared between industrially-finished PA66 (I-PA66) 
and laboratory washed PA66 (W-PA66). 
 
3.3.2. Plasma treatments 
In this research work, three different commercial plasma reactors have been 
employed: a corona plasma for treatments at atmospheric pressure and two low-
pressure plasma reactors. Surface activation and functionalization of fiber surfaces 
have been performed by corona plasma and low-pressure while coating by plasma 
polymerization has been carried out only with low pressure plasma.   
 
3.3.2.1.  Corona plasma treatment 
 
 
Figure 32: (a) Scheme of the corona plasma used to treat the textile samples. (b) Scheme of different 
reactive species present in the plasma generation zone. 
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Corona plasma treatments were carried out by means of an Ahlbrandt FG-2 (Germany) 
equipment, using air as gas for plasma generation. Distance between the electrode 
and the fabric was adjusted to 20 mm. Upper electrode size was of (400 × 20) mm. 
During the treatments, power, speed and incident current were kept constant at 380 
W, 15 r.p.m. and 1.90 A respectively. In these optimized conditions, each passage of 
the textile material between both electrodes corresponds to a 0.35 s plasma treatment 
for any point of the fabric. 
 
Fabrics were treated for 1, 3, 5, 10 or 20 plasma sequences, corresponding to 0.35 s, 
1.05 s, 1.75 s, 3.5 s and 7.0 s of contact between plasma and fabric surface. Textile 
samples were laid flat on the roll, attached at their ends with a piece of tape. 
 
 
Figure 33: Plasma generation with ambient air using an Ahlbrandt FG-2 corona plasma equipment. 
 
 
3.3.2.2.  Low pressure plasma treatment 
 
Low pressure plasma treatment was carried out by an Europlasma Junior Advanced 
PLC (Belgium) equipment. Plasma treatment of the fabrics has been carried out with 
the textile samples laid flat, without mechanical tension, on a glass support between 
both electrodes in the plasma chamber, as presented in Figure 34c. 
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Figure 34: Europlasma Junior Advanced PLC low-pressure plasma equipment using with air as gas for 
plasma generation (a). Focus of the panel control screen (b) and the inside of the chamber (c). 
 
Power supply was kept constant at 100 W while gas flow was studied in the range 
between 5 and 15 L/min, plasma treatment time between 30 s and 300 s, and gas 
pressure between 0.13 and 0.40 mbar. PA66 fabrics were laid flat on the ground of the 
reactor, as shown in Figure 35, so that only one side of the sample was directly 
exposed to the plasma treatment, although it can be considered that the plasma 
species may penetrate through the loose knit fabrics structure and modify both sides 
of the material (Poll, 2001).  
 
Figure 35: Picture of the low pressure plasma reactor used in this PhD. Thesis for the treatment of 
PA66 (a) and PP (b) fabrics with air as plasma generation gas.  
 
Low-pressure plasma treatment consists of the following stages: 
o Introduction of the textile samples in the chamber 
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o Initial vacuum of the chamber to a value < 0.40 mbar. 
o Entry of air for 30 s until keeping constant the pressure. 
o Plasma treatment between 30 s and 300 s at constant power of 
100 W and gas flow range between 5 and 15 L/min, as a function 
of the studied working conditions. 
 
3.3.2.3. Low pressure pulsed-plasma polymerization  
 
Plasma polymerization was carried out with an equipment of low-pressure radio-
frequency plasma (13.56 MHz) (Standard Femto Plasma System, Diener, Germany) 
(Figure 36), equipped with mass controllers for the gas inlet and a bubbler system for 
the introduction of monomer. 
 
 
Figure 36: Standard pulsed-plasma equipment used for polymerization (a). Schematic cross-section of 
the reactor (b).   
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In this work, plasma polymerization has been used to create a deposited 
biocompatible (PEG) film after active principle impregnation of PP fabrics to modulate 
its release and preserve a low cellular adhesion to the PP fibre, since polyethylene 
glycol is a well-known non-fouling material used for protein adsorption and cellular 
adhesion. To obtain coatings of PEG by plasma polymerization, it starts from a 
precursor with four repeating units, the tetraglyme, with molecular formula 
CH3O(CH2CH2O)4CH3 as presented in Figure 37.  
 
 
Figure 37: Tetraglyme molecule used as precursor for plasma polymerization. 
 
The plasma polymerization consists in introducing tetraglyme in the plasma chamber 
by bubbling liquid tetraglyme with a carrier gas, in the setup argon. Before the 
polymerization, a surface activation is carried out with argon. Activation plasma 
consists of the following stages: 
o Introduction of the textile samples in the chamber (maximum 3 
samples by plasma treatment) as shown in Figure 36. 
o Initial vacuum of the chamber to a value of 0.20 mbar. 
o Entry of argon gas for 1 min, keeping the pressure at 0.40 mbar. 
o Plasma treatment during 30 s and a power of 100 W. 
The plasma polymerization was carried out in pulsed mode, with plasma pulses of 20 
μs spaced of 20 ms (values set by the manufacturer) and consists of the following 
stages: 
o Initial vacuum chamber to a value of 0.20 mbar, right after the 
end of the activation step. 
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o Introduction of tetraglyme monomer in the chamber for 1 min 
by bubbling tetraglyme in liquid phase with argon gas. 
o Plasma pulses of 20 μs spaced of 20 ms with a power of 200 W 
during 30, 60 or 120 minutes to study the influence of treatment 
time. 
To minimize the ageing process of all plasma-treated samples, analysis and post-
treatments like fabric impregnation and surface analysis were carried out right after 
plasma treatment of the fabrics (Boyd, 1997; Canal, 2004; Canal, 2008). 
 
 
3.3.3.  Loading process of active principles into textile materials 
 
As described in Table 5, ketoprofen was been used as pharmaceutical active principle 
for the impregnation of PA66 fabrics aimed as topical application. PA66 was been used 
as textile support for the release of caffeine, theobromine and pentoxifylline, used as 
cosmetic active principles in the treatment of lipids and cellulite, also for topical 
application. Finally, antibiotic loading of PP meshes for body implant applications was 
done with ampicillin.  
 
Table 5: Classification of the active principles used with their corresponding textile fabrics as used in 
this PhD. Thesis. 
Polyamide 6.6 knitted fabric Polypropylene mesh 
 
Anti-inflammatory model drug 
 Ketoprofen 
Anti-cellulitic model drugs 
 Caffeine 
 Theobromine 
 Pentoxifylline 
 
   Antibiotic 
 Ampicillin 
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Different active principles have been used, and the loading methods have been 
optimized in each case as described in the following sections. 
 
3.3.3.1. Polyamide fabric impregnation 
 
3.3.3.1.1. Ketoprofen loading of PA66 knitted fabrics 
 
PA66 knitted fabrics were cut into discs of 2.5 cm diameter and impregnated dropwise 
with 150 μL of a 1% ketoprofen solution in H2O/EtOH (1:1 wt%). Samples were dried in 
an oven for 24 hours at 50 ˚C. The samples were weighed again to calculate the 
amount of ketoprofen absorbed by the fibres. 
Impregnation of the fabrics previously treated by plasma was carried out right after 
the plasma treatment, on the plasma-treated side of the samples. 
 
3.3.3.1.2. Caffeine and methylxantines loading of PA66 knitted fabrics 
 
PA66 knitted fabrics were cut into rectangular samples of 11.6×6.0 cm, weighing about 
1.90 g. Impregnation of the PA66 samples was carried out by immersion in 50 mL of a 
1% caffeine solution in distilled water, during 10 min, with continuous shaking at 90 
r.p.m. at 20 ˚C.  
Subsequently, PA66 samples were submitted to a double padding process under 1.0 
kg/cm2 pneumatic pressure and 1 m/min speed working conditions in a laboratory 
pneumatic padder (Tepa, Spain) (Figure 38) to guarantee an uniform distribution of the 
product on the textile fabric sample. Samples were finally dried in an oven during 24 
hours at 37 ˚C.  
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Figure 38: Padding equipment used for homogenization of the active principle on the PA or PP sample 
after impregnation process. 
 
Impregnation of the plasma-treated fabrics was carried out 10 min after plasma 
treatment to avoid ageing process of the sample and a loss of the wetting properties 
achieved with plasma treatment, as observed in previous works (Canal, 2004).  
 
Both for ketoprofen as well as for caffeine and methylxantines loading, the PA66 
samples were weighed before and after the impregnation process to calculate the 
amount of caffeine in the fibers and the impregnation ratio (% ), following the 
Equation (1).  
 
(1) 
 
 
where Wf is the final weight of the wet sample after impregnation and double padding 
process and Wi the initial weight of the fabric. Samples were kept in a dessicator until 
constant weight. 
 
3.3.3.2. Polypropylene fabric impregnation 
 
Polypropylene meshes were cut into rectangular samples of (7.0×5.0) cm, weighing 
about 0.32 g. Impregnation of the PP samples was carried out by immersion of 6 PP 
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samples in 20 mL of a 4% ampicillin solution in distilled water, during 24 h with 
continuous shaking at 160 r.p.m. at 20 ˚C. This setting corresponds to a bath to fabric 
ratio of 1/10 (2 g of fibers in 20 mL solution). Subsequently, PP samples were 
submitted to a double padding process under 1 kg/cm2 pneumatic pressure and 1 
m/min speed working conditions. Samples were finally dried in an oven during 24 
hours at 37 ˚C. The samples were weighed before and after the impregnation process 
to calculate the amount of ampicillin in the fibers and the impregnation ratio, 
according to Equation (1).  
As for PA66 samples, the impregnation of the plasma-treated PP fabrics was carried 
out 10 min after plasma treatment to avoid ageing of the wetting properties achieved 
with plasma treatment. Samples were dried until constant weight and stored in a 
dessicator.  
 
3.3.4.  In-vitro release assays 
 
The drug release assays, adapted from the dissolution experiments for solid 
pharmaceutical dosage forms of Farmacopea Española, were performed using 
untreated and plasma treated PA and PP fabrics impregnated with specific active 
principles to determine the rate of release and the yielded concentration of such 
molecules to an isotonic liquid medium. For the drug release study, five thermo-
stabilized vessels were used to have replicates of the measurements. They were filled 
with 300 mL of PBS (pH 7.4) and stirring and temperature were maintained constant at 
25 r.p.m. and 37 ºC respectively, during the 8 or 24 hours of the release experiment 
(Figure 39). It has been estimated that an average time of wearing a garment may be 
around the time interval, justifying this timeframe selection. The different textile 
samples, with the specific geometry described in the section 3.3.3, were placed on a 
vertical stainless steel holder that ensures uniform and continuous optimum contact 
between the textile materials and the buffer solution. 1 mL samples were withdrawn 
from the receptor compartment for latter spectroscopy analysis that allowed 
determining the quantity of drug that was released from the textile materials. After 
each sample withdrawal, the same volume of fresh PBS was added to the receptor 
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medium. Sink conditions were kept constant in the receptor solution during the 
experiment (Washington, 1990). To obtain the release profile of each type of fabrics, 4 
replicates of each drug-loaded textile material have been studied, together with a non-
loaded fabric used as a reference.  
 
Figure 39: Active principle release experiment. 
 
For the analysis of the concentration of the active principles, UV-Vis 
spectrophotometry was used at fixed wavelength depending on the maximum 
absorption of the determined active principle, as described in section 3.3.5.5.  
For ketoprofen concentration determination, the detection wavelength used was 233 
nm, corresponding to the wavelength of maximum peak of absorption. Maximum peak 
absorption has been detected at a wavelength of 273 nm for caffeine, of 264 nm for 
pentoxifylline, of 254 nm for theobromine and of 206 nm for ampicillin. In some 
experiments, for untreated and corona plasma-treated IF-PA66, caffeine concentration 
has also been determined by High-Pressure Liquid Chromatography as described in 
section 3.3.5.6. 
To obtain the percentage of drug released, the following calculations and corrections 
were made: Two volume corrections were taken into account to determine precisely 
the drug concentration in the trial compartment at each moment t: (i) A total volume 
correction due to evaporation and (ii) a step to step correction due to sample 
collection. 
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 Total volume correction 
 
This correction is due to the weak evaporation of liquid medium during the experiment 
so that the final volume is not the same than the initial one. Assuming a constant 
evaporation during the study, a linear correction is carried out taking into account 
initial and final volumes:  
 
(2) 
 
with  : corrected volume at the sampling time t (mL) 
 : duration of experiment (min) 
 : initial volume (mL) 
 : final volume (mL) 
 : sampling time (min) 
 
So, from the volume correction, a first correction of the drug concentration in the 
release media is done at each timepoint t by the following equation: 
 
(3) 
 
with   : corrected drug concentration at the sampling time t (mg/L) 
: drug concentration as obtained from the reading of the spectrophotometer (mg/L) 
 : initial volume (mL) 
 
 Step to step correction due to sampling : 
 
This correction is due to the withdrawal of the liquid sample from the release 
compartment. At each timepoint t, a certain volume of sample (1 mL) is withdrawn and 
the same volume of PBS is added. Therefore, a little variation of drug concentration 
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(slight dilution) after each withdrawal that has to be taken into account. The real 
concentration of drug at time t of the experiment is calculated the following equation: 
 
(4) 
 
with   : real released concentration of active principle (mg/L) at instant t 
 : drug concentration at instant t, already corrected for evaporation 
: drug concentration at instant (t-1), already corrected for evaporation 
 : corrected volume (mL) 
 : withdrawn sample volume (mL) 
 
The values obtained from Equations (3) and (4) are used in all the subsequent 
calculations. The released percentage of drug in the isotonic liquid media at a 
determined instant t of the experiment (Rt %) is obtained from Ctreal, the corrected 
volume vtcor and the weight of loaded-active principle in the fibres before the release 
experiment Δm, following the equation: 
 
 
(5) 
 
with  : drug released percentage in the isotonic liquid media at instant t (%) 
 : corrected concentration of drug in the isotonic liquid media at instant t (mg/L) 
 : corrected volume at instant t (mL) 
 : weight of active principle loaded in the fibres before release experiment (mg) 
 
From the values of drug release percentage R% at determined instant t of the assay, 
the drug release kinetics R%= f(t) have been plotted and the comparison of the drug 
release kinetics profiles from the different plasma-treated PA66 and PP fabrics has 
Experimental part 
 
 
137 
 
been performed to evaluate the influence of the kind of plasma treatment and the 
plasma working conditions on the release kinetics of the drug. 
 
3.3.5. Physical characterization techniques 
 
Different characterization methods have been used to investigate the influence of 
plasma treatment on the physical properties (topography, morphology) and the 
surface chemistry (wetting behavior and functional groups on the fibre surface) of such 
fibres.  These characterization techniques are reported in Table 6 and are described in 
details in the following sections. 
 
Table 6: Experimental techniques used for the physical characterization and the surface chemistry 
analysis of the elastic-compressive PA66 fabrics knitted fabric and the PP mesh. 
Experimental techniques used for the characterization of the fabrics 
 
Elastic-compressive polyamide 6.6 knitted 
fabric 
 
Polypropylene mesh 
 
 Static contact angle 
 Drop test 
 X- ray Photoelectron Spectroscopy 
 Scanning Electron Microscopy 
 
 
 Static contact angle on PP film 
 X- ray Photoelectron Spectroscopy 
 Scanning Electron Microscopy 
 Atomic Force Microscopy 
 Antibacterial assays 
 
 
3.3.5.1.  Scanning Electron Microscopy (SEM) 
 
A Scanning Electron Microscope (SEM) allows to produce image of objects in the micro 
to nanometer range with relatively lower diffraction effects. The optical wavelengths 
from deep UV to IR are in range of hundreds of nanometers while electron beams of 
energy in keV have wavelengths in fractions of nanometers. Using a SEM to produce 
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proper topographic image of a surface requires a judicious choice of beam energy, 
intensity, width and proper preparation of the sample being studied. Nowadays, the 
electron beam in a SEM is generated using a field emission filament that uses ideas of 
quantum tunneling. The deflection of an electron beam of a certain energy E is 
accomplished by means of electromagnetic lenses. Typical E values for conventional 
SEM can range from as low as 2-5 keV to 20-40 keV. 
 
A basic SEM consists of an electron gun (field emission type or others) that produces 
the electron beams, electromagnetic optics guide the beam and focus it. The detectors 
collect the electrons that come from the sample (either direct scattering or emitted 
from the sample) and the energy of the detected electron together with their intensity 
(number density) and location of emission is used and processed to put together 
image. Nowadays some SEM exquipments also offer energy dispersive photon 
detectors that provide analysis of X-rays that are emitted from the specimen due to 
the interactions of incident electrons with the atoms of the sample.  
 
 
 
Figure 40: (a) Jeol JSM-5000/5610 SEM Field-Emission Scanning Electron Microscopy. (b) Au-coated PP 
mesh fabrics prior to SEM observation (UPC, Terrassa, Spain). 
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In this work, two different SEM were used: 
Topography of PP and PA66 fibres was studied by Field- Emission Scanning Electron 
Microscopy using a Hitachi S-2300 SEM. All samples were C coated prior to SEM 
observation with a sputter coater.  Observations were carried out at 10 kV working 
voltage.  
Topography of PA66 fibers was studied by Field-Emission Scanning Electron 
Microscopy using a Jeol JSM-5000/5610 SEM (Figure 40). Samples were Au-coated 
before SEM observation with a Baltec SCD 005 sputter coater. Observations were 
carried out at 10 kV working voltage. 
 
3.3.5.2. Atomic Force Microscopy (AFM) 
 
Atomic force microscopy (AFM) is a powerful characterization tool for polymer science, 
capable of revealing surface structures with superior spatial resolution (Cohen, 1994). 
AFM is a modern technique for generating high resolution surface topography images 
and it can capture many orders of magnitude below the optical diffraction limit. It uses 
principally a similar to the one used by the phonograph developed by Thomas Edison. 
Essentially, the phonograph has a sharp object which is dragged across a moving 
surface, the tip is deformed by the features it encounters and the signal is converted in 
another one (acoustic signal in this case) (Frewin, 2012). AFM rests upon the same 
principle, with a more complex and precise feedback system.   
 
An AFM consists of a probe, a scanner, a controller, and a signal processing unit-
computer. AFM works by scanning a sharp probe across the surface to obtain a three-
dimensional surface topographic picture. As the probe rasters, it feels the highs and 
lows of surface topography through complex mechanisms of tip-surface interactions. 
The forces between the tip and the sample are measured during scanning, by 
monitoring the deflection of the cantilever (Cohen, 1994). These signals are sent back 
via a laser reflected back from the probe surface to a photo-detector. The photo-
detector through a feedback control loop, keeps the tip at constant height or constant 
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force from the surface (Figure 41a). The feedback signals are sent to a signal 
processing software, which generates a three-dimensional topographic image of the 
surface. Further interactions arising between the tip and the sample can be used to 
investigate other characteristics of the sample, the tip, or the medium in-between 
(Butt, 2005). AFM has developed into a multifunctional technique suitable for 
characterization of topography, adhesion, mechanical, and other properties on scales 
from tens of microns to nanometers (Sitterberg, 2010).  
 
Considering the versatility of types of samples, several modes have been developed 
and adapted to scope with the demand of the specific research field. The operating 
modes of AFM can be divided into static (DC) mode – the probe does not vibrate 
during imaging, and dynamic (AC) mode – the cantilever is excited to vibrate at (or off) 
its resonant frequency. In dynamic mode the character of repulsive forces between the 
tip and the sample enables examination of even single polymer molecules without 
disturbance of their integrity (Kocun, 2011).  
 
 
Figure 41: Schematic functioning principle of an Atomic Force Microscope (a). Picture of the Solver Pro 
NT-MDT Atomic Force Microscope used in this work (IJS Center, Ljubljana, Slovenia) (b).  
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Surface topography of the PP and PA fibres was investigated by Atomic Force 
Microscopy with a Solver Pro NT-MDT equipment (Figure 41b) in air environment, with 
manufacturer specific software. Oscillating semi-contact mode with Si cantilever was 
used for surface imaging over range (1×1) to (20×20) μm. Surface roughness Ra was 
calculated after substraction of the background from the image, using the following 
relation: 
 
(6) 
 
where N is the total number of height data per image, zi is the heightvalue of data 
point i and µ is the average height of the samplesurface after plane subtraction. 
 
3.3.5.3. X-ray Photoelectron Spectroscopy (XPS) 
XPS is an instrumental technique used to obtain chemical information from the first 
nanometers of the surface of a material. From the XPS spectra information is obtained 
on the surface chemical composition and chemical bonds. During the XPS analysis, a 
sample is illuminated with a monochromatic X-ray light in the spectrophotometer and 
the energy of emitted photoelectrons from the sample is analyzed. In the 
photoelectron spectrum, which represents the distribution of emitted photoelectrons 
as a function of their binding energy, peaks can be observed which are characteristic of 
the different element sfrom the sample surface until 6 nm in depth. In this PhD. Thesis, 
2 different XPS were used: 
(1) Surface chemistry of PA66 and PP samples was analyzed with a PHI ESCA-5500 
Multitechnique System (Physical Electronics) (Figure 42) with a monochromatic X-ray 
source (Al Kα line of 1486.6 eV energy and 350 W), placed perpendicular to the 
analyzer axis and calibrated using the 3d5/2 line of Ag with a full width at half maximum 
(FWHM) of 0.8 eV. The analized area was a circle of 0.8 mm diameter, and the selected 
resolution for the spectra was 187.5 eV of pass energy and 0.8 eV/step for the general 
spectra and 23.5 eV of pass energy and 0.1 eV/step for the spectra of the different 
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elements. All measurements were made in an ultra high vacuum chamber pressure 
between 6.7x10-9 and 2.7x10-8 mbar.  
 
 
Figure 42: PHI ESCA-5500 Multitechnique System (Physical Electronics) equipment (IJS Center, 
Ljubljana, Slovenia). 
 
(2) XPS analysis of PA66 samples aimed for ketoprofen loading was performed in 
XPS Spectrophotometer TFA XPS model, by Physical Electronics Inc. An Al 
monochromatic source of X-ray light with a power of 250 W was used. During the 
analysis, two types of spectra were recorded.  
 
First, a general spectrum was performed through a wide energy range. In this 
spectrum, the elements present in sample surface were identified and their relative 
concentrations were calculated by taking into account the relative sensitivity factors of 
each one provided by the XPS spectrophotometer manufacturer. The results were 
normalized to 100％. The relative error on the calculation of surface composition for 
XPS method sensitivity is about 0.5％. Each sample was analyzed at two different 
places and the average composition is calculated. The C1s peak was referred to the C-C 
bond energy of 285.0 eV (Brack, 1999). In addition to the wide energy range spectra, 
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high-energy resolution spectra of characteristic peaks of C1s element were recorded 
through a narrow energy range.  
Afterwards, C1s peaks were deconvoluted into subpeaks centered in characteristic 
energies that correspond to determined bondings with carbon atoms. This data 
processing allows identifying the predominant carbon bonds in polymer surface. In this 
PhD. Thesis, the deconvolution of C1s peak has been performed using Multipak and 
Origin softwares. 
 
3.3.5.4.  Wetting properties 
 
3.3.5.4.1.  Static contact angle 
 
Water static contact angle determines surface wettability by measuring the extent of 
spreading of a droplet on a surface. The sessile drop technique is used for the 
characterization of solid surface energies. The method consists in placing a droplet of 
liquid of known surface energy on a solid surface and then by measuring the contact 
angle it establishes with the solid surface, the surface energy of the material can be 
determined. The theoretical description of contact angle arises from the consideration 
of a thermodynamic equilibrium between the three phases: the liquid phase, the solid 
(S), and the gas phase (G). The shape of a liquid/vapor interface is determined by the 
Young–Laplace equation, with the contact angle playing the role of a boundary 
condition following the Young's Equation:  
γSG - γSL - γLG × cos θ = 0 (7) 
 
where γSG corresponds to the solid–vapor interface energy, γSL to the solid–liquid 
interfacial energy, γLG to the liquid–vapor interfacial energy (i.e. the surface tension) 
and θ the contact angle, as described in Figure 43.  
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Water can be used as a test liquid to establish whether a surface is hydrophilic (angle 
<45 ˚), hydrophobic (angle >90 ˚) or somewhere in-between (angle of 45 ˚ to 90 ˚) 
(ASTM Standard D7334). The lower the contact angle, the more hydrophilic the 
surface. As a surface becomes more oxidized, or has more ionizable groups introduced 
to it, hydrogen bonding with water becomes easier and the droplet spreads along the 
hydrophilic surface, resulting in a lower contact angle (Mittal, 2002).  
 
Figure 43: Schematic representation of the contact angle of a liquid drop on a solid surface. 
 
 
In this work, the determination of the wetting properties of PA66 fabrics with and 
without plasma treatment was done by static contact angle measurements. Contact 
angles were measured by means of a Krüss DSA100 goniometer equipped with a CCD 
camera, coupled with DSA3 software fitting a mathematical expression to the shape of 
the drop and then calculating the slope of the tangent to the drop at the liquid-solid-
vapor (LSV) interface line (Figure 44). PA66 textile samples were laid flat on a glass 
support without mechanical tension and 10 μL water droplets were laid on the fabrics. 
Measurements were carried out on the plasma-treated side of the samples. Al least 4 
replicates of each measurement were carried out. Given the open structure of PP 
meshes, a PP film was used as model surface for the determination of contact angle. 
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Figure 44: Krüss DSA100 goniometer (a) with detail of the sample support and the needle for 
deposition of the droplets (b). 
 
3.3.5.4.2. Drop Test 
 
Hydrophilicity of PA66 fabrics was evaluated according to the AATCC Test Method 39-
1980 by determining the wetting time in seconds using the drop test. The test 
schematically consists of laying down a droplet of water of constant volume on the 
surface of the fabric and measuring the time required for its complete absorption. 
Results are the average of at least four measurements. 
Drop test has also been used to follow the ageing of plasma-treated fabrics. The ageing 
of plasma-modified polymer surfaces is defined by the evolution of wettability with the 
elapse of storage time after plasma treatment (Canal, 2008). Therefore, an improved 
understanding of the ageing of modified surfaces during storage is required to 
optimize the processing conditions leading to interfacial properties that are controlled 
and predictable at the time of use. After plasma treatment of the textile materials, the 
samples were stored in an ambiental closed environment and measurements of the 
plasma-treated fabrics are repeated at different time points. Evolution of the static 
contact angle or water absorption time of 10 µL droplet is represented as functions of 
time to quantify this ageing. Also, measurements of untreated fabrics were carried out 
as control.    
 
3.3.5.5. UV-Visible Spectroscopy  
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Many molecules absorb ultraviolet (below 400 nm) or visible light (between 400 and 
800 nm). When a molecule is placed in solution between a light source and a 
spectrometer, the substance absorbs certain part of the spectrum. An absorption 
spectrum shows a number of absorption bands corresponding to specific structural 
groups of a molecule and which are directly associated to the excitation state of outer 
electrons. When sample molecules are exposed to light having an energy that matches 
a possible electronic transition within the molecule, some of the light energy is 
absorbed as the electron is promoted to a higher energy orbital. An optical 
spectrometer records the wavelengths at which absorption occurs, together with the 
degree of absorption at each wavelength. The resulting spectrum is presented as a 
graph of absorbance (A) versus wavelength λ. Absorbance usually ranges from 0 (no 
absorption) to 2 (99% absorption), and is precisely defined by spectrometer working 
range. The absorption spectrum, registered by the spectrophotometer on the all range 
of wavelengths of the equipment, is specific to a given molecule. The specific 
absorption spectrum of each molecule allows identifying and quantifying a given 
molecule. Absorbance follows the Beer's Law: 
A = ε × b × c (8) 
 
Where A is absorbance (no units) 
ε is a constant of proportionality, called the molar absorbtivity, in L.mol-1.cm-1 
b is the path length of the sample - that is to say the path length of the cuvette 
in which the sample is contained, expressed in cm. 
c is the concentration of the compound in solution, expressed in mol.L-1. 
 
Therefore, the absorbance of a solution, at a determined wavelength, increases with 
the increasing of the concentration of the molecule, and UV-visible spectroscopy 
allows correlating the absorbance with the concentration of some compound in 
solution. From the general absorption spectrum, the wavelength of the peak with the 
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maximum absorbance intensity is chosen for the quantification of the concentration of 
the molecule in aqueous solution.  
UV-visible spectrometers used for this work were double-beam spectrophotometers 
which can determinine the concentration of a determined molecule in solution 
comparing the absorbance of such solution (sample cell) with a reference cell 
containing the dispersive liquid media only, as described in Figure 45. 
 
Figure 45: Schematic of the working principle of a double beam UV-visible spectrophotometer. 
 
 
For the quantification of drug released, a ThermoSpectronic - Heλiosβ 
spectrophotometer was used for ketoprofen studies, while a Shimadzu UV-1800 
spectrophotometer model of Thermo Fisher Scientific Inc. with UV Probe software was 
used for methylxantines and ampicillin studies. 
 
3.3.5.6. High-Pressure Liquid Chromatography (HPLC) 
 
High pressure liquid chromatography (HPLC) is a chromatographic method that is used 
in analytical chemistry and biochemistry to separate a mixture into individual 
compounds for their identification, quantification or purification. This can be achieved 
by using the different interactions between compounds in solution and a stationary 
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phase. By selecting a particular combination of mobile and stationary phase, the mode 
of separation can be chosen and optimized. It provides dynamic retention of 
compounds possessing hydrophobic and organic functionality. Components in a 
mixture are separated on a column packed with silica-based particles (referred to as 
stationary phase) by pumping a solvent (referred to as mobile phase) through the 
column. Depending on the unique affinity of each compound (referred to as the 
analyte) between the mobile phase and the stationary phase, each compound 
migrates along the column at different speeds and emerges from the column at 
different times, thus establishing a separation of the mixture. Analytes with higher 
affinity for the mobile phase migrate faster down the column, whereas those with 
higher affinity for the stationary phase migrate slower. This migration time (referred to 
as retention time) is unique for each analyte and can be used in its identification. With 
the appropriate use of a detection method after the column, each compound can also 
be quantified for analysis. 
 
Figure 46: Agilent 1100 series HPLC equipment used in this PhD. Thesis. 
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For detection, even if UV-visible spectrometry is a sensitive detection method, not 
every compound exhibits UV-visible absorption, and usually a mass-spectrometer can 
be used as secondary detector. Quantification of the compounds can be performed by 
calculating the area under the curve of the peaks in the chromatogram. 
In this work, the caffeine concentration after release experiments from corona plasma 
treated PA66 was determined by HPLC (Agilent 1100 series) equipment using a 
Kromasil® 100-5C18 column (4.6×250 mm) with Methanol/Water/Acetic acid 40:59:1 
v/v (pH 2.8) as mobile phase(Figure 46). Retention time of caffeine in PBS (pH 7.4) was 
found to be 4.9 min at a flow rate of 1 mL.min-1 and at 25 °C. Detection of caffeine was 
done with a UV-Vis detector at λ=272 nm using an injection volume of 20 µL.  
 
3.3.5.7. Antibacterial assays 
 
The antibacterial activity was studied on untreated and plasma-treated PP meshes 
with ampicillin. Influence of plasma treatment conditions of PP samples loaded with 
ampicillin on antibacterial properties has been evaluated for corona plasma and low-
pressure plasma treatment, with special regard on the treatment time for both types 
of plasma and gas flow rate for low-pressure plasma. The activity of the treated 
meshes was tested against Staphylococcus Aureus (gram positive bacterium) and 
Escherichia Coli (gram negative bacterium).  
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Figure 47: Antibacterial assays. (a) Preparation of the Staphilococcus aureus culture media. (b) 
Placement of treated textile materials. (c) Measurement of the inhibition areas. 
 
To qualitatively determine the antibacterial activity on the treated textile materials the 
Parallel Streak Method AATCC Test Method 147-2004 was used. This method allows a 
relatively quick and easy qualitative method to determine antibacterial activity of 
diffusible antimicrobial agents on treated textile materials (Canal, 2009; Pinho, 2011). 
It consists in placing several parallel streaks in a standard Petri dish with the 
appropriate culture media for the bacteria tested (Figure 47). Bacteriological culture 
media of Staphylococcus Aureus and E. Coli. was prepared from Agar Bacteriological 
(Scharlau S.A., 07-004, 500 g, lot 100921) at concentration of 15.0 g.L-1 and Brain Heart 
Infusion Broth (BHI Broth) (Scharlau S.A., 02-599, 500 g, lot 10227) at [BHI] = 37.0 g.L-1 
The treated side of the samples was put in contact with the culture media and 
incubated at 37 °C for 24 h in an autoclave. Image treatment of the Petri dishes after 
24 h to determine the inhibition areas of the antibiotic-loaded PP meshes has been 
performed with Image J software, image processing program developed at the 
National Institutes of Health for this type of applications.  
 
3.3.6. Data analysis 
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Statistical differences were determined using one-way ANOVA a 95% confidence with 
Tukey's post-tests using Minitab 16 software (Minitab, Inc., State College, 
Pennsylvania, U.S.). Statistical significance was noted when p < 0.05. In this work, 
different symbols (*,**,***) indicate statistically significant differences. 
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4. RESULTS AND DISCUSSION 
 
The presentation of the results obtained in this PhD. Thesis is done in two main parts 
corresponding to the kind of textile material used (polyamide 6.6 and polypropylene) 
and the application that they aimed for (topical applications and implants for hernia 
repair, respectively). 
The first part presents the experimental results for elastic-compressive polyamide 6.6 
fabrics intended for use in topical applications. It emphasizes the influence of the initial 
state of PA66 on the effects produced by corona plasma and low-pressure plasma 
treatments on the physical and chemical surface properties of the fibers, as well as on 
the subsequent loading and release of ketoprofen and methylxantines from the PA66 
fibres.  
The second part focuses on polypropylene meshes aimed for implants for hernia 
repair. The influence of both types of plasmas has been studied on the physical and 
chemical surface properties of the fibers, as well as on the subsequent loading and 
release of ampicillin from the PP fibres and their microbiological behavior. 
Subsequently, plasma polymerization of polyethylene glycol (PEG) of the ampicillin-
loaded PP fibres previously modified with low-pressure pulsed plasma has also been 
studied to evaluate its influence in the modulation of adhesion of the PP fibres.  
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4.1. Part I – Plasma-treated polyamide 6.6 as drug delivery system for topical 
application 
 
The elastic-compressive PA66 fabrics used in this PhD. Thesis are aimed for a use as 
therapeutic compressive stockings, knee socks or socks, and for this, the loading of 
nonsteroidal anti-inflammatory drugs (NSAIDs) or of lipolitic active principles can be of 
interest to confer them an added therapeutic or cosmetic value, respectively. 
Modification of the surface of the PA66 fibres by plasma treatments is evaluated in this 
work to study how it may influence the loading and release of drugs from the PA66 
fibres, as it is the hypothesis of this work that they can greatly depend on the 
modification of the interactions between drug and fibre. 
 
Surface characterization of PA66 fabrics has been performed to study the effects of 
corona plasma and low-pressure plasma treatments, both using air as gas for plasma 
generation, on the surface properties of the fiber. In the following sections, the results 
obtained with both types of plasmas are presented, beginning with corona plasma 
results, and followed by those obtained with low-pressure plasma.  
  
Once the plasma-treated PA66 fabrics have been characterized, the influence of these 
modifications of the PA66 surface properties is studied on the loading of an active 
principle and its subsequent release from the PA66 fibres to an isotonic liquid media. 
Industrially finished fabrics were selected for this work in order to be closer to a 
potential insertion of the plasma technology in the textile chain and are thus copared 
to laboratory-washed PA66 fabrics. Therefore, in the presentation of the results, the 
nomenclature IF-PA66 refers to industrially-finished polyamide 6.6 fabrics, while the 
nomenclature W-PA66 refers to the same fabrics washed and dried, as described in 
section 3.3.1. This study of the influence of the initial state of preparation of the PA66 
fabrics on the effects of plasma treatment has been limited to the studies with corona 
plasma. 
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4.1.1. Influence of plasma treatment on wetting properties 
 
Corona plasma 
 
In order to study the wetting properties of PA66 fabrics, static contact angle 
determinations were carried out on untreated and corona plasma-treated samples. It 
is important to underline that contact angle was measured on the side of the fabric 
that had been directly exposed to the plasma treatment. Measurements were 
performed right after plasma treatment of the PA66 fabrics to avoid ageing of the 
samples, as previous studies (Nakamatsu, 1999; Molina, 2003; Canal, 2004; Canal, 
2008; Morent, 2008) on different natural and synthetic polymers and textiles indicated 
that surface modifications by plasma are not permanent and can progressively vary 
and therefore, subsequent processes have to be performed as soon as possible. 
 
Table 7 shows that both untreated PA66 fabrics are hydrophobic (> 90 °), with IF-PA66 
fabric presenting the highest value of 123.0 ± 2.6 °, thus being much more hydrophobic 
than PA6 rods presented in a previous work (Canal, 2004) that show a contact angle of 
71.4 °. It can be observed that the values of the static contact angle of the untreated 
IF-PA66 fabrics are 34 ˚ higher than those of W-PA66 fabrics, reflecting the presence of 
hydrophobic finishing products used in the fabrication process of the fabrics, which 
influences the wetting properties of the fibers. 
 
Table 7: Water static contact angle of corona plasma-treated PA66 fabrics. 
Polyamide 
samples 
tplasma (s) 
θs (º) 
0 s 1.05 s 1.75 s 3.5 s 
      IF-PA66 123.0 ± 2.6 ˚ 122.4 ± 2.7 ˚ 108.7 ± 3.7  ˚ 102.2 ± 4.6 ˚ 
     W-PA66 89.0 ± 2.1 ˚ 
Not measurable 
Very fast water absorption by W-PA66 
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Regarding the influence of corona plasma treatment time on IF-PA66 samples, a 
progressive decrease of the static contact angle is observed with longer plasma 
treatment times, up to a final difference of -20.83 ˚ between the untreated fabric and 
the 3.5 seconds-plasma treated fabric. 
  
After any corona plasma treatment (even at short times) on the W-PA66 sample, 
fabrics become highly hydrophilic and contact angle could not be measured due to the 
too fast absorption of water droplet by the fibers. It is widely known that these 
increased hydrophilic properties can be attributed to the introduction of oxygen-
containing functional groups on the surface and/or to a cleaning process of the surface 
(Berg, 1993), as will be shown in the following section 1.4.4. Therefore, the highest 
wettability improvement recorded in W-PA66 samples with regard to IF-PA66 ones has 
to be related to the surface being already prepared; in untreated IF-PA66, the plasma 
exerts a cleaning effect of the surface which is probably avoided in the already cleaner 
surface of W-PA66 and all plasma species reacting on the surface can be devoted to 
functionalization or etching processes. Even if it was not quantifiable, it could be 
perceived that absorption time was shortened at longer treatment times, so in this 
case plasma treatment also progressively increases the wetting properties of washed 
samples. 
 
 
Table 8: Water absorption time of corona plasma-treated PA66 fabrics as a function of plasma 
treatment time. 
 tabs (s) 
Corona plasma 
treatment time (s) 
IF-PA66 W-PA66 
0 18.5 ± 0.5 7.5 ± 0.5 
1.05 19.0 ± 1.0 < 1.0 
1.75 15.5 ± 0.5 < 1.0 
3.5 9.5 ± 1.0 < 1.0 
7 9.5 ± 1.5 < 1.0 
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As observed with the static contact angle of corona plasma treated PA66 fabrics, Table 
8 shows that corona plasma improved the wettability by reducing the absorption times 
of both W-PA66 and IF-PA66 fabrics. In Table 8, the correlation between static contact 
angle and drop test can be remarked, since the decrease of static contact angle 
corresponds to a decrease of the water absorption time, and the maximum difference 
in both cases is observed at 3.5 s corona plasma treatment. So, for the rest of surface 
characterization of PA66 fibres, 3.5 s plasma treatment has been used as the extreme 
condition of the treatment time. 
 
 
Untreated IF-PA66 presents a hydrophilic behavior. With a decrease of 34.0 ˚ 
observed in static contact angle measurements, the washing of the PA66 fabrics 
greatly improves the wetting properties of the PA66 fabrics. Corona plasma 
treatment also achieves an improvement of the hydrophilic behavior of the IF-PA66, 
with a decrease of 21.8 ˚ of the contact angle, in short treatment times. Moreover, 
when plasma treatment is combined with a previous washing of the polyamide 
fabrics, it has been shown that the contact angle further decreases, so that corona 
plasma treatment produces a better improvement of the wettability of PA66 fibres 
after the washing process. 
 
Low pressure plasma 
 
Regarding low pressure plasma-treated PA66 fabrics, drop test (AATCC Test Method 
39-1980) has been carried out to evaluate the wetting properties of the fabrics. This 
test allows a quick and reliable evaluation of the plasma effects on textiles and is 
closely related to contact angle (Canal, 2008).  
 
In order to select which parameters are relevant in the modification of polymer fibre 
surface, preliminary studies have been performed. By fixing plasma treatment time 
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and gas flow rate at 180 s and 5 L/min respectively, it has been shown that power 
supplies between 75 W and 150 W do not lead to significant differences in wettability, 
as measured through the drop test by water absorption and presented in Table 9.  
 
Table 9: Absorption time (tabs) of a 10µL water droplet (in seconds) of low pressure plasma-treated IF-
PA66 as a function of plasma power supply. Plasma treatment time of  180 s and gas flow rate of 5 
L/min. 
  tabs (s)  
Power supply (W) 75 100 150 
IF-PA66 46.8 ± 2.4 48.6 ± 3.9 45.0 ± 2.6 
 
It has therefore been decided to fix the power supply of the plasma generator at 100 
W for the subsequent experiments. 
 
The pressure of the reaction chamber is closely linked to the gas flow rate supplied to 
the chamber during the plasma treatment. For example, with a gas flow of 5 L/min, the 
pressure inside the chamber oscillates around 100 mT, while with a gas flow of 15 
L/min the pressure rises to 300 mT. Thus, the study of the effects of low pressure 
plasma treatment on the PA66 fibres has been focused on the influence of plasma 
treatment time and gas flow rate on the surface modification of the PA66 fibres. 
 
Therefore, water absorption time measurements by drop test of untreated and fabrics 
previously treated by low pressure plasma have been performed under different 
conditions of gas flow (air) and treatment time, and the results are reported in Table 
10. 
 
With a water absorption time of 19.0 ± 1.0 s, which corresponds to a static contact 
angle above 123 ˚ (Table 7), untreated IF-PA66 fabrics are hydrophobic. In the textile 
industry, wettabilities above 3 seconds (or contact angles above 90 ˚) are related to 
poor wettability. Usually, plasma treatments with oxygen-containing gases such as air 
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are related to surface wettability increase. However, according to Table 10, wettability 
of most of the plasma-treated PA66 fabrics studied is poorer than for untreated 
fabrics. Nevertheless, it can be observed, that wettability of plasma treated fabrics 
improved at higher flow rate. 
 
Table 10: Absorption time (tabs) of a 10µL water droplet (in seconds) of low pressure plasma-treated 
IF-PA66 as a function of plasma treatment time and gas flow rate (air). Power supply of 100 W. 
 
 
At constant plasma treatment time, between the plasma-treated samples, the increase 
of the gas flow rate improves the wettability of the IF-PA66 fabric, as it can be 
observed with the decrease water absorption time. In contrast, at constant gas flow 
rate, the increase of plasma treatment time leads to an increase of the water 
absorption time. Usually, in literature (Friedrich, 2012), it has been shown that the 
improvement of wetting properties of polymer material is related to the 
functionalization of the surface with polar groups. To deepen in the possible causes of 
the observed behavior, XPS analysis have been performed and presented in the 
following section, since wetting behavior used for the evaluation of the superficial 
changes experienced by the polyamide fibers is closely linked with chemical changes of 
the fiber surface (Berg, 1993). 
 
Combination of short plasma treatment time and higher flow rates yield improved 
wettability. Indeed, even if the evolution of water absorption time as a function of gas 
 tabs (s) 
 
0 60 180 300 
0 19.0 ± 1.0    
5   39.2 ± 3.4 104.0 ± 19.5 276.2 ± 16.8 
10   23.8 ± 1.7 48.6 ± 3.9 76.7 ± 9.0 
15  16.2 ± 1.3 27.7 ± 1.7 35.2 ± 1.5 
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flow rate followed the same decreasing tendency on fabrics treated either at 60, 180 
or 300 seconds as plasma treatment times, sustained plasma treatment time 
deteriorates wetting properties of the fabrics.  
 
The analysis of W-PA66 has not been possible due to the fast or the instantaneous 
water absorption (t<3 s) observed for the low-pressure plasma treated W-PA66 for all 
the studied conditions of plasma treatment. However this behavior allows confirming 
the trend observed with corona plasma treatment, since W-PA66 for all conditions 
studied shows improved wetting properties with respect to the IF-PA66. 
 
 
4.1.2. Influence of plasma treatment on surface chemistry 
 
Corona plasma 
 
In general, plasma treatment proceeds by free-radical introduction of a wide variety of 
oxygen-containing functional groups on the surface of the treated polymer. These 
oxidized functional groups may include C–OH, C=O, COOH, C–O–C, etc. To investigate 
the proportion of these functional groups on the fiber surface and its evolution with 
corona plasma treatment time, X-Ray photoelectron-spectroscopy (XPS) was 
performed on the IF-PA66 and W-PA66 fabrics, and the results, obtained from the 
general spectra presented in Figure 48 and Figure 49, are respectively reported in 
Table 11 and Table 12.  
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Figure 48: XPS general spectra of untreated IF-PA66 (a) and W-PA66 (b). 
 
The general spectra of untreated PA66 fabrics, either industrially finished or washed, 
reveals the presence of O1s, C1s as main peaks, and N1s and Si2s and Si2p in minor 
quantities (Figure 48).  
 
 
Figure 49: XPS general spectra of 1.75 s corona plasma-treated (a) and 3.5 s corona plasma-treated IF-
PA66 (b). 
 
The general spectra of air corona plasma-treated IF-PA66 fabrics (Figure 49), for 
different times, show that the main species present on the fibre surface are the same 
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than in the untreated samples. Details on the chemical composition are given in the 
following tables.  
 
Table 11: Surface elemental composition and atomic ratios of untreated and corona-plasma treated 
IF-PA66 fabrics. 
tplasma (s) 
Elemental composition (%) Atomic ratios 
C1s N1s O1s Si2p O/C N/C 
0  59.9 0.7 22.2 17.2 0.37 0.012 
1.75  46.0 0.3 31.5 22.2 0.69 0.007 
3.5  48.4 0.1 28.4 23.1 0.59 0.002 
 
The untreated sample consists of about 60 at.% of carbon, 22 at.% of oxygen, 17 at.% 
of silicon and 1 at.% of nitrogen. For pure PA66 one would expect 75.0 % of carbon, 
12.5 % of oxygen and 12.5 % of nitrogen. This difference can be explained taking into 
account that the fabrics used have been industrially finished with polydimethylsiloxane 
softeners (PDMS) of general formula CH3[Si(CH3)2O]n-Si(CH3)3. Therefore, Si and O are 
mainly due to the PDMS used in the finishing of IF-PA66 which covers the surface and 
explains also the low percentage of nitrogen observed coming from polyamide 66. 
Thus, the presence of these silicone-based finishing agents on the surface of the IF-
PA66 fibers also explains the high percentages of Si observed on the surface of the IF-
PA66 fabrics (17.2%), and the high O/C ratio (0.37) with respect to the theorical value 
(0.17). 
 
Surprisingly, plasma treatment increased the percentage of atomic Si on the surface of 
the fibres. This could be interpreted as an effect of thermomigration to the surface due 
to plasma: the local increase in temperature on the surface of the fibres due to the 
surface recombination of atomic species from the plasma phase and to the high 
temperature of the sparks of corona plasma may lead to migration of silicone 
compounds from the bulk of the fibre to the surface. It is coherent to expect higher 
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local surface temperatures on the more energetic corona plasma treatment than in a 
low pressure treatment, as will be shown in the next section, in part due to the corona 
being a filamentary discharge, with higher temperatures in the region of the sparks.   
 
Additionally, the fibre surface was functionalized by O-containing moieties from the 
corona plasma phase, as indicated by the 63% increase in the O/C ratio between 
untreated and longest plasma treatment time (3.5 s plasma treatment). Increase of O 
concentration in the IF-PA66 surface can possibly due to the contribution of both 
functionalization and surface thermomigrated silicones.   
 
The general spectra of air corona plasma-treated W-PA66 fabrics for 1.75 s and 3.5 s 
treatment time are shown in Figure 50 and the results of the main species present on 
the fibre surface are presented in Table 12 to study the influence of the corona plasma 
treatment on the elemental composition of the fibre surface and to be compared with 
the IF-PA66.  
 
Figure 50: XPS general spectra of 1.75 s corona plasma-treated (a) and 3.5 s corona plasma-treated W-
PA66 (b). 
The higher amount of nitrogen in W-PA66 indicates that the washing process reduced 
the polysiloxane layer with respect to IF-PA66, so the N atoms from the polyamide 
structure are visible for the XPS. Even if the surface of untreated W-PA66 presents less 
Si atoms with respect to IF-PA66, corona plasma treatment of the W-PA66, as 
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observed for IF-PA66, leads to the increase of Si and O, which could be attributed to 
the combined effects of a O-based functionalization with a thermomigration of Si 
atoms from the bulk to the surface of the fibres, as described previously. 
 
Table 12: Surface elemental composition and atomic ratios of of untreated and corona-plasma treated 
W-PA66 fabrics. 
tplasma (s) 
Elemental composition (%) Atomic ratios 
C1s N1s O1s Si2p O/C N/C 
0  62.0 3.5 21.0 13.5 0.34 0.056 
1.75  45.6 1.2 30.3 22.9 0.66 0.026 
3.5  45.4 < 0.1 30.6 24.0 0.67 <0.002 
 
 
As indicated by the general elemental compositions of the IF-PA66 and W-PA66 (Tables 
11 and 12), no significant differences are found between the two corona plasma 
treatment times evaluated (1.75 s and 3.5 s). 
 
Deconvolution analysis of C1s peaks was performed for IF-PA66 (Table 13) and W-PA66 
(Table 14) to estimate the new surface functional groups introduced on the surface, 
considering three main binding moieties: C–C and C–H bonds at a binding energy of 
285.0 eV, C–O bonds at 286.5 eV, and C=O groups 288.2 eV. Corona plasma treatment 
of IF-PA66 for 3.5 s shows an increase of 1.7% of C-O groups on the IF-PA66 surface,  
the most relevant effect observed being the introduction of carboxylic groups (C=O) 
that progressively increase from 3.6% for untreated IF-PA66 to 11.0% for 3.5 s corona 
plasma treatment. 
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Table 13: Fraction of carbon functional groups from high-resolution C1s XPS peaks of corona plasma 
treated IF-PA66 fabrics. 
tplasma (s) 
Relative chemical bonds (%) 
C1: 285.0 eV C2: 286.5 eV C3: 288.2 eV 
C-C, C-H C-O C=O 
0 85.6 10.8 3.6 
1.75  78.8 12.1 9.1 
3.5  76.5 12.5 11.0 
 
The increase of new oxygenated groups grafted with corona plasma on the W-PA66 
surface (Table 14) was comparable to the results obtained with IF-PA66, with the most 
significant increase registered being in C=O groups. In both cases (IF-PA66 and W-
PA66) the proportion of C-O groups does not vary between 1.75 s and 3.5 s corona 
plasma treatment, while the proportion of carboxylic groups still increases for a longer 
plasma treatment time (3.5 s). 
 
Table 14: Fraction of carbon functional groups from high-resolution C1s XPS peaks of corona plasma 
treated W-PA66 fabrics. 
tplasma (s) 
Relative chemical bonds (%) 
C1: 285.0 eV C2: 286.5 eV C3: 288.2 eV 
C-C, C-H C-O C=O 
0 83.8 12.2 4.0 
1.75  74.2 15.3 10.5 
3.5  73.8 15.1 12.1 
 
The results of the XPS analysis indicate a significant change in the surface chemistry of 
both IF-PA66 and W-PA66 with corona plasma treatment, as functionalization with O-
containing groups, through C-O and mainly C=O bonds, leads to an increase of the 
possible bonding sites for the subsequent attachment of active molecules. This grafting 
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of O-containing groups on the PA66 fibre surface also explains the increase of 
wettability observed with corona plasma treatment in the previous section. 
 
Low pressure plasma 
 
XPS spectra were carried out on IF-PA66 fabrics exposed to different gas flow 
conditions in the plasma chamber (Figure 51). The relative atomic surface composition 
of the textiles before and after different plasma treatments is shown in Table 15.   
 
Figure 51: XPS general spectra of of untreated and low pressure plasma treated IF-PA66 for 5, 10 and 
15 L/min as gas flow. 
 
As shown in Table 15, low-pressure plasma treatments modify the surface chemical 
composition of IF-PA66 by increasing N and O in parallel to decreasing carbon and 
silicon concentration with the increasing gas flow rate in the plasma chamber. This 
indicates an effective etching process of the PDMS on the surface of PA66, as 
confirmed by the Si/N ratio decrease with the increasing flow rate, which reflects the 
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elimination of PDMS chains which render N from amide bonds of polyamide more 
visible for the XPS.  
 
Table 15: Surface elemental composition and atomic ratios of low pressure plasma treated IF-PA66 as 
a function of gas flow. 
Gas flow 
(L/min) 
Elemental composition  
(%) 
Atomic ratios 
C1s N1s O1s Si2p O/C C/N Si/N 
0 59.9 0.7 22.2 17.2 0.37 85.51 24.57 
5 56.9 1.1 28.0 14.0 0.49 50.77 12.53 
10 58.8 1.0 25.7 14.5 0.44 58.23 14.34 
15 56.4 2.3 29.3 12.1 0.52 24.96 5.34 
 
The increase of O1s percentage with the increase of gas flow rate into the plasma 
chamber may indicate an additional functionalization process of the fiber surface. This 
simultaneous etching and functionalization processes by low temperature plasma 
were previously observed in fibers with different finishing processes (Canal, 2007). This 
coupled effect can be explained by the fact that, in low-pressure plasma treatment, 
the increase of the gas flow or the pressure - since the pressure depends on the gas 
flow - possibly leads to increased density of active species in the reactor, as described 
in other works (Cvelbar, 2008).  
 
The results obtained with low pressure plasma contrast with those observed in the 
previous section where corona plasma treatment produced an increase of silicon 
moieties, attributed to a thermomigration process from the bulk to the surface of 
the PA66 fibers. In this case, regarding silicon compounds, low pressure plasma 
treatment achieves principally a cleaning of the surface silicone-based agents. Due to 
the fact that corona plasma is a filamentary discharge, it is coherent to expect such 
results since the more energetic corona plasma treatment allows reaching higher 
local surface temperatures (with higher temperatures in the region of the sparks) 
than the low pressure plasma, and therefore allows the initiation of the thermo-
migration of these compounds.  
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In order to investigate the changes of functional groups in the surface of low pressure 
plasma-treated PA66 fabrics, deconvolution analysis of the high-resolution C1s peaks 
was carried out. The original peak of each PA66 fabric showed three components 
(Figure 52a) with binding energies of at 285.00 eV, 286.53 eV and 288.21 eV which 
may be assigned to the presence of aliphatic C-C (or C-H), C-O (or C-N) and C=O bonds 
in the chain (Dorris, 1978; Brack, 1999), respectively. 
 
Table 16: Fraction of carbon functional groups from high-resolution C1s XPS peaks. 
Gas flow  
(L/min) 
Relative chemical bonds (%) 
C1: 285.0 eV C2: 286.5 eV C3: 288.2 eV 
C-C, C-H C-O, C-N C=O 
Untreated 83.5 12.4 4.1 
5  75.9 12.0 11.8 
10  76.5 12.5 11.0 
15  72.2 12.0 15.8 
 
Table 16 shows the results of the deconvolution analysis for the C1s peak (Figure 52), 
showing a decrease of C–C, C–H content after the plasma treatment while C-O remain 
constant and C=O groups increase. It can be remarked that the progressive increase in 
C=O bonds with higher gas flow, reflect the functionalization process of PA66 fibers by 
carbonyl groups. Previous work on PA 6 films or fabrics also showed incorporation of 
C=O groups on the surface by low pressure plasma (Gao, 2009) or post discharges 
(Canal, 2007), respectively. 
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Figure 52: Deconvolution of C1s peaks for untreated IF-PA66 sample (a) and plasma-treated PA66 
under 5 (b), 10 (c) and 15 (d) L/min gas flow rate. 
 
Surface functionalization of polymer fibers with oxygen moieties from low 
temperature plasmas is associated with improved wettability (Canal, 2004; Canal, 
2007; Canal, 2008), while the presence of PDMS softeners on the surface of textiles is 
related to low wettability (Canal, 2007). Variations in superficial chemistry of the fibers 
are closely linked with the wetting properties. 
 
It has been shown by XPS that PDMS were etched by the low-pressure plasma 
treatment, although they were not completely removed from the fiber surface. The 
higher wetting times recorded in section 4.1.1. for increasing times of plasma 
treatment may indicate redeposition of part of the etched material (i.e. hydrocarbons 
originating from the etched methyl groups which increase hydrophobic properties) or 
PDMS chain reticulation, while the progressive decrease in water absorption times 
obtained at increased flow rates have to be related to the etching of PMDS and 
functionalization with oxygenated moieties observed by XPS. 
(d) (c) 
(b) (a) 
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4.1.3. Influence of plasma treatment on PA66 fiber topography 
 
Corona plasma 
 
Figure 53 shows the surface of untreated IF-PA66 and W-PA66 fabrics. On the one 
hand, imaging of untreated IF-PA66 fibers by SEM shows highly uniform and regular 
fibers of 12–15 µm diameter arranged in yarns as corresponds to man-made fibers. It 
can be observed that IF-PA66 presents some irregularities on the surface which can be 
attributed to silicone aggregates.  
 
 
Figure 53: SEM micrographs of untreated IF-PA66 (a) and W-PA66 (b) fabrics. 
 
Corona plasma treatment improved homogeneity of the surface topography by 
removal of the aggregates of the silicone-finishes present on untreated IF-PA66 fibers, 
as can be observed in Figure 54(a) and (c).  
 
On the other hand, a smooth fiber surface can be observed in untreated W-PA66 due 
to the elimination of the finishing products by aqueous washing. No relevant 
topographic modifications at short plasma treatment times were detected in the W-
PA66 fabrics (Figure 54(b) and (d)). In both kinds of samples, at the longest corona 
plasma exposure studied (after 3.5 s), some melt polymer or localized creasing of the 
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fibres can be randomly observed in some isolate regions of the surface due to the 
sparks of the corona plasma, although no generalized etching effects can be observed 
on the materials surface. 
 
 
 
 
 
Figure 54: Influence of plasma treatment on PA66 fiber topography. SEM micrographs of 1.05 s corona 
plasma-treated IF-PA66 (a) and W-PA66 (b) fabrics, and 3.5 s corona plasma-treated IF-PA66 (c) and 
W-PA66 (d) fabrics. 
 
Low pressure plasma 
 
Scanning electron microscopy has also been used to study the influence of low 
pressure plasma treatment on the topography of PA66 fibers. As previously remarked, 
the presence of the PDMS finishing products can be also observed on the surface of 
the untreated IF-PA66 fibers as agglomerates in some regions of the fibers, and 
binding between some fibers. Etching effects by plasma pointed out by XPS can be 
confirmed by SEM in Figure 55b, where the cleaning effect by plasma treatment 
removed PDMS agglomerates leaving a clean and homogeneous fiber surface. 
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Figure 55: SEM images for (a) untreated IF-PA66 fibers and (b) low pressure plasma-treated PA66 
fibers at 100 W, 180 s, 10 L/min. 
 
SEM was carried out on IF-PA66 fabrics treated under different gas flow rate 
conditions and are presented in Figure 56. As observed for untreated fabrics, the 
surface of plasma-treated PA66 fibers is regular and the only roughness observed can 
be attributed to the presence of PDMS. In other works (Canal, 2007), the presence of 
PDMS on the surface of wool fibres was also detected by SEM as aggregates on the 
fibre surface. Except for the cleaning effect of the PDMS of the surface, low pressure 
plasma treatment did not produce remarkable changes on the topography of PA66 
fibers.  
 
Figure 56: SEM images for untreated (a) and plasma-treated IF-PA66 fabrics with various treatment 
times and gas flow conditions at 1.33 mbar pressure and 100 W power supply as fixed working 
parameters. Effect of 60 s (b) and 300 s (c) minutes plasma treatment time on fiber topography for 5 
L/min gas flow rate and effect of 5 (d), 10 (e), 15 (f) L/min gas flow on PA66 topography for 180 s 
plasma treatment time. 
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Regarding the cleaning of the PDMS, it can be also underlined that the increase of gas 
flow or treatment time allows a more effective elimination of these products (Figure 
56(e) and (f)). It is interesting to remark that this type of plasma treatment is milder for 
the fiber than the corona plasma treatment shown in previous section where the 
presence of sparks in the plasma, locally increasing the temperature, provoked the 
apparition of creasing of the outer polymer layer of some corona plasma-treated PA66 
fibres. In spite of a long exposure time, in this work, melt material, alteration of the 
fibers or creation of microcraters were not observed. While corona plasma treatment 
on IF-PA66 has as the advantage of improving the wetting properties of the fabrics 
with shorter times of treatment, the low pressure plasma treatment used does not 
alter fiber topography and is able to improve wettability at higher flow rates. 
 
4.1.4. Ageing of plasma-treated PA66 fabrics 
 
In this section the ageing, or evolution of the surface chemistry of the plasma-treated 
fabrics as a function of storage time, is studied on IF-PA66 fabrics by measuring the 
changes of the wetting behavior of the fibres by means of drop test.   
 
Corona plasma 
 
It has often been observed that the properties imparted by plasma treatment change 
with time. This phenomenon is commonly called as ageing. Previous studies (Morent, 
2008; Canal, 2004; Canal, 2008; Molina, 2002; Molina, 2003; Nakamatsu, 1999; Borcia, 
2004; Krump, 2005), on different natural and synthetic polymers indicated that surface 
modifications achieved by plasma treatment are not permanent and can progressively 
vary depending on the storage conditions of the sample and time.  
 
The ageing effects observed depend on the nature of the polymeric materials, 
structure, crystallinity, (Novak, 2004) porosity etc. Additionally, it has been reported 
(Leroux, 2006), that the fabric porosity which depends on the fabric structure (e.g. 
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woven, nonwoven, knitted) influences the ageing of air-atmospheric plasma treated 
fabrics subjected to humidity at room temperature and pressure. It was also shown 
that for a low porosity-(high density) woven fabrics, oxidized species formed at the 
fabric surface are more easily removed by simple washing than for high porosity textile 
structure. 
 
In the present study, the hydrophobic recovery of corona-plasma treated IF-PA66 
fabrics has been measured up to 9 days, and is presented in Figure 57. The results 
obtained on the IF-PA66 samples show clearly that the improvement of the wetting 
properties of IF-PA66 fabrics is not permanent. The water absorption time of plasma-
treated IF-PA66 increases, and therefore its hydrophobicity, in the course of one week 
storage. However, after that period of time, the drop test of either of the samples has 
not achieved the value of the untreated ones, so their wetting properties remain 
improved.  
 
Figure 57: Evolution of water absorption time of 3.5 s corona-plasma treated IF-PA66 fabrics as a 
function of storage time, during 9 days. 
 
Compared to the values obtained in previous papers for other textile fibres (Canal, 
2004; Canal, 2008), where contact angles of PA6 rods treated by low pressure plasma 
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with air (100 Pa, 100 W, 13.56 MHz, 120 s) increased from 39 ° to 44 ° after 9 days of 
storage (Canal, 2004), the evolution observed in this work for IF-PA66 fabrics reveals a 
moderate degradation process of the wetting properties. As suggested in these 
previous studies, the increase in hydrophobicity of the plasma treated fabrics as a 
function of storage time indicates that the concentration of hydrophilic groups on the 
surface decreases, which has been attributed to the reorientation or the 
reorganization of these groups toward the bulk phase of PA during their storage in air 
environment. Some results suggest the existence of different mechanisms of 
hydrophobic recovery during the storage of plasma-treated fabrics: water adsorption, 
migration (through rotation or translation) of the amide groups, migration and/or 
rotation of the hydrophilic groups generated by the plasma towards the outer surface, 
surface contamination, blooming of additives, or absorption of ubiquitous 
contaminants (Morra, 1989; Boyd, 1997; Novak, 1999; Novak, 2001; Bhat, 2003; Canal, 
2004; Pandiyaraj, 2009; Morent, 2008; Molina, 2002; Molina, 2003; Nakamatsu, 1999; 
Borcia, 2004; Krump, 2005). For this PhD. Thesis, a maximum lapse of 30 minutes has 
been fixed to perform any subsequent treatment on the plasma-treated materials.  
 
Nevertheless, even though the water absorption time values increase, the corona 
plasma treated PA66 fabrics do not reach the contact angle values of the untreated 
fibres, even after 90 days of storage (16.0 ± 1.5 s), so the wetting properties still 
remain improved, as it could be observed in the work of Canal et al. in 2004, where 
contact angle of low pressure plasma-treated PA6 rods reached 58 ° after 77 days, far 
from the 71.8 ° of the untreated PA6 rod sample, demonstrating that the wetting 
properties also remained improved. Another study using XPS to follow the ageing 
process of Polypropylene films (Boyd, 1997) also revealed the gradual reduction of the 
O-containing groups achieved by atmospheric plasma treatment, through the decrease 
in the O/C ratio with time, pointing out that the time between plasma treatment and a 
subsequent bonding is a critical parameter. 
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It has been confirmed that the surface modifications achieved by corona plasma 
treatment are not permanent and that a hydrophobic recovery of a corona-plasma 
treated IF-PA66 fabrics progressively happens with the storage of the IF-PA66 in air 
environment. This wettability decrease necessarily influences the adsorption of 
chemicals and active principles on the treated fabrics, so in any case, it is advisable 
to carry out any subsequent treatment—in this case impregnation of the plasma 
treated fabrics with the active principle—as soon as possible after corona plasma 
treatment. Nevertheless the corona plasma treated PA66 fabrics does not reach the 
contact angle values of the untreated fibres after 3 months of storage, still showing 
improved wetting properties. 
 
Regarding the W-PA66 samples and the low-pressure plasma IF-PA66 and W-PA66, the 
quick absorption time of the water droplet by the plasma-treated fibres, as observed in 
the previous section 4.1.1., did not allow following the evolution of the wetting 
properties with the time of storage of the samples, using either drop test or static 
contact angle. 
 
4.1.5. Influence of plasma treatment on the loading and release of the active 
principles  
 
Once characterized the surface effects of corona plasma and low pressure plasma 
treatments on PA66 fabrics that they have provoked, in the following sections their 
influence on the loading of drug molecules such as ketoprofen and methylxantine 
compounds is analyzed. 
 
4.1.5.1. Ketoprofen 
 
4.1.5.1.1. Loading 
Results and discussion 
 
 
182 
 
 
As mentioned in the introduction, ketoprofen was used in this work as an NSAID for 
the treatment of rheumathoid arthritis that, taking advantage of the compressive 
effect of the PA66 knitted fabrics used, could be used for the local treatment of the 
ankle and knee joints. Ketoprofen was incorporated from a hydro-alcoholic solution to 
IF-PA66 fabrics, as described in section 3.3.3.1.1. Ketoprofen impregnation of PA66 
fibres has just been evaluated with corona plasma-treated IF-PA66 fabrics, focusing the 
study on the influence of the corona plasma treatment treatment time. Monitoring of 
the ketoprofen loading was carried out by measuring the dry weight of the materials 
before and after impregnation of the IF-PA66 fabrics, and the results are presented 
normalized in Figure 58 in grams of ketoprofen loaded in the fabrics for 1 g of IF-PA66. 
 
Figure 58: Ketoprofen impregnation for corona plasma-treated IF-PA66 for 1.75 s and 3.5 plasma 
treatment. Weight of ketoprofen loaded in the IF-PA66 for 1 g of IF-PA66 fabric. 
 
Untreated IF-PA66 samples present a ketoprofen loading of 0.0073 ± 0.0006 g for 1 g 
of PA66 fibres, which is enhanced by corona plasma treatment which leads to an 
increase of the ketoprofen loading up to 0.0108 ± 0.0016 g and 0.0121 ± 0.0018 g, for 
1.75 s and 3.5 s treatment time, respectively. While this improvement of the loading is 
significant at the shortest corona plasma treatment time, no significant difference is 
observed between the two time conditions studied. 
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4.1.5.1.2. Release 
 
In order to determine if the amount of ketoprofen released from a PA66 fabric could 
be modified by plasma treatment, release experiments were performed from 
untreated and  
corona plasma treated PA66 fabrics. 
 
Figure 59: Accumulated ketoprofen release percentage from untreated, 1.75 s and 3.5 s corona 
plasma-treated IF-PA66 fabrics. 
 
Figure 59 shows the release profiles obtained. The maximum amount of ketoprofen 
released is achieved after 5-6 hours, for both untreated and corona plasma-treated 
PA66 fabrics. The maximum ketoprofen released has been observed around 80% after 
24 h. In plasma treated fabrics, the amount of ketoprofen released is higher than 
without treatment. The effects of plasma on release of ketoprofen from PA66 fabrics 
can be clearly observed in Figure 59. The atmospheric plasma treatment carried out 
increases the percentage of ketoprofen released up to 90%. This 10% increase in the 
ketoprofen released after 24 h could be explained by the fact that the plasma treated 
fabrics can be easily wetted by the aqueous receptor solution. 
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4.1.5.2. Caffeine 
 
4.1.5.2.1. Loading 
 
Caffeine is widely used in cosmetics as an active substance because of its action on 
lipids (Bolzinger, 2008) and, due to its low molecular weight (194.2 g.mol-1), is found in 
a number of commercial cosmetic formulations for topical applications as gels, creams 
or patches. It presents a 2.2 g/L solubility in water at 20 ˚C.  Microemulsions and 
emulsions are also described as vehicles for percutaneous penetration trough the skin 
in literature (Bolzinger, 2008), but direct loading of caffeine in the fibers, coupled with 
the use of plasma technology as described in this work, is a novel vector for 
transdermal applications. 
 
Caffeine was selected as cosmetic active principle of interest for the treatment of 
cellulite by taking advantage of the improved venous return in the legs thanks to the 
compressive effect of the fabrics studied. The design of the tubular fabrics would allow 
focusing on the local treatment of thighs and calf, where the cellulite affection is 
particularly found. 
 
First, impregnation studies of both IF-PA66 and W-PA66 fibres was done using caffeine 
as active principle to evaluate how the corona plasma and the low pressure plasma 
treatments affect its loading on the fibres.  These studies have been mainly focused on 
the influence of plasma treatment time in the case of corona plasma treatment, and 
on the influence of chamber pressure, gas flow rate, plasma treatment time and power 
supply using low pressure plasma on the caffeine loading. 
 
To deepen the fundamental study regarding the interactions established between 
plasma treated surface and drug, a panel of experiments has been designed using 
different molecules from the family of methylxantines, with distinct polarities.  
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Corona plasma 
 
Figure 60 shows the caffeine impregnation weight percentage for IF-PA66 and W-PA66 
fabrics as a function of the corona plasma treatment time applied.  
 
 
Figure 60: Caffeine impregnation percentage for IF-PA66 and W-PA66 fabrics as a function of corona 
plasma treatment time.  
 
 
Around 70% weight percentage of caffeine was incorporated to the untreated fabrics 
from the 1% solution of caffeine employed. W-PA66 fabrics incorporate slightly more 
active principle than IF-PA66 samples (although no statistically significant differences 
were recorded), essentially due to the absence of oil and polysiloxane-based finishing 
products on the surface of the W-PA66 fibers, which is related to better wettability of 
the fabrics and thus improved contact with the impregnation solution. This trend is 
followed in the plasma-treated fabrics. For both types of PA66 fabrics, longer plasma 
treatment times tend to progressively reduce the percentage of caffeine impregnated 
on the fabrics, diminishing about 11% between untreated and 3.5 s-plasma treated 
fabrics.  
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So, while the plasma treatment improves the wetting properties of polyamide 
fabrics, it does not revert in an increase of the incorporation of active principle into 
the fiber. Although caffeine is a polar molecule, with a dipolar moment of 3.64D, 
given its relatively large molecular size, the charges are distributed over a large 
distance, making the molecule less polar than water. Thus, after plasma treatment, 
the new oxygen moieties on the plasma-treated fiber surface lead to increased 
surface electronegativity, so if the surface is more polar, it is expected that 
interaction with caffeine may be hampered, possibly justifying this tendency to 
lower drug incorporation.  
 
 
Low pressure plasma 
 
The effects of low pressure plasma treatment were evaluated on the caffeine loading 
of IF-PA66 fabrics, using a 1% caffeine aqueous solution, and the results are reported 
in Table 17. It can be observed that impregnation of plasma-treated fabrics with low 
flow rate (5 L/min) and short plasma treatment time (60 s) presents a percentage of 
impregnation similar to that of untreated fabrics. Further increase of the flow rate and 
treatment time of the plasma treatment of IF-PA66 leads to a decrease of the quantity 
of drug loaded in the fabric. This behavior can be related with the decrease of 
wettability of the low-pressure plasma treated samples with respect to the untreated 
one as observed in section 4.1.1. This could be explained by the scheme proposed in 
Figure 61. Plasma treatment at high flow rates reduces the thickness of the PDMS layer 
(as shown by XPS and SEM) and increases surface functionalization by oxygen moieties. 
In views of the chemical structure of caffeine, binding to the fiber can be expected to 
take place mainly by hydrogen bonds. 
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Table 17: Caffeine impregnation percentage of untreated and low-pressure plasma-treated IF-PA66 
fabrics as a function of the gas flow (air) and treatment time. 
 IF-PA 66 
Gas flow (L/min) 0 
 
5  10  15 
tplasma (s) 0 
 
60 180 300  180  180 
Caffeine 
impregnation (%) 
67.2 
± 0.4 
 
66.2 
± 0.5 
42.2 
± 0.2 
47.5 
± 1.0 
 
44.6 
± 0.6 
 
44.9 
± 0.3 
 
The presence of the PDMS layer offers higher number of hydrogen bonding sites, so its 
progressive elimination with plasma treatment somehow reduces the capacity of the 
material to incorporate the drug. The proposed mechanism of Figure 61 also explains 
the effects of increasing treatment times with corona plasma treatment on the 
amount of caffeine incorporated to the IF-PA66 fibres. 
 
 
Figure 61: Proposed mechanism of PDMS layer reduction with the increase of gas flow in plasma 
treatment and its relationship with caffeine incorporation to the fibre. 
 
 
4.1.5.2.2. Release 
 
Corona plasma 
In the present work, in vitro release experiments of caffeine-loaded samples were 
performed on both IF-PA66 and W-PA66 fabrics with and without plasma treatment. 
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Release kinetics are shown in Figure 62. 
 
 
Figure 62: Accumulated caffeine release percentage from W-PA66 (a) and IF-PA66 (b) fabrics. 
Influence of corona plasma treatment on caffeine release kinetics.* and ** indicate statistically 
significant differences. 
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For both kinds of fabrics, two different stages can be distinguished: an initial fast 
release phase and a second stage of slower release. In both IF-PA66 and W-PA66 
materials, plasma treated samples show higher release percentages, with no 
significant differences between the two different corona plasma treatment times 
evaluated. In all cases, burst release is recorded, up to 70% and 83% in the first hour 
for untreated and plasma-treated materials, respectively. This stage is followed by a 
slower release up to 8 hours, without reaching the stationary stage in any of the 
samples, and thus, with potential for longer release. 
 
 
Figure 63: Caffeine release percentages at the end of 8 hour release assay, for untreated, 1.75 s and 
3.5 s corona plasma-treated IF-PA66 and W-PA66 fabrics, with details of the dominant plasma 
contribution. 
 
While previous laboratory washing of untreated PA66 leads to a final caffeine release 
+7.0 % higher with respect to the untreated IF-PA66, no significant difference is 
observed between W-PA66 and IF-PA66 for corona plasma-treated fabrics for all the 
plasma treatment times studied. This behavior indicates that the cleaning of the PA66 
surface achieved by the plasma allows reaching a cleaning as good as for the washing 
of the PA66 fabrics by wet process.    
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In particular, the difference between the untreated IF-PA66 and W-PA66 samples 
indicates the specific effect of the washing process on the release percentage of 
caffeine (Figure 63). Plasma-treated IF-PA66 samples present final caffeine release 
percentages around 89%, improving around 9% with respect to the untreated sample. 
Untreated W-PA66 already has a higher release of 87% with respect to untreated IF-
PA66, indicating that the cleaning effect of plasma or the washing process carried out 
prepare the surface of PA66 industrial fabrics in a similar way. This has allowed 
distinguishing between the contribution of plasma to the preparation of the surface 
(cleaning effect) and the intrinsic contribution of plasma functionalization, with regard 
to the drug release. 
 
Comparative study with topical therapeutic level of commercial products 
 
 
As shown in Table 18, the accumulated percentage released in the different samples 
after 8 hours corresponds to a caffeine dose between 496.6 and 540.9 mg/ 100 g for 
IF-PA66 fabrics, and between 560.6 and 620.4 mg/ 100 g for W-PA66 fabrics.  
 
Table 18: Effect of low-pressure plasma treatment time on the release percentage of caffeine and the 
released quantity of caffeine from IF-PA66 and W-PA66 fabrics. 
 
IF-PA66 fabrics W-PA66 fabrics 
tplasma (s) 0 1.05 1.75 3.5 0 1.05 1.75 3.5 
%R (after 8 h) 
80.6 
± 3.3 
89.1 
± 2.0 
87.9 
± 2.6 
89.2 
± 1.0 
87.0 
± 0.8 
88.1  
± 1.4 
89.7  
± 0.2 
91.1  
± 0.8 
Released 
caffeine 
 after 8 h 
(mg/100 g 
PA66) 
540.9 
± 22.1 
514.7 
± 11.6 
520.6 
± 15.4 
496.6 
± 5.6 
604.5 
± 5.6 
570.9  
± 9.1 
560.6  
± 1.2 
620.4  
± 5.4 
 
 
Taking into account that the PA66 samples used for this research have a weight by 
square meter of 272 g/m2, 100 g of fabric correspond to an area of 3678.9 cm2. 
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Considering elastic-compressive leggings covering the legs from the hip to the knees, 
with an upper part of 112 cm of diameter and 44 cm of diameter in the lower part of 
each leg, the quantity of active compound which will be released by such PA66 mesh 
can be calculated. With a total surface area of 3500 cm2, caffeine release after 8 hours 
would be between 472.4 mg and 590.2 mg. Compared to other caffeine-containing 
commercial formulations such as gels, which usually contain between 4% and 5% of 
caffeine (e.g. Somatoline CosmeticTM), a dose of 10-15 g of the formulation applied on 
the skin corresponds to between 400 and 750 mg of caffeine.  
 
Therefore, the caffeine dose released from plasma-treated PA66 is comparable to the 
commercial ones and could be proposed as a novel alternative for anticelulitic therapy. 
Furthermore the homogeneity of distribution of an active compound in gel form 
applied by the user does not ensure uniform topical doses on the skin, while this type 
of textile support may avoid this issue. Also the efficacy of the compressive effect of 
such polyamide textile fabric on the treated skin can contribute to improve the 
mentioned therapeutic/cosmetic effects. 
 
It could be speculated that the use of the compressive PA66 fabrics could also be 
combined with gel formulation treatments, alterning day/night treatments, to provide 
an optimal efficacy of the anti-cellulitic treatment during 24 hours.  
 
Release kinetics modeling 
 
The modeling of drug release from delivery systems is important for the understanding 
and the elucidation of the transport mechanisms. To compare the release profiles of 
the samples with different treatments, several models were tested, including 
Korsmeyer-Peppas, Higuchi, Zero order, First order, Hixson-Crowell and Weibull 
(Higuchi 1961, Higuchi 1963; Gibaldi and Feldman, 1967; Wagner, 1969; Hixson and 
Crowell, 1931; Langenbucher, 1972; Goldsmith et al., 1978).  
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In spite of the complexity of the phenomena involved in drug release mechanisms, the 
mathematical expressions used in pharmaceutics to describe the kinetics of drug 
release from a large variety of devices are rather simple, and they can be summarized 
briefly in three basic laws. Basically, the mathematical expressions used to describe the 
kinetics of drug release and the discernment of the release mechanisms are the 
Higuchi law (Higuchi, 1961), the Peppas equation or the so-called power law (Ritger, 
1987; Siepmann, 2001) and the Weibull equation. 
 
For the simplest geometry of thin films with negligible edge effects, Higuchi published 
the famous square root of time relationship between the amount of drug released 
from a thin ointment film with a large excess of drug (initial drug concentration drug 
solubility in the carrier material) in 1961 (Higuchi, 1961). The first approach of Higuchi 
relies on Equation (11), which indicates that the fraction of drug released is 
proportional to the square root of time: 
 
(9) 
 
where Mt is the cumulative amount of drug released at time t, A is the surface area of 
the controlled release device exposed to the release medium, D is the drug diffusivity, 
and co and cs are the initial drug concentration and the drug solubility, respectively. 
This law is valid for systems where the drug concentration is much higher than the 
drug solubility.  
An important advantage of this equation is its simplicity. However, when applying it to 
controlled drug delivery systems, Higuchi based his equation on assumptions that must 
be all fulfilled, including: 
 The initial drug concentration in the system must be much higher than drug 
solubility. 
 The device geometry is that of a thin film with negligible edge effects. 
 The size of the drug particles is much smaller than the thickness of the film. 
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 The carrier material does not swell or dissolve. 
 The diffusivity of the drug is constant (not dependent on time or position). 
 Perfect sink conditions are maintained throughout the experiment. 
 
Unfortunately, Higuchi equation is often misused and applied to controlled drug 
delivery systems which do not fulfill all these assumptions.  
 
 The second approach, the Korsmeyer-Peppas equation is based on the semi-empirical 
Equation (11): 
 
(10) 
 
where  and  are the absolute cumulative amount of drug released at time t and 
infinite time, respectively; k is a constant incorporating structural and geometric 
characteristics of the system, and n is the release exponent, which might be indicative 
of the mechanism of drug release, being n the exponent which is used to describe the 
kinetics beyond the release (Ritger, 1987) (Table 19).  
 
Table 19: Ritger-Peppas diffusion exponent and mechanism of diffusional release from various non-
swellable controlled release systems. 
Diffusion exponent, n 
Drug release mechanism 
Thin film Cylindrical sample 
Spherical 
sample 
0.50 0.45 0.43 Fickian diffusion 
0.50 < n < 1.0 0.45 < n < 1.0 0.43 < n < 1.0 Non-fickian diffusion 
1.0 1.0 1.0 Zero-order release 
 
Nicholas Peppas was the first to introduce this equation in the field of drug delivery 
(Peppas, 1984; Peppas, 1985; Korsmeyer, 1986a,b). When pure Fickian diffusion is the 
controlling release mechanism, n= 0.5 for a thin film, and Equation (10) collapses to 
Equation (9). Both Equation (9) and (10) are short time approximations (Siepmann, 
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2001; Kosmidis, 2003a) of complex exact relationships and therefore their use is 
confined for the description of the first 60% of the release curve.  
 
Another alternative for the description of release profiles is based on the empirical use 
of the Weibull function: 
 
(11) 
 
where a and b are constants. Although this function is frequently applied to the 
analysis of dissolution and release studies (Van Vooren, 2001; Adams, 2002; Koester, 
2004; Varma, 2005), its empirical use has been criticized (Costa, 2001a). The criticism is 
focused on: (i) the lack of a kinetic basis for its use and (ii) the non-physical nature of 
its parameters (Costa, 2001b). Besides, various attempts have been made to improve 
its performance and validate its use (Macheras, 2000; Elkoshi, 1997; Lansky, 2003). 
Recently, Monte Carlo simulation techniques were used for the study of Fickian 
diffusion of drug release both in Euclidian and fractal spaces (Kosmidis, 2003b,c). It was 
found that Equation (10) describes nicely in both cases the entire drug release curve 
when the drug release mechanism is Fickian diffusion. In the case of release from 
Euclidian matrices studied by Kosmidis, 2003b, the value of the exponent b was found 
to be in the range 0.69–0.75. In the case of release from the two-dimensional 
percolation fractal (Kosmidis, 2003c) the values of b ranged from 0.35 to 0.39. It was 
shown that the Weibull function arises from the creation of a concentration gradient 
near the releasing boundaries of the Euclidian matrix (Kosmidis, 2003b) or because of 
the “fractal kinetics” behavior associated with the fractal geometry of the environment 
(Kosmidis, 2003c). The lower value of b in the percolation cluster reflects the slowing 
down of the diffusion process in the disordered medium. These Monte Carlo 
simulation results are apparently pointing to a universal law since the Weibull model 
provides a simple physical connection between the model parameters and the system 
geometry (Papadopoulou, 2006). 
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Korsmeyer-Peppas and Higuchi models are only valid for the first 60% of release, and 
the former showed good fitting to that part of the curve Mt / M∞ = k × tn. 
 
In Table 20, a summary of the release percentage and the corresponding quantity is 
shown for the samples of IF-PA66 and W-PA66 treated with corona air plasma at 
different times. Additionally, the fitting parameters to Korsmeyer-Peppas model are 
shown. The other model evaluated did not show adequate fitting so they are not 
presented here. 
 
Table 20: Impregnated and released caffeine (in mg) from 100 g of corona plasma treated PA66 
fabrics. 
 
IF-PA66 fabrics W-PA66 fabrics 
tplasma (s) 0 1.05 1.75 3.5 0 1.05 1.75 3.5 
%R (after 8h) 
80.6 
± 3.3 
89.1 
± 2.0 
87.9 
± 2.6 
89.2 
± 1.0 
87.0 
± 0.8 
88.1 
± 1.4 
89.7 
± 0.2 
91.1 
± 0.8 
Released caffeine 
after 8h 
(mg/100 g PA66) 
540.9 
± 22.1 
514.7 
± 11.6 
520.6 
± 15.4 
496.6 
± 5.6 
604.5 
± 5.6 
570.9 
± 9.1 
560.6 
± 1.2 
620.4 
± 5.4 
Korsmeyer
-Peppas 
n 1.03 1.04 1.06 1.06 1.06 1.03 1.07 1.07 
k 34.24 41.26 42.67 40.49 46.35 47.26 47.53 44.32 
R2 0.999 0.998 0.999 0.999 0.999 0.991 0.999 0.999 
 
 
As reflected in Table 20, R2 was very good for all samples, which all presented an 
exponent n very close to 1. Assuming that the geometry of our fabric samples can be 
regarded like a film, for the sake of simplification, this value of the exponent 
corresponds to a Zero-order release mechanism meaning that the drug is released at a 
constant rate over time. This kind of release is desirable in case of drugs that are 
rapidly absorbed and rapidly eliminated because it minimizes potential drug 
concentration peaks and fluctuations in the blood (Siegel, 2012), which may lead to 
periods of underexposure or overexposure, and thus out of the therapeutic window.   
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As confirmed by the release profiles, the release mechanism is affected neither by the 
washing treatment nor by the corona plasma treatment. From the k values it can be 
inferred that the initial caffeine release rate of IF-PA66 samples is increased by the 
plasma treatment.  
 
Korsmeyer-Peppas fitting of the caffeine release curves of untreated and corona 
plasma-treated PA66 revealed zero order release mechanism in both cases, showing 
that the treatment did not alter the release mechanism.  
 
Finally, the overall contribution of the corona plasma on the loading and release of 
caffeine from the W-PA66 fiber is summarized in Figure 64. 
 
 
Figure 64: Global effects of the low pressure plasma treatment on the loading and the release of 
caffeine from the W-PA66 fibres. 
 
 
It is shown that the plasma treatment of W-PA66, on the one hand, leads to a 
decrease of the impregnation percentage of caffeine, and on the other hand, 
achieves an improvement of the release percentage. Regarding the overall set of 
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operations, it is shown that, through the plasma treatment, an equal or greater yield 
in the amount of caffeine release from the fiber is obtained (Table 18 and Figure 64).  
 
 
Corona plasma treatment of the PA66 fabrics leads to achieve the desired topical 
therapeutic levels, with the advantage of allowing to save active principle with 
respect to the untreated PA66, since the lower caffeine impregnation of the corona 
plasma treated PA66 fabrics combined with the higher percentage released, allows 
similar amount of caffeine released from the PA66 fibres. 
 
 
Low pressure plasma 
 
Release experiements performed with low-pressure plasma treated PA66 fibres have 
only been performed with IF-PA66 and caffeine, focusing the research on the influence 
of the low-pressure plasma conditions (gas and time) on the release of the caffeine. In 
vitro release profiles of caffeine during 24 h from untreated and plasma treated IF-
PA66 fabrics are shown in Figure 65. In this case, the release assays have been 
performed during 24 h, since the equilibrium of the drug delivery system was not been 
reached after 8-hour experiments. 
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Figure 65: Influence of (a) gas flow rate into the plasma chamber (samples treated for 180 s) and (b) 
plasma treatment time (samples treated under 5 L/min of gas flow) on the caffeine release kinetics 
from IF-PA66 fabrics (*indicates no significant differences at p < 0.05). 
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Release kinetics of untreated PA66 shows a moderate burst release during the first 
hour of experiment, only up to 20%, due to the high solubility of caffeine in aqueous 
media. The effects of plasma on the release of caffeine from IF-PA66 fabrics can be 
clearly remarked, the increase of gas flow (air) in the chamber provoking a significant 
increase of caffeine release after 24 hours. Untreated IF-PA66 presents a maximum 
release value of 72% after 24 h, while plasma-treated fabrics under 15 L/min of air flow 
present a final caffeine release value close to 90%, with a constant increase of the 
percentage of caffeine released with the increasing of gas flow. However, as observed 
with caffeine loading, no significant difference is observed for the low-pressure 
plasma-treated IF-PA66 for 5 L/min with respect to the untreated fabric. Among 
plasma treated samples, increased gas flow improves wettability, as shown in section 
4.1.1. This allows better contact between fabrics and release media, so plasma-treated 
fabrics can be more easily wetted by the aqueous receptor solution and therefore 
more easily release the drug. 
 
When the effects of treatment time with air plasma were evaluated on the caffeine 
release from IF-PA66 fabrics, all plasma-treated samples displayed higher release 
percentages than the untreated ones. However, significant differences were observed 
among them. This may possibly be explained by the thinner polysiloxane layer on the 
surface of the fibers, facilitating diffusion of the drug to the release media.  
 
It has been remarked that all curves display the same profile, which suggests that the 
plasma treatment does not alter the mechanism of release from knitted PA66 fabrics. 
Nevertheless, it can be noticed that caffeine release kinetics for plasma-treated 
fabrics, at high flows (10-15 L/min) and longer plasma treatment time (5 min), present 
a higher final slope than untreated fabrics, pointing out to a modification in the surface 
interactions. In addition, during the 24 hour experiment, the stationary state was not 
achieved, and the final slope of the release profile was higher in samples treated with 
plasma at high flow rate and longer treatment time, reflecting faster caffeine release. 
The effects of plasma gas flow on drug release have to be related with wetting 
properties of the materials, as well as with the thickness reduction of the outer PDMS 
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layer which facilitates the diffusion of the drug through the PDMS layer. All the results 
seem to indicate that hydrophilic properties of the PA66 fibers and thickness of the 
PDMS layer are the two main factors which affect the caffeine incorporation and 
release process from the PA66 fiber. 
 
As for corona plasma treatment of the IF-PA66 and W-PA66, the release of caffeine 
enters in the topical therapeutical range of the active principle, since the quantity of 
caffeine loaded remains unchanged and the release percentages of caffeine from the 
fabrics are in the same range between both kinds of plasma treatment.  
 
4.1.5.3. Methylxantines 
 
4.1.5.3.1. Loading 
 
As W-PA66 presents a better incorporation of caffeine than IF-PA66, only washed PA66 
fabrics have been employed in this part of the study, focused on the influence of the 
corona plasma effect and the molecule polarity on the active principle loading. The 
corona plasma conditions yielding more clear effects (3.5 s) have been selected for the 
fundamental studies with the three methylxantines.  
Table 21: Methylxantine weight percentage for untreated and 3.5 s corona plasma-treated W-PA66 
fabrics. 
  
 
 
Treatment 
time (s) 
Caffeine Theobromine Pentoxifylline 
0 69.47 ± 2.33 70.35 ± 2.34 69.86 ± 0.82 
3.5 58.05 ± 0.28 61.62 ± 0.54 58.31 ± 0.42 
 
Corona plasma treatment of PA66 fabrics for 3.5 s reduces the loading of the three 
methylxantines in the W-PA66 fibres as shown in Table 21. Caffeine, theobromine and 
pentoxifylline present an impregnation percentage decrease after 3.5 s corona plasma 
treatment of 11.4%, 8.7% and 11.5% respectively.  
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4.1.5.3.2. Release 
 
 
Figure 66: Caffeine (a), theobromine (b) and pentoxifylline (c) release percentage from W-PA66 fabrics. Influence of 3.5 s corona plasma treatment on the release 
kinetics of the methylxantine molecules. 
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Table 22: Relevant properties of the methylxantines used for the release study. 
 Theobromine Caffeine Pentoxifylline 
Molecular 
weight 
180.164 g/mol 194.19 g/mol 278.31 g/mol 
Formula C7H8N4O2 C8H10N402 C13H18N4O3 
 
  
 
Solubility in 
water 
330 mg/L at 20 °C 2200 mg/L at 20 °C 517 mg/L at 20 °C 
Polarizability 16.86 18.95 29.27 
Polar surface 
area 
67.23 58.44 75.51 
 
While the impregnation percentages remain unchanged between all kinds of 
methylxantines loaded for the untreated W-PA66 and 3.5 s corona plasma treated W-
PA66 (Table 21), the increase of the release percentages vary as function of the kind of 
methylxantines due to the effect of plasma treatment, in the following order: 
Caffeine < Theobromine < Pentoxifylline 
 
To assist in the understanding of this behavior, Table 22 summarizes some relevant 
properties of the methylxantines studied in this work.  
 
As described before, plasma treatment of PA66 achieves the functionalization of the 
fibre surface by creating new reactive groups. As shown in Figure 67, the polar surface 
area of the methylxantines determines the increase in release percentage due to the 
plasma treatment. It can be observed that when the molecule has higher polar 
surface area, a much higher percentage is released after the plasma treatment with 
respect to the untreated sample.  
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Figure 67: Increase of release percentage between untreated and 3.5 s corona plasma treated W-PA66 
for pentoxifylline, theobromine and caffeine as a function of the polar surface area of each 
methylxantine. 
 
This behavior can be explained through the interactions established between the drug 
and the surface of fibres. After plasma treatment the surface of PA66 is functionalized 
with O-containing polar groups which increase the electro-negativity of the fibre 
surface. In that case, the molecules with higher polar area (pentoxifylline) feel more 
repulsion from the higher electronegative surface of the plasma-treated samples, and 
thus show higher release percentages. 
 
Loading of an active principle on the plasma-treated PA66 fibres and its subsequent 
release from such fibres not only depends on the modification of the surface 
chemistry and topography of the fibre due to plasma treatment but also on the 
polarity of the molecules loaded, since plasma treatment with air increases the 
electronegativity of the surface and thus modifies the electronic attraction/repulsion 
between the molecule and the polymer substrate. 
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4.2. Part II – Plasma-treated polypropylene meshes as drug-delivery body 
implants 
 
This part of the PhD. Thesis is focused on the evaluation of the relevance of corona 
plasma and low temperature plasma as efficient tools to modify the incorporation and 
release of an antibiotic (ampicillin) from PP meshes aimed for body implant for 
abdominal hernia repair. The relevance of the loading of antibiotics on PP surgical 
meshes rests upon the need to treat and alleviate post surgical infections using the 
mesh as drug-delivery system, confering it a functional added value to its main body 
tissue support function. 
 
First, surface characterization of PP meshes has been performed to study the effects of 
corona plasma and low-pressure plasma treatments on the surface properties of the 
fiber. Both plasmas used air as gas for plasma generation. In the following sections, like 
in the previous part, the results obtained with both types of plasma are presented, 
beginning with corona plasma results, and followed by those obtained with low-
pressure plasma. Taking into account the biomedical applications of the PP meshes, 
the studies have always been done with washed PP fabrics. 
 
Second, a process based on plasma polymerization of PEG, using tetraglyme as 
precursor, has been designed for the deposition of a thin biocompatible film on the 
ampicillin-loaded PP fibres to evaluate the possibility of slowing down the release 
kinetics of ampicillin, acting as a retention membrane. 
 
4.2.1. Influence of plasma treatment on wetting properties 
 
Given the open structure of the knitted PP mesh selected for this study, not allowing 
deposition of a water droplet, the static contact angle (θs) has been studied by using a 
PP film as a model. Figure 68 shows the static contact angle of a water droplet on the 
untreated and plasma-treated PP film. It can be observed that the surface of the 
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untreated PP film, with a contact angle of 124.4 °, has a clear hydrophobic character. 
However, when this polypropylene surface is treated by plasma, under any of the 
experimental conditions tested, it acquires hydrophilic properties, showing a contact 
angle below 90 ° (Figure 69).   
 
Figure 68: Profile shape of a 10 μL H2O droplet on the untreated (a), 0.35 s corona plasma-treated (b) 
and 30 s low pressure plasma-treated PP film for 30 L/min gas flow and 100 W power supply. 
 
Corona plasma 
 
As shown in Figure 69a, at the shortest corona plasma treatment time, corresponding 
to 0.35 s, PP film shows a static contact angle of 52.4 ± 2.3 °. With the increase of the 
plasma treatment time, corona plasma-treated PP film shows a decrease of the 
contact angle value down to 23.1 ± 2.8 ° with 7.0 s corona plasma treatment time. It 
has also been observed that the static contact angle values do not show any significant 
statistical difference for treatment times longer than 7.0 s (not shown in the figure for 
clarity). 
 
Low-pressure plasma 
 
Static contact angle of low-pressure plasma treated PP surface was measured for 30, 
60 and 180 s treatment time with air gas flow and power set at 30 L/min and 100 W, 
respectively, according to the results shown in the previous section using the plasma 
treatment conditions. As for corona plasma treatment, the same trend of exponential 
decrease of the contact angle value with the increase of plasma treatment time can be 
observed with low pressure plasma-treated PP film. The shortest low pressure plasma 
treatment time, corresponding to 30 s of treatment, reaches a static contact angle of 
(a) (b) (c) 
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35.8 ± 3.4 °, 3.5 times lower than the untreated PP.  PP surfaces treated for 60 s and 
180 s low-pressure plasma treatment show even better hydrophilic properties, with 
contact angles of 22.01 ± 3.08 ° and 18.08 ± 3.88 ° respectively, which are values 
similar to a corona plasma treatment of 7.0 s. However, no significant difference was 
observed between low-pressure plasma treatment for 60 s and 180 s, allowing 
concluding that plasma treatments longer than 60 seconds do not further enhance the 
wetting properties of the PP surface. 
 
 
Figure 69: Water static contact angle as a function of the plasma treatment source and plasma 
treatment time. Comparison of corona plasma treatment (a) and low pressure plasma treatment at 30 
L/min gas flow and 100 W power supply (b). 
 
 
In both corona and low pressure plasma treatments it can be observed that the 
wetting properties show an exponential decrease as a function of treatment time. A 
plateau is reached in corona plasma after 3.5 s of treatment at around 25 ˚, while 
longer times of 60 s are required in low pressure plasma treatment to get close to 
the plateau region, with contact angles around 20 ˚.  
 
4.2.2. Influence of plasma treatment on surface chemistry 
 
Corona and low-pressure plasma 
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The relationship of the wettability improvement with the chemical modifications of the 
surface was evaluated through XPS, and the general spectra are shown in Figure 70 for 
untreated, 1.75 s and 3.5 s corona plasma treated, and for 60 s low-pressure plasma 
treated PP meshes. The plasma treatment times have been selected for XPS analysis 
from the static contact angle results presented in section 4.2.1, since longer plasma 
treatment times did not further improve of the wetting properties of PP meshes.  
 
 
Figure 70: XPS general spectra of untreated (a), corona plasma-treated for 1.75 s (b) and 3.5 s (c), and 
low-pressure plasma treated PP meshes for 60 s with power supply and gas flow set at 100 W and 30 
L/min respectively (d). 
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It can be observed that C1s and O1s are the main species, which is according to the 
chemical structure of polypropylene. It can also be observed the presence of Si in the 
untreated mesh even though the samples have been washed/prepared prior to their 
use, as well as the grafting of N atoms on the fibre surface with the low pressure 
plasma treatment. The quantification and the evolution of the surface chemistry with 
plasma treatment on the surface of PP meshes is reported in Table 23.   
 
Table 23: Surface elemental composition and atomic ratios of untreated and plasma-treated PP 
meshes. 
tplasma (s) 
Chemical composition (%) Atomic ratios 
C1s N1s O1s Si2p O/C N/C 
Untreated 84.0 0.3 10.0 5.8 0.12 0.004 
1.75 s corona 84.2 0.1 13.4 2.3 0.16 0.001 
3.5 s corona 79.7 0.7 18.5 1.1 0.23 0.009 
60 s low-pressure 75.4 2.7 20.9 1.1 0.28 0.036 
 
 
Table 23 reports the elemental relative composition of the fiber surface of untreated, 
corona plasma-treated and low pressure plasma-treated PP fibers. Untreated PP mesh 
presents a surface composition with 84% of C1s and 10% of O1s. Since the 
polypropylene structure does not include oxygen atoms in its formula (CH2=CH-CH3), 
and even if the meshes have been previously washed by the provider as well as in our 
laboratory, it can be observed that in untreated PP meshes a small percentage of Si is 
present on the fiber surface. Thus, it can be deduced that the fiber surface of the 
untreated mesh contains some contamination with silicone-based compounds that can 
justify the presence of oxygen. 
 
For both types of plasma, the results observed after the treatment of the PP fabrics 
with air as gas for plasma generation show a progressive increase of oxygen groups 
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combined with a reduction of silicon. As described in the preceding part of this PhD. 
Thesis for polyamide 66, the increase of oxygen moieties comes from the 
functionalization of the fibre surface, while the reduction of silicon comes from the 
elimination of the remaining of finishing products that have not been removed by the 
initial washing of the PP fabrics, or rests of some surfactants in the fibre surface.   
 
In the case of low pressure plasma treatment it has been observed an apparition of 
nitrogen groups in surface of the fibers of 2.7% for a plasma treatment of 60 s. This 
introduction of nitrogen can be attributed exclusively to a functionalization process by 
N2 molecules coming from the air plasma studied. For low-pressure plasma, only the 
sample treated for 60 s was selected, taking into consideration the contact angle 
results shown in Figure 69, as the hydrophilic properties are much improved in these 
conditions and longer treatment times do not lead to significant improvements.   
 
Figure 71 shows the C1s high resolution XPS spectra of the untreated, corona plasma-
treated and low pressure plasma-treated PP meshes. The surfaces of untreated and 
plasma-treated PP fibers show two distinct peaks at 284.73 eV and 286.21 eV, 
corresponding, respectively, to (–C–C, –C–H) and (–C–N, –C–O) groups. Relative 
functional groups on the fibre surface, calculated from the relative area of each peak, 
are reported in Table 24. 
 
It can be observed that the C-C and C-H bonds are predominant for the untreated PP 
mesh (97.7%) since the structure of PP includes only these atoms and type of bonding. 
Submitted to corona plasma treatment, the PP fibres undergo a progressive 
functionalization process of the fibre surface by O and N atoms with the plasma 
treatment time up to 6.8% for 3.5 s of corona plasma treatment. Regarding the results 
in Table 23 of the surface elemental composition of the untreated and corona plasma 
treated PP meshes, with a ratio of N atoms < 1 in all cases, it can be concluded that the 
predominant bonding due to the functionalization by corona plasma is the C-O 
bonding.  
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Figure 71: C1s high-resolution XPS spectra of the untreated (a), corona plasma-treated (b, c) and low 
pressure plasma-treated (d) PP fabrics. 
 
 
Table 24: Fraction of carbon functional groups from high-resolution C1s XPS peaks for untreated, 
corona plasma-treated and low-pressure plasma-treated PP meshes. 
Sample 
Relative functional groups (%) 
284.73 eV 286.21 eV 
C-C, C-H C-O, C-N 
Untreated 97.72 2.28 
1.75 s corona 96.74 3.26 
3.5 s corona 93.20 6.80 
60 s LPP 91.02 8.98 
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Low pressure plasma treatment for 60 s (100 W, 30 L/min, 300 mT) maximized the 
increase in C-O, C-N groups on the PP surface to 9.0%. While corona plasma 
treatment carries out the functionalization of the PP surface by grafting mainly 
oxygen atoms by covalent bonding with carbon atom of the PP fibres, low-pressure 
plasma treatment also increases the attachment of N atoms with the 
macromolecular chain of PP and achieves a functionalization with O and N atoms, as 
reflected by the increase of N in Table 23. 
 
4.2.3. Influence of plasma treatment on PP fiber topography 
Corona plasma 
In this section, the topographic surface modifications introduced by different corona 
plasma treatment times are investigated by Scanning Electron Microscopy (SEM) and 
by Atomic Force Microscopy (AFM).  
 
 
Figure 72: SEM images for untreated (a) and corona plasma-treated PP mesh for 1.75 s (b), 3.5 s (c) 
and 7.0 s (d). 
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The SEM micrographs of the untreated PP mesh presented in Figure 72a and the AFM 
morphology presented in Figure 73 reveal that the surface is mainly flat showing a 
limited nanometric roughness, with an average roughness (RRMS) of 5.8 nm (Table 25). 
In general, untreated PP meshes present a smooth surface, as also shown in previous 
works, in which AFM has been used to characterize PP surfaces (Wei, 2006; Gomathi, 
2009).  
 
 
Figure 73: AFM topography of untreated PP meshes (a), with 3D reconstitution image (b). 
 
Figure 74 shows the AFM topography of corona plasma-treated PP meshes with the 3D 
reconstruction images for 0.35 s, 1.75 and 3.5 s plasma treatment time.  
 
In the case of corona plasma treatment, important changes in roughness are observed 
with the longer plasma treatment time studied. While short plasma treatment times 
(0.35 s) do not affect significantly the roughness regarding the untreated sample, the 
value of mean roughness (RRSM) increased from RRSM= 5.8 nm for the untreated PP 
mesh to RRSM= 20.3 nm for the sample treated for 1.75 s with corona plasma and RRSM= 
18.3 nm for the 3.5 s corona plasma treatment. As observed in previous sections, this 
plasma treatment condition is the one showing the major changes in surface 
chemistry. Quantification of the evolution of the average roughness with the plasma 
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treatment is reported in Table 25 with the maximum roughness values for each plasma 
treatment condition studied. 
 
       
 
 
 
 
 
Figure 74: AFM topography with the corresponding 3D reconstitution images of 0.35 s (a, b), 1.75 s (c, 
d) and 3.5 s (e, f) corona plasma-treated PP meshes. 
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This change of surface topography results in a pattern of peaks and valleys on the 
polypropylene fibre surface. In fact, as shown in previous works (F. Poncin-Epaillard, 
1997; Médard, 2002; Fresnais, 2006), different mechanisms are taking place. 
Combined etching processes, photo oxidation and thermal oxidation are taking place 
on the amorphous regions of the polymer. The energy transferred to the polymer 
thermally and from UV-VIS by the corona (which is characterized by the presence of 
highly energetic sparks) acts as a reaction initiator on the weakest regions of the 
polymer (i.e. amorphous regions in between spherulites) which is then continued and 
enhanced by the presence of O and N radicals, as well as by the highly reactive O3 also 
present in the plasma, that results in the apparition of the peaks/spherulites on the 
surface of PP fibres. 
 
 
 
Figure 75: Roughness analysis of untreated (a) and corona plasma-treated PP meshes for 0.35 s (b), 
1.75 s (c) and 3.5 s (d). Relative repartition of height of the analyzed surface from (600×600) nm AFM 
pictures. 
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Table 25: Average (Rrms) and maximum roughness (Rmax) of untreated and plasma-treated PP meshes, 
computed from (600×600) nm AFM images. 
 
Roughness of untreated and plasma-treated PP 
fibres  
 Rrms  
(nm) 
Rmax 
(nm) 
Average height 
(nm) 
Untreated PP 5.8 27.8 14.0 
0.35 s corona plasma-treated PP 8.7 37.9 19.1 
1.75 s corona plasma-treated PP* 20.3 99.3 49.9 
3.5 s corona plasma-treated PP 18.3 77.9 39.0 
60 s low pressure-treated PP 6.6 30.3 15.0 
* Highest roughness achieved by plasma treatment 
 
The change observed on the surface topography of the PP fibre after corona plasma 
treatment has also been described in a previous study on the modification of surface 
properties of polypropylene (PP) film using glow discharge air plasma (Pandiyaraj, 
2009). Like the apparition of roughness on the PP surface observed in this PhD. Thesis 
with corona plasma treatment, untreated PP surface is described as smooth one 
(Pandiyaraj, 2009), and the surface roughness of the PP film increased after the glow 
discharge plasma treatment even for shorter exposure time (2–10 min). The etching 
effect produced by the plasma treatment results in protrusions, with similar shape as 
observed in this work. For longer treatment time, from 10 min to 20 min, protruding 
spikes get flattened due to continued etching. This behavior supports the use of short 
plasma treatment times to achieve higher roughness, and therefore a larger apparent 
surface of the PP fibre to attach molecules. A major apparent surface implies a higher 
availability of bonding sites regarding the loading of the drug, in this case ampicillin.  
 
Low pressure 
 
The surface topography of PP meshes treated by low-pressure plasma for 60 s at 30 
L/min of gas flow inside the chamber has been studied by SEM and AFM, and the 
respective micrographs are shown in Figure 76 and Figure 77. 
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Figure 76: Scanning Electron Micrographs of untreated (a) and low pressure plasma-treated PP fabrics 
for 60 s, 100 W, 30 L/min (b). 
 
The roughness of the low-pressure plasma-treated PP mesh (RRMS= 6.6 nm) is not significantly 
increased with respect to the untreated PP mesh, even if a wave-shaped pattern can be 
distinguished in the parallel direction of the fibre spinning, as observed in the SEM micrograph.  
 
 
Figure 77: AFM morphology of low pressure plasma-treated PP meshes for 60 s, 100 W and 30 L/min 
plasma conditions (a), with 3D reconstitution image (b). 
 
 
While untreated PP fibres present a smooth surface, the surface roughness of the 
polymer is clearly enhanced with corona plasma treatment times of 1.75 seconds 
and longer. The surface topography of the corona-plasma treated PP mesh presents 
a pattern of peaks and valleys, resulting from the combined effect of different 
mechanisms such as etching processes, photo oxidation and thermal oxidation that 
are taking place on the amorphous regions of the polymer. Low-pressure plasma 
treatment is milder and does not produce significant modifications on the surface 
topography of the PP fibres.   
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4.2.4. Influence of plasma treatment on the ampicillin loading 
 
Once characterized the surface effects of corona plasma and low pressure plasma 
treatments on the PP mesh, in this section their influence on the loading of ampicillin 
is analyzed. Loading of ampicillin from an aqueous solution at 4% (c.f. section 3.3.3.2) 
in the PP mesh has been studied in views of designing an antibiotic-loaded surgical 
mesh to avoid post-surgical infections. 
 
Corona plasma 
In this section the effects of corona plasma are investigated with regard to the 
impregnation of ampicillin. 
 
Table 26: Evolution of ampicillin impregnation percentage of the PP meshes as a function of corona 
plasma treatment time. Power supply at 100 W. 
 t (s) 
 0 0.35 1.75 3.5 7.0 
Impregnation 
(%) 
20.8 ± 2.9 38.0 ± 4.1 44.9 ± 2.2 59.5 ± 2.9 59.2 ± 5.8 
 
Evolution of ampicillin impregnation percentage of corona plasma-treated PP meshes 
at different plasma treatment time is presented in Table 26. Untreated PP presents a 
low impregnation percentage of 20.8%. With the increase of corona plasma 
treatment time, a better impregnation is achieved until a 59.5% for a plasma 
treatment time of 3.5 s, which corresponds to an ampicillin quantity loaded in the PP 
fibres 2.9 times higher than the untreated ones. The creation of C-O and C-N groups, 
mainly C-O groups, in the surface of PP fibres, observed by XPS in section 4.2.2, leads 
to an increase of the bonding sites for the ampicillin sodium salt in anionic form in the 
impregnation solution. 
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Longer corona plasma treatment time (7.0 s) does not lead to a significant 
improvement of the ampicillin loading, the same way that 7.0 s corona plasma 
treatment did not lead to an improvement of the wetting properties with respect to 
3.5 s plasma treatment as observed with the static contact angle in section 4.2.1, 
neither leads to an improvement of surface roughness, as observed by SEM and AFM 
in section 4.2.3. Therefore, for further studies related with the wetting properties, the 
surface topography and the impregnation percentage of ampicillin, 3.5 s corona 
plasma treatment will be considered as the optimal condition of corona plasma 
treatment to enhance such properties.   
 
This high impregnation can be related to the improved wettability of the materials. To 
study the relationship between the wetting properties of corona plasma-treated PP 
meshes and the loading of ampicillin in the PP fibres, ampicillin impregnation 
percentage has been represented as a function of the static contact angle of the 
corresponding corona plasma-treated mesh in Figure 78. 
 
Figure 78: Ampicillin impregnation percentage as function of the static contact angle of PP surface due 
to the corona plasma treatment. 
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Figure 78 shows a linear increase of the ampicillin impregnation percentage with the 
decrease of the static contact angle, corresponding to longer corona plasma 
treatment times. For the corona plasma conditions studied, this trend results in a 
linear fit for all plasma-treated samples.   
 
So, beside the increase of the specific area of the PP fibres achieved by corona plasma 
treatment, as observed by SEM and AFM in section 4.2.3, this comparative study 
between the evolution of the wetting properties and the impregnation percentage of 
the antibiotics reveals the importance and the predominance of the influence of the 
modified-surface chemistry on the improvement of the ampicillin impregnation. 
 
Low pressure plasma 
 
Different low pressure plasma conditions, varying plasma treatment time and gas flow, 
were tested with regard to ampicillin loading. Higher gas flow in plasma treatment 
could be related with higher density of reactive species in the plasma treatment, while 
higher plasma treatment time is related with a higher exposition time to such reactive 
species, and both parameters seem relevant since they could influence the 
impregnation percentage of the low-pressure plasma-tread PP meshes.  
 
To study the influence of the plasma treatment time on the loading of ampicillin in the 
fibre, gas flow (air) has been set at 10 L/min and plasma treatment time has been 
studied for 30, 60 and 180 seconds, while to study the influence of gas flow inside the 
chamber during the low-pressure plasma treatment, plasma treatment time has been 
set at 60 s and air flow has been studied for 10, 30 and 50 L/min as reported in Table 
27 and represented in 3D in Figure 79. 
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Table 27: Evolution of ampicillin impregnation percentage of the PP mesh with low pressure plasma 
treatment. Influence of plasma treatment time and gas flow (air) inside the chamber. Power supply 
fixed at 100 W.   
 Treatment time (s) 
30 60 180 
Gas flow 
(L/min) 
10 46.0 ± 1.1 69.0 ± 1.1 69.6 ± 5.0 
30 - 69.3 ± 7.1 - 
50 - 72.7 ± 0.1  - 
 
Ampicillin impregnation percentages of low-pressure plasma treated PP meshes show 
an improved impregnation for all the studied conditions regarding the untreated PP 
mesh (that presents a 20.8% ampicillin impregnation). While the variation of gas flow 
inside the chamber during the low-pressure plasma treatment of the samples does not 
lead to relevant differences in the loading of ampicillin in the fibres, it can be observed 
that the plasma treatment time has greater influence on the impregnation percentage 
of the antibiotic. For 30 s low-pressure plasma treatment, PP meshes show an 
ampicillin impregnation of 46.0%, increasing until 69.6 for 60 s plasma treatment that 
is to say 3.3 times more than the untreated mesh. 
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Figure 79: Evolution of ampicillin impregnation percentage of the PP mesh with low pressure plasma 
treatment. Error bars in Table 27. 
Results and discussion 
 
 
221 
 
 
Longer plasma treatment times (180 s or 300 s) do not further improve the loading of 
the antibiotic in the PP fibres , in parallel to the observations regarding the wetting 
properties shown in section 4.2.1. 
 
Low-pressure plasma treatment leads to an increase of the ampicillin impregnation 
percentage of the PP meshes. The improvement of the ampicillin loading depends on 
the plasma treatment time of the PP fibres, until 60 s plasma treatment, a condition 
in which ampicillin impregnation percentage is 3.3 times higher than that of 
untreated PP mesh. 
 
 
4.2.5. Influence of plasma treatment on the release of ampicillin from PP 
meshes 
 
In order to determine if the amount of ampicillin released from PP meshes could be 
modified by plasma treatment, release experiments were performed from untreated, 
corona plasma-treated and low-pressure plasma-treated PP meshes.  
 
Corona plasma 
 
The influence of the corona plasma treatment time on the release of ampicillin from 
PP meshes to an isotonic liquid media has been studied by means of “in vitro” release 
assays of 4 hours, following the protocol described in section 3.3.4. Ampicillin release 
from the PP mesh has been studied for PP meshes treated with corona plasma using 
air as gas for plasma generation during 0, 0.35, 1.75, 3.5 and 7.0 seconds.  
Figure 80a shows the ampicillin release percentage during the 4-hour release assay 
from corona-plasma treated PP meshes. Untreated PP mesh presents an instant burst 
release to reach a 74.0% of ampicillin released after one minute experiment, followed 
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by a stabilization, as the release after 4 hours achieves a 74.7% at the end of the 
release assay. 
 
Figure 80: Ampicillin release percentage during the 4-hour release assay from untreated and corona-
plasma treated PP meshes at different treatment times (a). Enlargement of the ampicillin release 
percentage during the first 15 minutes of the 4-hour release assay (b). 
 
Corona plasma-treated PP meshes show the same behavior, with burst release within 
the first minute of release as can also be observed in the enlargement of release 
kinetics profile in Figure 80b. However, the results of plasma-treated PP fibres show 
slightly higher ampicillin release from the PP meshes, reaching values of 84.6% for 3.5 s 
corona plasma-treated PP fibres at the end of the assay, so about 10% above the 
untreated ones.  Even if the improvement of the ampicillin release from the PP meshes 
seems to increase with plasma treatment time, the differences are not statistically 
significant. 
 
Figure 81 presents the accumulated release of ampicillin from the PP fibres to the 
isotonic liquid media at the end of the 4-hour release assay.  
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Figure 81: Maximum release percentage of ampicillin from corona plasma-treated PP meshes after 4-
hour experiment. 
 
 
It has been observed that both untreated and corona plasma-treated PP meshes 
present a burst ampicillin release in the first minutes of the assay. Anyhow, the 
corona plasma treatment improves the ampicillin release from the PP fibres, with an 
ampicillin release percentage of 74.7% for untreated PP fibres while for 3.5 s corona 
plasma-treated PP fibres it is of 84.6%, probably due to the improved contact with 
the receptor media due to 2 factors: a higher specific surface area and a better 
wettability. From these results, it can be concluded that corona plasma treatment 
has an influence on the ampicillin released amount. Nevertheless, corona plasma 
treatment of the PP mesh does not influence the release kinetics of the ampicillin 
with time, and does not slow down the burst release of ampicillin presented by the 
untreated mesh. 
 
 
 
Unfortunately, the new interactions generated with the plasma are not strong enough 
so as to significantly reduce the burst release observed. Thus, other strategies have 
been investigated to try controlling this pattern (see next section). 
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Low pressure plasma 
 
Figure 82 presents the influence of the gas flow during the low-pressure plasma 
treatment of the PP meshes on the release of ampicillin from such PP fibres. Ampicillin 
release percentage is represented for untreated PP meshes as well as for low-pressure 
plasma treated PP meshes at 10, 30 and 50 L/min of gas flow (air) during 60 seconds, 
with power supply set at 100 W. 
 
Figure 82: Influence of the gas flow during the low-pressure plasma treatment on the ampicillin 
release percentage from the PP meshes. Release kinetics of the 4-hour release assay of the antibiotic 
for untreated PP mesh and low-pressure plasma-treated meshes for 10, 30 and 50 L/min (a), with the 
cumulative release percentage of ampicillin from the meshes at the end of the release experiment. 
Plasma treatment time set at 60 seconds and power supply at 100 W. 
 
The untreated PP mesh presents an ampicillin release of 74.7% after 4 hours. Low 
pressure plasma treatment leads to a significant increase of the ampicillin release for 
the three gas flows studied. Final ampicillin percentage released improves 
progressively with gas flow. The major difference is reached for a plasma treatment 
with gas flow of 30 L/min, presenting an increase of + 15.8% of ampicillin release 
with respect to the untreated PP mesh. Above this value, no statistically significant 
differences could be recorded. 
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The influence of the plasma treatment time has also been studied on such release, 
setting gas flow at 10 L/min and power supply at 100 W. Low-pressure plasma has 
been studied for plasma treatment times of 30, 60 and 180 seconds and the results are 
reported in Figure 83. As in the previous cases, release follows a burst profile. 
 
Figure 83: Influence of the low-pressure plasma treatment time on the ampicillin release percentage 
from the PP meshes at 30 s, 60 s and 180 s (a). Accumulated release percentage of ampicillin from the 
meshes at the end of the release experiment. Gas flow set at 10 L/min and power supply at 100 W. 
 
Low pressure plasma treatment leads an increase of the ampicillin release with the 
plasma treatment time up to 85.9% until low-pressure plasma treatment time of 60 
s, presenting a difference of +11.2% of ampicillin release from the plasma-treated PP 
mesh respect to the untreated one. However, longer plasma treatment times (180 s) 
show lower ampicillin release than plasma treatment times of 30 s and 60 s, even if the 
value of ampicillin release for this condition remains improved respect to the 
untreated PP mesh.   
 
As observed with both types of plasma, plasma treatments only influence the 
amount of ampicillin released from the PP fibres, without affecting the release 
kinetics profile. 
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The improved behavior of both ampicillin impregnation and ampicillin release 
percentage from the PP fibres with plasma treatment could be explained by two 
factors: 
 Wettability 
 Interactions drugs-functional groups 
Plasma treatment leads to the creation of new oxygen and nitrogen-containing 
functional groups on the propylene surface, increasing the wettability as well as the 
availability and the variety of bonding sites for the ampicillin molecule with the 
polypropylene fibres. The presence of mainly C-O and C-N groups on the surface of the 
plasma-treated PP fibres allows increasing the possibility of interactions with the 
ampicillin since the two methyl groups of the ampicillin could establish hydrogen 
bonds with N or O atoms on the PP surface (Figure 84).  
 
 
Figure 84: Proposed interactions by H-bonds of ampicillin on the PP fibre surface for untreated PP (a) 
and plasma-treated PP meshes (b). 
 
On the one hand, both plasma treatments lead to the increase of the availability of the 
bonding sites with the incorporation of new grafted moieties on the fibre surface with 
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combined with the improved wettability lead to higher drug loadings. On the other 
hand, the bonds between the functional groups created on the polymer surface and 
the ampicillin are weaker than the interactions of the antibiotic directly with the 
macromolecular chain of carbon of the polymer, so with the improved contact with the 
release media derived from the better wettability, plasma-treated PP meshes have a 
lower ability to retain ampicillin in the PP fibre in the release assays.  
 
Air plasma treatment of the polypropylene fibres leads to the functionalization of 
the PP surface of new O and N-containing groups, improving the wettability, which is 
reflected by an improvement of the ampicillin loading in the plasma-treated PP 
meshes, for both corona and low-pressure plasma treatments. However, the new 
chemical bonds in the surface of the polymer and the bonding between ampicillin 
and polypropylene resulting from this modification of the surface chemistry are not 
sufficient to retain the drug, and the improved wettability leads to a higher 
ampicillin release from the fibres to the receiving isotonic liquid receptor. 
 
It has been shown that plasma-treated PP meshes can achieve a better released 
amount of drug than untreated PP meshes, and that much higher loadings can be 
obtained. However, in the development of biomaterial-based drug delivery systems, a 
great part of the attention is focused on slow- or controlled delivery systems in order 
to achieve an optimal therapeutic effect on a determined period of time. 
 
The release kinetics profile, that remains unchanged for both untreated and plasma-
treated PP meshes, needs to be modified to design an effective drug delivery system 
using this PP fibres as drug support. One potencial strategy to delay drug release could 
be to create a biocompatible plasma polymer coating on the ampicillin-loaded PP 
fibres, with the aim that it may act as a membrane by limiting the diffusion of the 
antibiotic. 
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In implantable materials, cell adhesion is a highly relevant parameters towards the 
response of the host tissue to the implant. It has been shown in the previous sections 
that plasma treatments, improved the wettability and the roughness – and therefore 
the adhesion – of the PP meshes. To keep unaltered the biological response to the 
materials, the creation of an antifouling layer could be of great interest, and plasma 
polymerization a mean to obtain such coating of the PP fibres.  
 
4.2.6. Plasma polymerization of PP meshes 
 
The purpose for the use of plasma polymerization is twofold: 
1. To create a thin biocompatible film on the ampicillin-loaded PP fibres which can 
slow down the release kinetics of ampicillin, acting as a retention membrane to 
avoid a quick release of the drug in the first minutes of the assay. 
2. To create an antifouling layer on the polymer surface to keep cell adhesion 
unaltered with respect to the untreated PP meshes which are widely used in 
clinics with success.  
 
The use of plasma polymerization to achieve this coating is justified for three main 
reasons: 
o To continue having a complete dry process, using environmentally friendly 
technique. 
o To prevent that the active principle previously loaded into the fiber is released 
as it could happen via a wet process. 
o To prevent degradation of the drug using wet chemical processes.  
 
For further in vivo and in vitro studies and applications, a low immune response in 
tissue (histocompatibility) and good blood compatibility (hemocompatibility) are the 
most important properties for biocompatible materials (Goddard, 2007; Ratner, 2007; 
Williams, 2008). Poly(ethylene glycol) (PEG) polymer is a well-known coating material 
in biomedical applications that acts as an effective repellent against proteins and cell 
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adsorption, offering sufficient biocompatibility (Choi, 2013b). As such, the Food and 
Drug Administration (FDA) has approved the PEG polymer for human use. Deposition 
of PEG plasma coating on different substrates has been carried out by plasma 
polymerization using tetraethylene glycol dimethyl ether (tetraglyme) as precursor 
(Goessl, 2001a; Goessl, 2001b; Choi 2013), but there are no precedents of using it on 
PP meshes as barrier layer for drug release.  
 
In this PhD. Thesis, to study the effect of the deposited coating on the release of the 
antibiotic from the PP fibres and observe if such deposited biocompatible coating is 
able to slow down the release kinetics previously observed from the PP surgical 
meshes, PEG coating by plasma polymerization of ampicillin-loaded PP meshes has 
been carried out for untreated and 3.5 s corona plasma treated PP meshes (Figure 85).  
 
Plasma polymerization of PEG from tetraglyme as precursor has been performed 
during 1 hour after a surface activation of the fibres by argon plasma, as described in 
section 3.3.2.3. The choice of these two ampicillin-loaded PP meshes for this study not 
only rests upon the results achieved by 3.5 s corona plasma treatment on the surface 
chemistry but also on the topography of the sample.  Indeed, while the untreated PP 
mesh presents a relative flat surface (RRMS= 5.8 nm), 3.5 s corona plasma treated PP 
meshes presents a higher roughness with the apparition of protrusions until 77.9 nm 
height, and both types of PP samples could be interesting regarding the deposition of 
PEG coating in surface of the fibres since the topography could affect the uniformity of 
the deposition of the biocompatible polymer. 
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Figure 85: Concept beyond the PEG coating of the ampicillin-loaded PP meshes proposed in views of 
creating a retention membrane allowing slowing down the release kinetics of ampicillin from the 
fibres. Stages of the designed of the textile-based antibiotic delivery for untreated PP (a) and corona 
plasma-treated PP surgical meshes (b). 
 
 
As in previous section, wetting properties of the PEG-coated PP material has been 
evaluated on PP film due to the open structure of the surgical mesh. The 
measurements of the static contact angles on uncoated and plasma-coated PP films 
are reported in Table 28. 
 
Table 28: Comparison of the static contact angles of untreated and 3.5 s corona plasma-coated PP film 
PEG-coated with the uncoated ones. 
PP film tplasma (s) 
θs (º) 
0 s 3.5 s 
Uncoated 124.38 ± 2.51 27.17 ± 3.19 
PEG-coated 77.92 ± 3.42 ≈ 0 
 
The decrease of the static contact angle of - 46.5% between the untreated PP film and 
the untreated PP film PEG-coated reflects a change in the surface chemistry of the PP 
material, maybe due to the deposition of the PEG coating on the surface of the PP 
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material. To quantify this modification of the surface chemistry, XPS analysis has been 
performed. 
 
Figure 86 shows the general spectra of the untreated PP mesh PEG-coated and 3.5 s 
corona plasma-treated PP mesh PEG-coated during 1 hour.  
 
 
Figure 86: General XPS spectra of untreated PP mesh PEG-coated (a) and 3.5 s corona plasma-treated 
PP mesh PEG-coated (b). 
 
Surface elemental composition computed from the general spectra and atomic ratios 
are reported in Table 29 for uncoated or PEG-coated samples either untreated or 
previously trated with corona plasma for 3.5 s.  
 
 
Figure 87: Polyethylene glycol (PEG) chemical structure. 
 
While surface chemistry should show a theorical percentage of carbon and oxygen of 
66.6% / 33.3% for a homogenous deposition of PEG coating in the surface of the PP 
mesh, surface chemistry of the untreated PP mesh submitted to plasma 
polymerization shows percentages of 83.8% / 15.5%.  
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Table 29: Surface elemental composition and atomic ratios of untreated and plasma-treated PP 
meshes PEG-coated. 
Sample 
Chemical composition (%) Atomic ratios 
C1s N1s O1s Si2p O/C 
Untreated  84.0 0.3 10.0 5.8 0.12 
3.5 s corona plasma-
treated  
79.7 0.7 18.5 1.1 0.23 
Untreated + PEG 83.8 0.1 15.5 0.6 0.18 
3.5 s corona plasma + PEG 81.2 <0.1 18.8 <0.1 0.23 
 
Surface chemistry of plasma treated PP mesh PEG-coated presents a similar 
relashionship in its atomic composition with the uncoated ones. This behavior 
indicates that the conditions used for plasma polymerization possibly lead to the 
deposition of a very thin PEG film, below the depth of detection of the XPS technique, 
with analyzes the first 10 nm of the surface, so the measurement is also taking into 
account C atoms proceding from the PP fibre.  However, the decrease observed for the 
Si compounds on the surface of the mesh from 5.8% for the untreated PP mesh to 0.6 
% for untreated PP mesh PEG-coated could indicate either the deposition of a thin film 
on the surface of the polymer, or an etching effect by Ar radicals during plasma 
polymerization. Also, the O/C ratio of plasma-polymerized PP meshes points out to the 
deposition of a PEG-like film, since its value (O/C = 0.2) is comparable with other works 
related with surface characterization of plasma-polymerized polyethylene glycol thin 
ﬁlm on a PP film (Choi, 2013a; Choi, 2013b). 
 
Modification of the carbon functional groups present in surface of the PP fibres with 
the plasma polymerization has been studied from the deconvolution of the C1s high 
resolution XPS spectra of the untreated and 3.5 s corona plasma-treated PP meshes 
PEG-coated for 1 hour plasma polymerization, as presented in Figure 88.   
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Figure 88: C1s high-resolution XPS spectra of the untreated (a) and 3.5 s corona plasma-treated (b) 
meshes PEG-coated for 1 hour plasma polymerization. 
 
It can be observed that the deconvolution of C1s peak results in 4 sub-peaks (Figure 
88), while the uncoated PP meshes presented only 2 peaks (Figure 71) issues from the 
deconvolution corresponding to C-C, C-H and C-O, C-N functional groups, respectively 
centered in bonding energies of 284.8 eV and 286.16 eV. For PEG-coated PP fibres, 
both sub-peaks still appear in major proportion with 2 new peaks centered in bonding 
energies of 287.22 eV and 288.66 eV, corresponding to bonding energies of C=O and 
COOH groups, respectively. Relative quantification of these carbon functional groups in 
the surface of the PEG-coated PP meshes is presented in Table 30. 
 
Table 30: Fraction of carbon functional groups from high-resolution C1s XPS peaks for untreated and 
3.5 s corona plasma-treated PP meshes PEG-coated for 1 hour plasma polymerization. 
Sample 
Relative chemical bonds (%) 
284.76 eV 286.16 eV 287.22 eV 288.66 eV 
C-C, C-H C-O, C-N C=O COOH 
Untreated + PEG 86.80 6.64 2.29 4.27 
3.5 s corona plasma + PEG 84.66 7.14 4.56 3.64 
 
 
While the untreated PP mesh presented a relation between C-C, C-H groups and C-O, 
C-N groups of 97.72 % / 2.28 % and the 3.5 s corona plasma treated-PP mesh of 93.2% 
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/ 6.80% (Table 24), the PEG-coated meshes present a lower proportion of C-C, C-H 
groups, which could result from the deposition of new material combined with the 
coating on the PP fibres that “hides” the C-C and C-H groups of the macromolecular 
chain of the polymer. The presence of this coating of the surface of the PP textile 
material as consequence of the plasma polymerization is also supported by the 
apparition of the C=O and COOH groups in similar proportion, as also observed in other 
works on PEG-like coating by plasma polymerization (Choi, 2013a; Menzies, 2011). 
  
As for uncoated PP surgical meshes, AFM and SEM techniques have been used to study 
the changes in morphology of the PP fibres resulting from the PEG coating by plasma 
polymerization, as it can be seen in Figure 89 and Figure 90. Determination of the 
average surface roughness, maximum surface roughness and avergage height of the PP 
fibre has been done from AFM analysis by a statistical analysis of 10 000 points 
computing from the surface (Figure 93a), and results are reported in Table 31.  
 
 
Figure 89: Scanning Electron Micrographs of untreated PP mesh PEG-coated. 
 
Untreated PP meshes PEG-coated by plasma polymerization presents an average 
roughness of the fibre surface similar to the untreated PP mesh observed in section 
4.2.3. The untreated PP mesh PEG-coated presents a Rrms value of 6.6 nm while the 
uncoated PP mesh presented a Rrms value of 5.8 nm. However, the surface of the 
coated fibre is not as flat as the untreated one and presents a surface morphology with 
a pattern comparable with the effects of the treatment of the PP fibres with low-
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pressure plasma treatment. Plasma polymerization, carried out in a low-pressure 
reactor, leads to a wave-shaped surface of the PP fibres.  
 
 
 
Figure 90: AFM pictures of PEG-coated untreated PP mesh with its 3D reconstitution for (600×600) nm 
(a)(b), with (600×600) nm enlargements (c)(d) . 
   
 
Otherwise, the absence of agglomerates in the fibre surface indicates, if the PEG 
coating has been depositied as desired, that the deposition of such coating of the PP 
mesh has been done in a homogeneous way.  
 
Figure 89 and Figure 90 present the surface topography of 3.5 s corona plasma-treated 
PP mesh PEG-coated observed respectively by SEM and AFM. As done for untreated PP 
mesh, determination of the average surface roughness, maximum surface roughness 
and avergage height of the PP fibre has been done from AFM analysis by a statistical 
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analysis of 10 000 points computing from the surface (Figure 93b), and results are 
reported in Table 31. 
 
 
 
Figure 91: Scanning Electron Micrographs of PEG-coated 3.5 s corona plasma-treated PP mesh. 
 
 
Figure 92: AFM pictures of 3.5 s corona plasma-treated PP mesh PEG-coated with its 3D reconstitution 
for (600×600) nm (a)(b), and (200×200) nm enlargements (c)(d). 
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Corona plasma-treated PP meshes PEG- coated show a pattern similar to the uncoated 
corona plasma-treated samples, with peaks and valleys resulting from the apparition 
of protrusions in the corona plasma treatment of the PP meshes due to the sparks of 
the corona plasma. The observation of these protrusions suggests that the low 
pressure plasma polymerization does not affect the surface morphology. However, the 
increased of the roughness observed by AFM, from RRMS= 18.3 nm to RRMS= 30.2 nm 
between uncoated and PEG-coated PP mesh, as well the wave-shaped pattern 
distinguished in the valleys as observed by SEM (Figure 91), indicate that plasma 
polymerization affects the morphology of the surface of the PP fibres and result in a 
combined effect of the previous corona plasma treatment of the surgical mesh and of 
a low pressure plasma treatment. All these topographical effects can be attributed to 
etching by the Ar species of the carrier gas, which, after such a long treatment, 
produce very significant effects. 
 
 
 
Figure 93: Roughness analysis of PEG-coated untreated PP mesh (a) and PEG-coated 3.5 s corona 
plasma-treated PP mesh (b). Relative repartition of height of the analyzed surface from (600×600) nm 
AFM pictures. 
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Table 31: Average (Rrms) and maximum roughness (Rmax) for PEG-coated untreated PP mesh and 3.5 s 
corona plasma-treated PP mesh from (600×600) nm images.  
 Roughness of PEG-coated PP fibres (nm) 
 Rrms 
(nm) 
Rmax 
(nm) 
Average height  
(nm) 
Untreated PP 5.8 27.8 14.0 
3.5 s plasma treated PP 18.3 77.9 39.0 
Untreated PP PEG-coated 6.6 29.1 14.5 
3.5 s plasma treated PP PEG-coated 30.2 137.4 68.1 
 
 
Low-pressure plasma polymerization of the PP meshes leads to a pattern of surface 
morphology that combines the surface morphology of the uncoated PP mesh with 
the pattern observed for low-pressure plasma treatment of the polymer material. 
This results in a wave-shaped pattern for untreated PP mesh PEG-coated, and in a 
peaks and valleys pattern, with wave-shaped topography in the valleys, for 3.5 s 
corona plasma-treated PP mesh PEG-coated by plasma polymerization for 1 hour. 
Regarding the roughness, while plasma polymerization does not achieve significant 
difference for untreated PP mesh, average and maximum roughness are increased 
1.7 times for corona-plasma treated PP meshes. 
 
 
Subsequently, ampicillin release kinetics of PEG-coated PP meshes have been 
performed with untreated and 3.5 s corona plasma-treated PP mesh loaded with 
ampicillin following the impregnation process described in section 3.3.3.2. The stability 
of the ampicillin has been check by means of spectrophotometry technique to observe 
if the polymerization of the ampicillin-loaded PP meshes affects the molecule of the 
antibiotic. The general spectrum of the ampicillin released to the isotonic medium (pH 
7.4) from impregnated PP fibers has been compared with those of the ampicillin 
released from impregnated PP fibres and PEG-coated by plasma polymerization (Figure 
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94). The overlapping of the two spectra shows there is no difference in the released 
ampicillin after PEG coating by plasma polymerization. 
 
 
Figure 94: Study of the stability of the ampicillin by UV-spectrophotometry. Comparison of the general 
spectra of ampicillin released from untreated PP mesh PEG-coated by plasma polymerization with 
those released from untreated PP mesh. 
 
 
 Figure 95 presents the release kinetics of ampicillin from untreated PP mesh and PEG-
coated untreated PP mesh, submitted to a plasma polymerization during 1 hour. The 
general spectra of the ampicillin released from the untreated PP mesh fits the spectra 
of the ampicillin molecule in aqueous solution, indicating that the ampicillin loaded to 
the PP mesh has not been altered in the loading process. Ampicillin release kinetics 
from the PEG-coated untreated PP mesh presents the same shape regarding the 
release kinetics profile than the uncoated one, revealing a similar release mechanism 
between both samples.  
 
As for the uncoated PP fibres, PEG-coated PP meshes show a burst release of ampicillin 
in the first minute of the release assay, pointing that plasma polymerization of PP 
fibres during 1 hour does not achieve slowing down the release kinetics as the 
designed process had been aimed for.  
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Figure 95: Ampicillin release percentage during the 4-hour release assay from untreated PP mesh and 
untreated PEG-coated PP mesh (a) with the enlargement of the ampicillin release percentage during 
the first 15 minutes of the release assay (b). 
 
 
However, the maximum release percentage after 4 hours of release assay decreases 
slightly for PEG-coated PP meshes, presenting a value of 61.8% while the uncoated one 
presented a final value of 74.7%.  
 
Results of ampicillin release percentage from the 3.5 s corona plasma-treated PP 
meshes PEG-coated for 1 hour are presented in Figure 96. Just as for untreated PP 
mesh PEG coated, plasma polymerization for 1 hour of the 3.5 s corona plasma-treated 
PP mesh loaded with ampicillin leads to a decrease of the ampicillin release from 
84.6% for the uncoated PP mesh to 68.5% for the PEG-coated PP mesh at the end of 
the release assay. This decrease of ampicillin release percentage after plasma 
polymerization of the PP meshes is even higher for corona-plasma treated PP fibres (- 
16.1%) than the untreated PP fibres (- 12.9%).  
 
Plasma polymerization of the untreated and corona plasma treated-PP meshes has 
also been performed during 2 hours has also been performed and it has been check 
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that this longer plasma polymerization neither slows down the ampicillin release 
kinetics. 
 
Figure 96: Ampicillin release percentage during the 4-hour release assay from 3.5 s corona plasma-
treated PP mesh and 3.5 corona plasma-treated PP mesh PEG-coated (a) with the enlargement of the 
ampicillin release percentage during the first 15 minutes of the release assay (b). 
 
Two interpretations of this behavior can be done: 
 The coating created by the deposition of PEG by plasma polymerization retains 
a part of the ampicillin, like a membrane. 
 A part of  the ampicillin has been removed by etching reactions with Ar species 
during the plasma polymerization process 
Beyond these interpretations regarding the decrease of ampicillin release percentage 
with the plasma polymerization, the unsolved problem to slow-down down the release 
kinetics of the ampicillin from the PP mesh and avoid the burst release effects also 
leads to three possible causes to explain the unchanged release kinetics. It could be 
come from the fact that: 
 No polymer layer has been deposited in surface of the fibre. 
 The PEG-coating layer is very permeable. 
 The PEG-coating layer quickly dissolved in the isotonic release media.   
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Crossing both analyses, with the results of surface chemistry by XPS, it can be 
concluded that plasma polymerization leads to the deposition of a very thin layer 
(below 4 nm). Focus Ion beam technique has also been used to try confirming the 
existence of the thin coating film of PEG by performing the cross-section of a plasma-
polymerized PP mesh but no coating could be observed. 
Regarding biocompatible polymeric coating of the PP mesh to slow down the burst 
release kinetics of antibiotics from the PP fibres, it has been described recently 
(Guillaume, 2012) how a commercially available polypropylene mesh was modified to 
minimize the risk of post-implantation infection, alike in this PhD. Thesis. This coating 
was composed of three layers containing ofloxacin and rifampicin dispersed in a 
degradable polymer layer made up of [poly(ε-caprolactone) (PCL) and poly(DL-lactic 
acid) (PLA)]. Drug release kinetics was managed by varying the structure of the 
degradable polymer and the multilayer coating. Sustained release of the two 
antibiotics from the coated mesh prevented mesh contamination for at least 72 h. 
Before optimized the antibiotics release system to obtain a sustained release of 72 
hours, a simple layer coating of PCL had been designed and the coated mesh no longer 
released significant amounts of antibacterial drugs after 24 hours. 
 
Solvent free low pressure plasma polymerization strategy was also recently used to 
develop multilayer biodegradable nanometric PCL-co-PEG (poly (ε-caprolactone)-poly 
(ethylene glycol) copolymer) coatings for the controlled delivery of cisplatin, an 
anticancer drug (Bhatt, 2013). The resulting multilayer PCL-co-PEG coatings drug 
delivery device, built on a model surface (silicon wafer), can be tailored in such a way 
to have controlled cell-surface interactions and barrier layer dependent release. 
Methylene Blue (MB) was used as a model to simulate the drug release kinetics and 
the nature of which was examined by using the Korsmeyer-Peppas model for polymer 
coatings to optimize the system. Barrier layer dependent release was investigated by 
varying the deposition time from 5 to 50 min. The results show that by gradually 
increasing the barrier layer thickness with deposition time, the MB released was 
slowed down. 
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These other works (Guillaume, 2012; Bhatt, 2013), using wet processes produce thick 
polymer layers able to slow down the release of antibiotics (rifampicin and ofloxacin) 
from PP fibres, in which antibiotics are contained in a biodegradable polymer layer 
acting as a matrix for the antibiotics. Thus, the strategy proposed in this work is 
adequate but being focused only in dry plasma processes, would require further 
improvement/optimization of the thickness of the polymer layer produced.   
 
 
4.2.7.  Influence of plasma treatment on antibacterial effect of PP mesh 
 
The application of antibiotics to some medical materials, like the surgical PP meshes 
for abdominal hernia repair used in this case, requires checking the conservation of the 
activity of the drug to study whether the previous plasma treatment of the mesh 
affects its antibacterial activity. The following section presents the in vitro evaluation 
of the antibacterial activity of the plasma-treated PP materials. 
 
Corona plasma 
 
Figure 97: Images of the inhibition area of ampicillin-loaded PP meshes Staphylococcus Aureus (a) and 
E. Coli (b). 
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To evaluate the evolution of the antibacterial activity with the plasma treatment, the 
inhibition areas tested for Staphylococcus Aureus and Escherichia Coli for corona 
plasma-treated PP meshes loaded with ampicillin are respectively presented in Figure 
98 and Figure 99. It has been verified using control samples that there is no inhibition 
area for untreated and plasma-treated PP meshes without ampicillin. The values 
presented are the average of at least 3 replicates. It has been verified using control 
samples that there is no inhibition area for untreated and plasma-treated PP meshes 
without ampicillin. 
Untreated PP mesh presents an inhibition area of 45.03 ± 8.29 mm2. Even if at short 
corona plasma treatment times (0.35 s and 1.75 s) there seems to be a decrease of the 
inhibition area with respect to the untreated PP mesh with ampicillin, there is not 
statistical significant difference between these three samples, confirming that 
antibacterial activity has been preserved after corona plasma treatment. 
 
Figure 98: Inhibition areas for corona plasma-treated PP meshes loaded with ampicillin, tested for 
Staphylococcus Aureus. Influence of plasma treatment time and subsequent plasma polymerization. 
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Figure 99: Inhibition areas for corona plasma-treated PP meshes loaded with ampicillin, tested for 
EEscherichia Coli. Influence of plasma treatment time and subsequent plasma polymerization. 
 
However, antibacterial activity of the ampicillin-loaded PP meshes tested for E. Coli. 
shows an increase of the inhibition area for the corona plasma-treated PP meshes with 
respect to the untreated mesh, from 402.6 ± 26.4 mm2 for untreated mesh to 752.4 ± 
45.4 mm2 for 3.5 s corona plasma treatment. This behavior can be related with the 
increased loading of ampicillin of the PP meshes obtained after corona plasma 
treatment. Including after PEG-based plasma polymerization of the corona-plasma 
treated PP meshes, this increased activity against E. Coli is conserved. Even if ampicillin 
has a broad spectrum of activity and is able to penetrate gram-positive and 
some gram-negative bacteria, the higher resistance of Staphylococcus Aureus against 
ampicillin could explained that no difference have been recorded between untreated 
and corona plasma-treated PP meshes. 
 
Low pressure plasma 
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Antibacterial activity has only been tested for Staphylococcus Aureus for low-pressure  
plasma-treated PP meshes loaded with ampicillin, and results are presented in Figure 
100, where the evolution of the inhibition areas have been studied as a function of the 
plasma treatment time and the gas flow (air) inside the chamber during the plasma 
treatment. 
 
 
Figure 100: Inhibition areas for low pressure plasma-treated PP meshes loaded with ampicillin, tested 
for Staphylococcus Aureus. Influence of plasma treatment time (a) and gas flow in the reactor (b). 
 
For low pressure plasma treatment, it has been checked that the gas flow in the 
reactor during plasma treatment does not affect the antibacterial activity against 
Staphylococcus Aureus (Figure 100b). The same trend is observed with the plasma 
treatment times, with only one significant difference observed for the longest plasma 
treatment time probed corresponding to 180 s (Figure 100a), since the plasma-treated 
mesh present a bigger inhibition area with respect to the other ones.     
 
As determined by bacterial assays, the biological activity of the antibiotic against 
E.Coli and Staphylococcus Aureus was conserved after the different plasma 
treatments performed on the surgical PP meshes, and it has even been improved 
against E.Coli with corona-plasma treated PP meshes.  
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4.2.8. Influence of plasma treatment on cell adhesion 
 
Cell adhesion plays a role in tissue and organ formation, in the generation of traction 
for the migration of cells, and it also important in determining the biocompatibility of 
synthetic implant materials. For example, the adhesion of microbial cells to surfaces is 
believed to be critical step in the pathogenesis of device-centered infections (Lamba, 
1998) and designing materials with controlled surface properties is a key element in 
basic and biomedicine applied research (Antonini, 2014).  
One of the aims of the present work is designing materials with controlled surface 
properties that are fundamentals in basic and biomedicine applied research, mostly 
using surgical mesh aimed for implants. In this respect, the surface chemistry and 
topography are the two major elements found to affect the cell adhesion to the 
biomaterial surface (Sardella, 2008). A lot of studies are done to separate the relative 
importance of these two factors with the help of pre formed structures to check the 
intrinsic effects of surface topography and the presence of a well defined chemistry. It 
was demonstrated that the surface roughness induces beneficial effects on cell 
proliferation (Pistillo, 2009). As for the chemistry, it is known that it influences the 
hydrophilic/hydrophobic character of the substrate. It is generally assumed that 
hydrophilic surfaces stimulate cell adhesion (Altankov, 2000; Antonini, 2014). 
Therefore, the study of the cell adhesion on the plasma-modified surgical PP meshes is 
necessary with views on the use of such meshes as implants. 
The following preliminary results have been performed by the research group “Grup 
de Recerca en Cirurgia General – Vall d’Hebron Institut de Recerca” through an 
ongoing collaboration. Therefore, the following section does not present the results 
exhaustively, but only the main effects are shown as an indication of the performance 
of the materials developed.  
Initially, THP1 cells were seeded on the sterilized (Gamma radiation, 25KGy) PP 
materials with corona plasma treatment, with or without ampicillin loading, and after 
low pressure plasma polymerization treatments. Cell concentration and viability of the 
cell suspension were determined at different times (1, 2, 3, 4, 7 days). It has been 
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observed that cell morphology is not altered during incubation (confocal microscopy). 
In general, cells grow on all the materials studied and cell viability is maintained in all 
the meshes studied, so the plasma treated materials are non toxic for the cells.  
To evaluate cell adhesion on the PP fibres, 3T3 rat fibroblasts were seeded onto the 
sterilized PP meshes with the different treatments. After culturing for 5 days, staining 
was performed with Violet crystal and the cells were imaged (Figure 101).  
 
 
Figure 101: Cell adhesion to the PP fibres for untreated (a) and corona plasma treated for 3.5 s (b) 
meshes previously loaded with ampicillin. PEG-coating of the respective meshes (c) (d). 
 
While untreated PP fibers present a low cell adhesion (Figure 101a), corona plasma 
treatment of the PP mesh shows high fibroblast adhesion to the fibres (Figure 101b), 
which can be attributed both to the improved wettability and to the higher roughness 
of the fibre surface. Figure 101c and Figure 101d show the adhesion of fibroblasts to 
the PEG-plasma coated meshes, either untreated or 3.5 s corona plasma-treated PP 
meshes and loaded with ampicillin.  As shown in the images, the plasma coating of the 
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PP fibres with a PEG-like biocompatible thin film turns the cell adhesion back to the 
original level observed with the untreated mesh.   
 
Thus, it has been shown that the surface chemistry and topography have significant 
effects on the cell biological functions, such as adhesion and proliferation, as 
observed in previous works (Keselowsky, 2003; Keselowsky, 2004). Besides, it has 
been demonstrated that plasma polymerization of a PEG-like film on the PP meshes 
can be a technique a means to obtain fibre surfaces with controlled functionalities 
able to regulate cell adhesion.  
 
 
Figure 102: Effects of both (non- and polymerizing) plasma treatments on the antibiotic loading and 
the cell adhesion on the plasma-modified PP meshes. 
 
As shown in the previous section, this PEG coating does not affect the ampicillin 
loading and release from the PP fibres, and plasma-treated PP meshes still show an 
improved release to the isotonic liquid media respect to the untreated PP mesh. 
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Moreover, cultures with Staphylococcus Aureus and Escherichia Coli confirmed that the 
antibiotic activity was preserved, since the inhibition areas presented by the untreated 
and corona plasma-treated PP meshes coated by plasma polymerization do not show 
statistical significant differences respected to the uncoated PP meshes.   
 
Thus, the requirement of the subsequent PEG-like coating by plasma polymerization is 
completely justified since it does not affect the improved properties conferred by the 
first plasma treatment, and leads to obtaining a finished PP mesh those cell adhesion is 
low enough to allow its use as an implant avoiding cell proliferation on the textile 
material. The importance of both kinds of plasma treatments (non- and polymerizing) 
is summarized schematically in Figure 102.   
 
Thus, both kinds of plasmas, non- and polymerizing plasma treatments, are justified 
in the design of the finished product. The first plasma process improves the loading 
of the antibiotic in the PP mesh through surface functionalization and etching, while 
the second one allows maintaining a low cell adhesion to the PP fibres through 
deposition of a nanometric antifouling PEG-like layer. 
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5. CONCLUSIONS 
 
General conclusions 
 
Plasma treatments (either non- or polymerizing) can be considered as a relevant tool 
to confer an added value to textile materials for biomedical applications, as has been 
shown in this PhD. Thesis and is summarized in the following general conclusions: 
 Atmospheric and low-pressure plasma treatments with air of polymer fibres 
(PA66 and PP) lead to the modification of the surface chemistry and 
topography due to combined effects of surface functionalization and etching 
processes. 
 Functionalization of the polymer fibre surface mainly takes place through the 
introduction of O-containing groups, mostly C-O and C=O groups, which is 
related to an improved wettability of the textile material and provides more 
bonding sites for the attachment of an active molecule. 
 The modification of the surface topography of the polymer fibre results 
generally in the increase of the surface roughness, with the observation of 
distinct patterns as function of the kind of plasma treatment employed.  
 Since atmospheric and low-pressure plasmas present different energy 
transfers, modification of the topography and the surface chemistry greatly 
depends on the kind of plasma used for the treatment of the fibres, and the 
selection of one of them rests upon the compromise between the conferred 
properties, the improvement of specific properties and the application for 
which the textile material is aimed for.  
 The loading of an active molecule on the plasma-treated fibres varies as 
consequence of the modification of the physical and chemical properties of the 
fibre surface. The polarity of the desired active principle conditions the increase 
or the decrease of the loading of such molecule on the polymer fibre. 
 Both atmospheric and low-pressure plasma treatments, in optimized 
conditions, lead to a moderate modification of the release amount of the active 
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molecules from the textile materials, without affecting the mechanisms of the 
release kinetics. 
 Plasma polymerization of the drug-loaded fibres with a nanometric PEG-like 
coating allows switching down the increased cell adhesion observed with 
plasma-treated textile materials. 
 Combination of functionalization of the polymeric fibres by plasma treatment 
with plasma polymerization of biocompatible coating allows designing textile-
based biomaterials with improved properties, such as high drug loading and 
low cell adhesion.  
 
These general conclusions can be divided into two parts according to the textile 
material used and the application for which they are aimed for. 
 
Polyamide as textile support for topical applications 
 
 Untreated IF-PA66 presents a hydrophobic behavior in nature. The washing of 
the IF-PA66 fabrics greatly improves the wetting properties of the PA66 fabrics, 
with a decrease of 34.0 ˚ observed in static contact angle measurements. 
Corona plasma treatment also achieves an improvement of the hydrophilic 
behavior of the IF-PA66, with a decrease of 21.8 ˚ of the contact angle with 
short plasma treatment of 3.5 s. Moreover, when plasma treatment is 
combined with a previous washing of the polyamide fabrics, synergy is 
observed between both treatments, producing a further improvement of the 
wettability of PA66 fibres. 
 This improvement of wettability has been related with the modification of the 
surface chemistry and the introduction of new oxygenated groups grafted on 
the surface with both types of plasmas, with the most significant increase 
registered being in C=O groups, reflecting the functionalization process of PA66 
fibers by carbonyl groups. 
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 The presence of silicone-based finishing agents on the surface of the IF-PA66 
leads to significant differences between both kinds of plasma treatments. 
While low-pressure plasma treatment of IF-PA66 causes surface etching, 
removing the PDMS present in the fibre surface, corona plasma treatment of 
IF-PA66 promotes the thermomigration of these Si-based compounds from the 
bulk to the surface of the PA66 fibre, mainly due to higher local surface 
temperatures reached by the sparks of the corona plasma. Anyway, it has been 
shown by XPS for both types of plasmas that PDMS were etched by the plasma 
treatment, although they were not completely removed from the fiber surface. 
 Corona plasma treatment improved homogeneity of the surface topography by 
removal of the aggregates of the silicone-finishes present on untreated IF-PA66 
fibers. While no relevant topographic modifications at short plasma treatment 
times were detected in the W-PA66 fabrics, for both kinds of samples (IF-PA66 
and W-PA66), at the longest corona plasma exposure studied (3.5 s plasma 
treatment), some melt polymer and localized creasing of the fibres can be 
randomly observed on some isolate regions of the surface due to the sparks of 
the corona plasma. Low pressure plasma treatment did not produce 
remarkable changes on the topography of PA66 which, after any of the 
treatments evaluated under different gas flow rate conditions. Regarding the 
cleaning of the PDMS, it can be also underlined that the increase of gas flow or 
treatment time allows a more effective elimination of these products. 
 Corona plasma treatment of the IF-PA66 fabrics leads to an increase of the 
ketoprofen loading in the fibres, as well as an increase of the ketoprofen 
released. 
 Atmospheric plasma treatment leads to an increase of 10% of the ketoprofen 
release percentage after 24 h, which can be attributed to a better wettability of 
the textile material that allows improved exchange with the release media. 
 For both caffeine-loaded IF-PA66 and W-PA66 materials, corona plasma-
treated samples show higher release percentages, with no significant 
differences between the two different corona plasma treatment times 
evaluated. In all cases, burst release is recorded, up to 70% and 83% in the first 
hour for untreated and plasma-treated materials, respectively. This stage is 
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followed by a slower release up to 8 hours, without reaching the stationary 
stage in any of the samples, and thus, with potential for longer release. 
 Low pressure plasma treatment of IF-PA66 shows an increase of the caffeine 
release with the increase of gas flow. This behavior has to be related with the 
improvement of the wettability observed between plasma treated samples 
with increasing gas flow.  
 In general, plasma treatment of PA66 fabrics reduces the loading of caffeine 
and the other methylxantines, which may be related to the low polarity of the 
active principles and the increased electronegativity of the plasma treated 
PA66 surface.  
 The fundamental study with methylxantines showed that the polar surface of 
the methylxantines determines the increase in release percentage due to the 
plasma treatment. It can be observed that when the molecule has higher polar 
surface area, a much higher percentage is released after the plasma treatment 
with respect to the untreated sample due to the modified polarity of the fiber 
surface.  
 The implementation of the drug loading process directly to the industrial chain 
employing finished fabrics such as IF-PA66 can be considered viable for the 
loading of cosmetic active principles such as caffeine. 
 
Polypropylene as textile support for implantable drug delivery systems 
 
 Corona plasma and low pressure plasma have been used to modify PP meshes. 
Both plasma treatments can greatly change the surface chemistry of the PP 
fibre, as well as on its topographic morphology in the case of corona plasma 
treatment. The polar functional groups generated due to plasma treatment on 
the surface of polypropylene lead to increased wettability.  
 For both types of plasma treatments, analysis of XPS spectra of plasma-treated 
PP fibres with air revealed an increase of O atoms and O-based functional 
groups. However, while corona plasma treatment carries out the 
Conclusions 
 
 
264 
 
functionalization of the PP surface by grafting mainly oxygen atoms by covalent 
bonding with carbon atom of the PP fibres, low-pressure plasma treatment also 
increases the attachment of N atoms with the macromolecular chain of PP and 
achieves a functionalization with O and N atoms. Low pressure plasma 
treatment for 60 s (100 W, 30 L/min, 300 mT) maximized the increase in C-O, C-
N groups on the PP surface to 9.0%.  
 While untreated PP fibres present a smooth surface, the surface roughness of 
the polymer is clearly enhanced with corona plasma treatment times of 1.75 
seconds and longer. The surface topography of the corona-plasma treated PP 
mesh presents a pattern of peaks and valleys, resulting from the combined 
effect of different mechanisms such as etching processes, photo oxidation and 
thermal oxidation that are taking place preferentially on the amorphous 
regions of the polymer. Low-pressure plasma treatment is milder and does not 
produce significant modifications on the surface topography of the PP fibres.   
 The chemical and morphological changes made on surface of PP fibres lead to 
increase the hydrophilic properties and the apparent surface of the PP fibre, 
and allowing a better availability of bonding sites for subsequent attachment of 
molecules. 
 Untreated PP presents a low impregnation percentage of 20.8%. With the 
corona plasma at increasing treatment times, impregnation is progressively 
improved up to 59.5% for a plasma treatment time of 3.5 s, which corresponds 
to a 2.9 times higher ampicillin quantity loaded in the PP fibres than in the 
untreated ones. Low-pressure plasma treatment also leads to an increase of 
the ampicillin impregnation percentage of the PP meshes with treatment time 
up to 60 s, condition for which ampicillin impregnation percentage is 3.3 times 
higher than those of untreated PP meshes. 
 Both untreated and corona plasma-treated PP meshes present a burst 
ampicillin release in the first minutes of the assay. Anyhow, the corona plasma 
treatment improves around 10% the ampicillin release from the PP fibres, 
reaching 84.6% for 3.5 s corona plasma-treated PP meshes, probably due to the 
improved contact with the receptor media due to 2 factors: a higher specific 
surface area and a better wettability. Thus, corona plasma treatment has an 
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influence on the ampicillin release amount although it does not influence the 
release kinetics of the ampicillin with time, nor slows down the burst release of 
ampicillin presented by the untreated mesh. Low pressure plasma treatment 
also leads to a significant increase of the ampicillin release with the different 
conditions studied, up to an increase of + 15.8% with gas flow rates of 30 L/min 
with respect to the untreated PP meshes. 
 Low-pressure plasma polymerization of the PP meshes with Tegraglyme leads 
to very high wettabilities, and also a highly modified surface topography with 
complex patterns combining the different etching effects observed both for the 
corona plasma treatment and for the plasma polymerization treatment.  
 The PEG-coated PP meshes display a burst release of ampicillin, combined with 
a decrease of the percentage released which may indicate that the coating 
created by the deposition of PEG by plasma polymerization retains a part of the 
ampicillin, like a membrane, or that a part of loaded-ampicillin has been 
removed during the plasma polymerization process. Further research needs to 
be done in order to increase the thickness of the layer and achieve slowing 
down the release of the antibiotic from the PP fibres. 
 As determined by bacterial assays, the biological activity of the antibiotic 
loaded in the surgical PP mesh was conserved after the different plasma 
treatments performed on the fabrics. 
 The increased surface energy of plasma treated PP leads to high cellular 
adhesion which may not be adequate for in vivo use. The plasma 
polymerization treatment performed has been shown to produce low cell 
adhesive PP surfaces.  
 Thus, the combination of surface functionalization with subsequent plasma 
polymerization can be a means of obtaining PP meshes with improved 
antibiotic loading in the PP mesh, while maintaining low cell adhesion to the 
surface of PP fibres. 
  
 6. FURTHER INVESTIGATION LINES  
In view of the results of this work, some recommendations are proposed for possible 
future research: 
Polyamide as textile support for topical application 
- The studies on the modification of the fibre surface of the PA66 fabrics and its 
relevance on the loading of active molecules and their posterior release from 
such fibres can be extended by using other plasma gases or mixtures of gas, 
even other plasma reactors, to evaluate the kind of functionalization and 
determine if further improved conditions for the attachment of active 
molecules can be achieved. 
- Regarding the study of the release kinetics, the next step for the in vitro release 
experiments of the active principle from the PA66 fabrics could be the 
introduction of a synthetic membrane or skin in the design the release 
experiment, as a membrane between the fabric and the receptor isotonic 
liquid media.  
- Deeper and applied studies on the evaluation of the influence of environmental 
effects of the PA66 fabrics and the active principle stability, degradation and 
release such as sweat, temperature, humidity, etc. could be one approach to 
broaden the research. In this way, it could be designed release studies of 
ketoprofen or caffeine on animals.  
Polypropylene as textile for implantable drug delivery system 
- As for the PA66 fabrics, study of the modification of the fibre surface of the 
surgical PP mesh and its relevance on the loading of an antibiotic and its 
release from such fibres could be extended by using other gas for the plasma 
treatment or gas mixtures, to evaluate the kind of functionalization and 
determine if further improved conditions for the attachment of the antibiotic 
can be found.  
Further investigation lines 
 
 
267 
 
- Evaluation of other antibiotics, other plasma reactors or other biocompatible 
coatings to compare with the results obtained in this work can be one approach 
to enlarge the study. 
- In this PhD. Thesis, the importance of the plasma polymerization of a PEG-like 
thin film on the PP fibres to maintain a low cell adhesion on the surface of the 
corona plasma-treated fibres has been demonstrated. However, working on 
the optimization of the plasma conditions of the plasma polymerization (type 
of plasma, power, time, flow, pressure…) to obtain a polymerized film with 
desired thickness and permeability for the path of the antibiotic, this coating 
could be also exploited in the modulation of the release kinetics to slow down 
the release of the antibiotic. Even if it has been described in other works that 
biocompatible coating of polymeric fibres can be obtained by chemical way to 
act as a membrane to retain active principles, if the implementation of plasma 
polymerization could be carried out, it will allow obtaining a final product 
achieved only by dry processes. 
- Slowing down the release kinetics remains the main challenge to be solved to 
contemplate further pre-clinical and clinical studies. Release kinetics of the 
ampicillin on longer periods would have to be achieved to fulfill the 
specification of such polymeric surgical mesh regarding its role on the 
prevention and the contention of post-surgical infections and neusocomial 
diseases. 
- Regarding the biological aspect, complementary experiments regarding 
biological response and cell adhesion would have to be performed respectively 
with other kinds of cells, to have a more complete overview.  
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8. APPENDIX 
 
8.1. List of abbreviations 
 
AFM Atomic Force Microscopy 
CCD Camera-Coupled Device 
DDS Drug Delivery System 
FDA Food and Drug Administration 
FIB Focus Ion Beam 
HPLC High-Pressure Liquid Chromatography 
IF-PA66 Industrially-finished  Polyamide 6.6 
ISO International Standard Organization 
KP Ketoprofen 
LPP Low Pressure Plasma 
LSV Liquid-Solid-Vapor 
MB Methylene Blue 
MEDTECH Medical Textiles 
MD/CMD Machine Direction (MD)/ Cross Machine Direction (CMD) 
NSAID Non-Steroidal Anti-Inflammatory Drug 
OES Optical Emission Spectroscopy 
PA66 Polyamide 6.6 
PBS Phosphate Buffer Saline 
PCL Poly(ε-caprolactone) 
PCM Phase Change Materials 
PEG  Polyethylene glycol 
PES Polyester 
PDMS Poly-dimethylsiloxanes 
PLA Poly(-lactic acid) 
PP Polypropylene 
PTFE Polytetrafluoroethylene 
R&D Research and Development  
SEM Scanning Electron Microscopy 
UV Ultra-Violet 
XPS X-Ray Photospectroscopy 
W-PA66 Washed  Polyamide 6.6 
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8.4. List of techniques used in this PhD. Thesis 
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 Goniometry: Static contact angle  
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 UV-visible spectrophotoscopy 
 High-Pressure Liquid Chromatography (HPLC) 
 Antibacterial assays 
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8.5. Glossary 
 
Adhesion: Joining of two different materials. 
Adsorption: Physical attachment of foreign material on a surface. 
Anti-inflammatory: Substance or treatment that reduces inflammation. Anti-
inflammatory drugs make up about half of analgesics, remedying pain by reducing 
inflammation as opposed to opioids, which affect the central nervous system.  
Antibiotics: Types of medications that destroy or slow down the growth of bacteria 
and are used to treat infections caused by bacteria. 
Antibiotic prophylaxis: Prevention of infection complications using antimicrobial 
therapy (most commonly antibiotics). 
Atmospheric pressure plasmas: Typical atmospheric pressure plasma systems regroup 
corona discharges, dielectric barrier discharges (DBD) and plasma torches.  
Biomaterial:  Synthetic material used to replace part of living system or to function in 
intimate contact with living tissue (to improve its condition). 
Biocompatibility: Acceptance of an artificial implant by the surrounding tissues and by 
the body as whole. Ability of a biomaterial to perform its designed function with 
respect to a medical therapy, without eliciting any undesirable local or systemic effects 
in the host body and generating the most appropriate beneficial cellular or tissue 
response and optimizing the clinical relevant performance of the therapy. The 
biomaterial must not be degraded by the body environment, and its presence must 
not harm tissues, organs, or systems. If the biomaterial is designed to be degraded, 
then the products of degradation should not harm the tissues and organs. 
Burst release: Rapid release of drug. 
Cellulite: Unsightly skin dimpling that is frequently found on the thighs and buttocks of 
women. 
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Cold plasmas: Cold plasmas are divided in thermal plasmas, which regroup arc plasmas 
or plasma torches, and non-thermal plasmas, which include laboratory plasmas such as 
corona plasma, glow discharge, dielectric barrier discharge, low-pressure plasmas, etc. 
Contact angle (θ): Angle made when a drop of liquid spreads over a solid surface. It is 
governed by the balance of surface tension at various interfaces. 
Corona plasma: Corona discharge is characterized by bright filaments extending from a 
sharp, due to the high-voltage between two electrodes towards the substrate. 
Cosmetics: Care substances used to enhance the appearance or odor of the human 
body. They are generally mixtures of chemical compounds, some being derived from 
natural sources, many being synthetic. 
Cosmetotextiles: A cosmetotextile is a textile containing a substance or preparation 
intended to be released permanently on different parts of the epidermis and claiming 
one (or several) special property(ies) such as cleaning, fragrance, change in 
appearance, protection, upkeep or correcting body odors. 
Covalent bonding: Bonding of atoms or molecules by sharing valence electrons. 
Cream: Semisolid dosage forms that contain one or more drug substances dissolved or 
dispersed in a suitable base. This term traditionally has been applied to semisolids that 
possess a relatively soft, spreadable consistency formulated as either water-in-oil or 
oil-in-water emulsions. However, more recently the term has been restricted to 
products consisting of oil-in-water emulsions or aqueous microcrystalline dispersions 
of long-chain fatty acids or alcohols that are water washable and more cosmetically 
and aesthetically acceptable. 
Drug delivery system: A drug delivery system (DDS) is defined as a formulation or a 
device that enables the introduction of a therapeutic substance in the body and 
improves its efficacity and safety by controlling the rate, the time, and the place of 
release of drugs in the body. This process includes the administration of the 
therapeutic product, the release of the active ingredient, and the subsequent 
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transport of the active ingredients across the biological membranes to the site of 
action. 
Elastic-compressive sockings: Specific compressive hosiery designed to prevent the 
occurrence of venous disorders in the leg region and guard against their further 
progression.  
Etching (ablation): Action to remove material from a surface. 
Fibres: Materials characterised by high ratio of length to thickness. Fibres can be 
natural or man-made. 
Filament: Single strand of a natural or synthetic fibre. 
FDA (Food and Drug Administration): Government agency regulating testing, 
production, and marketing of food and drugs including medical devices within the 
United States. 
Foam: Emulsified systems packaged in pressurized containers or special dispensing 
devices that contain dispersed gas bubbles, usually in a liquid continuous phase, that 
when dispensed has a fluffy, semisolid consistency. 
Gel: Semisolid systems consisting of either suspensions composed of small inorganic 
particles or large organic molecules interpenetrated by a liquid. 
Hernia: Protrusion of an organ or the fascia of an organ through the wall of the cavity 
that normally contains it from within. As example, an abdominal hernia is a protrusion 
of the abdominal-cavity contents due to tissue that bulges out of a weak spot in the 
abdominal wall. 
Infection: Invasion by and multiplication of pathogenic microorganisms in a bodily part 
or tissue, which may cause desease and produce subsequent tissue injury and progress 
to overt disease through a variety of cellular or toxic mechanisms. Infections are 
caused by infectious agents such as viruses, viroids, and prions, microorganisms such 
as bacteria, nematodes, arthropods, fungi, and other macroparasites.  
Inguinal hernia repair: Surgical operation for the correction of an inguinal hernia. 
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Knitted fabric: Textile strcture created by interlocking yarns by means of needles. 
 
Laparoscopic hernia repair: Consists in a small cut (incision) made in or just below the 
navel. The abdomen is inflated with air so that the surgeon can see the abdominal 
organs. A thin, lighted scope called a laparoscope is inserted through the incision. The 
instruments to repair the hernia are inserted through other small incisions in the lower 
abdomen. Mesh is then placed over the defect to reinforce the abdominal wall. 
Lotion: Although the term lotion may be applied to a solution, lotions usually are fluid, 
somewhat viscid emulsion dosage forms for external application to the skin. Lotions 
share many characteristics with creams. 
Low pressure plasmas: Class of plasmas generated under atmospheric pressure. 
Medical textiles (MEDTECHs): Textile products for medical applications and hygiene. 
Mesh:  Interlaced structure / material made of a network of wire or thread. 
Nanotechnology: Branch of technology that deals with dimensions and tolerances of 
less than 100 nanometers. 
Non-wovens: Fabrics made from webs of fibres held together and then bonded by 
some method. 
Non-steroidal anti-inflammatory drugs (NSAIDs): Class of drugs that provides 
analgesic and antipyretic (fever-reducing) effects, and, in higher doses, anti-
inflammatory effects. The term nonsteroidal distinguishes these drugs from steroids, 
which, among a broad range of other effects, have depressing effects. 
Ointment: Ointments are semisolids intended for external application to the skin or 
mucous membranes. They usually contain less than 20% water and volatiles and more 
than 50% hydrocarbons, waxes, or polyols as the vehicle. Ointment bases recognized 
for use as vehicles fall into four general classes: hydrocarbon bases, absorption bases, 
water-removable bases, and water-soluble bases. Each therapeutic ointment 
possesses as its base one of these four general classes. 
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Open hernia surgery: Consists in a single long incision is made in the groin. If the 
hernia is bulging out of the abdominal wall (a direct hernia), the bulge is pushed back 
into place. If the hernia is going down the inguinal canal (indirect), the hernia sac is 
either pushed back or tied off and removed. After reducing the hernial sac into the 
abdominal cavity the defect is covered with a surgical mesh. 
Plasma polymerization: Coating by plasma polymerization is defined as the formation 
of polymer materials, on a surface, under the influence of plasma conditions. 
Polymer surface functionalization: Addition of chemical groups, small moieties, 
oligomers, and even other polymers (grafting copolymers) onto the surface or 
interface of a polymeric material. 
Polypropylene fibres: Polypropylene (PP) is the generic name of fibres constituted by 
linear macromolecules of saturated alifatic hydrocarbons, in which one of every two 
atoms has a methyl ramification, usually in isotactic configuration (-CH2-CH(CH3)-)n. 
Polyamide fibres (nylon): Chemical fibres formed from a polymer of synthetic linear 
macromolecules in which the chain is a sucession of amide groups, with a minimum of 
85% of them linked to alifatic or cycloalifatic groups. 
Powders: Solids or mixture of solids in a dry, finely divided state for external (or 
internal) use. 
Pressure: Ratio of force to the area over which that force is distributed. (1 Pa = 0.01 
mbar).  
Repeating unit: Basic molecular unit that can represent a polymer backbone chain. The 
average number of repeating unit is called the degree of polymerization. 
Route of administration: The path by which a substance / a drug may be administered 
into the body, such as intradermally, intrathecally, intramuscularly, intranasally, 
intravenously, orally, rectally, subcutaneously, sublingually, topically, or vaginally. 
Spark: Refers to the luminous phenomenon resulting from a disruptive discharge 
through an insulating material or to the discharge itself. 
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Spray: Products formed by the generation of droplets of solution containing dissolved 
drug for application to the skin or mucous membranes. The droplets may be formed in 
a variety of ways but generally result from forcing the liquid through a specially 
designed nozzle assembly.  
Stratum corneum: The stratum corneum is the outermost layer of skin that forms the 
main barrier for diffusion of the permeants through the skin. 
Surface tension (surface energy): Amount of free energy exhibited at the surface of a 
material. 
Surface activation: Modification of the surface of a polymer by attaching polar or 
functional groups to it. 
Surface roughness: The roughness is a measure of the texture of a surface. It is 
quantified by the vertical deviations of a real surface from its ideal form. If these 
deviations are large, the surface is rough; if they are small the surface is smooth.  
Suture: Material used in closing a wound with stitches. 
Topical drug delivery (or topical application): Topical drug delivery is the term used 
for localized treatment of dermatological condition where the medication is not 
targeted for systemic delivery. 
Topical aerosols: Products that are packaged under pressure. The active ingredients 
are released in the form of fine liquid droplets or fine powder particles upon activation 
of an appropriate valve system. A special form is a metered-dose aerosol that delivers 
an exact volume (dose) per each actuation. 
Topical solutions: Liquid preparations, that usually are aqueous but often contain 
other solvents such as alcohol and polyols that contain one or more dissolved chemical 
substances intended for topical application to the skin. 
Topical suspensions: Liquid preparations that contain solid particles dispersed in a 
liquid vehicle intended for application to the skin. 
Appendix 
 
 
293 
 
Transdermal drug delivery (or transdermal administration): Transdermal delivery is 
the term that is confined to a situation in which the drug diffuses through different 
layers of the skin into systemic circulation to elicit the therapeutic response. 
Transdermal delivery system: Transdermal delivery systems (TDS) are self-contained, 
discrete dosage forms that, when applied to intact skin, are designed to deliver the 
drug(s) through the skin to the systemic circulation. Systems typically comprise an 
outer covering (barrier), a drug reservoir that may have a drug release–controlling 
membrane, a contact adhesive applied to some or all parts of the system and the 
system/skin interface, and a protective liner that is removed before the patient applies 
the system. The dose of these systems is defined in terms of the release rate of the 
drug(s) from the system and surface area of the patch and is expressed as mass per 
unit time for a given surface area. With these drug products, the skin typically is the 
rate-controlling membrane for the drug input into the body. The total duration of drug 
release from the system and system surface area may also be stated. 
Wound dressings: Any material used for covering and protecting a wound.  
Wound healing: Intricate process whereby the skin (or another organ-tissue) repairs 
itself after injury. 
Woven fabrics: Fabrics that consist of two sets of threads, the warp and weft, which 
are interlaced at right angles to each other. 
